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Abstract
Abstract
Marine sponges have been an abundant source of new metabolites in recent years. The sym-
biotic association between the bacteria and the sponge has enabled scientists to access the
bacterial diversity present within the bacterial/sponge ecosystem. This study has focussed on
accessing the bacterial diversity in two Irish coastal marine sponges, namely Amphilectus fu-
corum and Eurypon major. A novel species from the genus Aquimarina has been isolated from
the sponge Amphilectus fucorum. The study has also resulted in the identication of an α–
Proteobacteria, Pseudovibrio sp. as a potential producer of antibiotics. Thus a targeted based
approach to specically cultivate Pseudovibrio sp. may prove useful for the development of
new metabolites from this particular genus.
Bacterial isolates from the marine sponge Haliclona simulans were screened for anti–fungal
activity and one isolate namely Streptomyces sp. SM8 displayed activity against all ve fungal
strains tested. The strain was also tested for anti–bacterial activity and it showed activity
against both against B. subtilis and P. aeruginosa. Hence a combinatorial approach involv-
ing both biochemical and genomic approaches were employed in an attempt to identify the
bioactive compounds with these activities which were being produced by this strain.
Culture broths from Streptomyces sp. SM8 were extracted and puried by various techniques
such as reverse–phase HPLC, MPLC and ash chromatography. Anti–bacterial activity was
observed in a fraction which contained a hydroxylated saturated fatty acid and also another
compound with a m/z 227 but further structural elucidation of these compounds proved un-
successful. The anti–fungal fractions from SM8 were shown to contain antimycin–like com-
pounds, with some of these compounds having dierent retention times from that of an an-
timycin standard.
A high–throughput assay was developed to screen for novel calcineurin inhibitors using yeast
as a model system and three putative bacterial extracts were found to be positive using this
screen. One of these extracts from SM8 was subsequently analysed using NMR and the cal-
cineurin inhibition activity was conrmed to belong to a butenolide type compound.
A H. simulans metagenomic library was also screened using the novel calcineurin inhibitor
high–throughput assay system and eight clones displaying putative calcineurin inhibitory ac-
tivity were detected. The clone which displayed the best inhibitory activity was subsequently
sequenced and following the use of other genetic based approaches it became clear that the in-
hibition was being caused by a hypothetical protein with similarity to a hypothetical Na+/Ca2+
exchanger protein.
The Streptomyces sp. SM8 genome was sequenced from a fragment library using Roche 454
pyrosequencing technology to identify potential secondary metabolism clusters. The draft
genome was annotated by IMG/ER using the Prodigal pipeline. The Whole Genome Shotgun
project has been deposited at DDBJ/EMBL/GenBank under the accession AMPN00000000.
The genome contains genes which appear to encode for several polyketide synthases (PKS),
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non–ribosomal peptide synthetases (NRPS), terpene and siderophore biosynthesis and ribo-
somal peptides. Transcriptional analyses led to the identication of three hybrid clusters of
which one is predicted to be involved in the synthesis of antimycin, while the functions of
the others are as yet unknown. Two NRPS clusters were also identied, of which one may
be involved in gramicidin biosynthesis and the function of the other is unknown. A Strepto-
myces sp. SM8 NRPS antC gene knockout was constructed and extracts from the strain were
shown to possess a mild anti–fungal activity when compared to the SM8 wild–type. Subse-
quent LCMS analysis of antC mutant extracts conrmed the absence of the antimycin in the
extract proving that the observed anti–fungal activity may involve metabolite(s) other than
antimycin. Anti–bacterial activity in the antC gene knockout strain against P. aeruginosa was
reduced when compared to the SM8 wild–type indicating that antimycin may be contribut-
ing to the observed anti–bacterial activity in addition to the metabolite(s) already identied
during the chemical analyses. This is the rst report of antimycins exhibiting anti–bacterial
activity against P. aeruginosa.
One of the hybrid clusters potentially involved in secondary metabolism in SM8 that displayed
high and consistent levels of gene–expression in RNA studies was analysed in an attempt to
identify the metabolite being produced by the pathway. A number of unusual features were
observed following bioinformatics analysis of the gene sequence of the cluster, including a
formylation domain within the NRPS cluster which may add a formyl group to the growing
chain. Another unusual feature is the lack of AT domains on two of the PKS modules. Other
unusual features observed in this cluster is the lack of a KR domain in module 3 of the cluster
and an aminotransferase domain in module 4 for which no clear role has been hypothesised.
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Objectives
Objectives
1. To assess the bacterial diversity of two Irish coastal marine sponges, namely Amphilec-
tus fucorum and Eurypon major using culture–dependent approach. By identifying the
symbiotic bacteria associated with these sponges it was hoped to generate additional
knowledge on the potential metabolites that they may produce. Thus by identifying
novel bacteria from these sponges it was hoped that new metabolites could be discov-
ered.
2. Screen the culturable bacteria associated with these sponge to identify potential bioac-
tive molecules and subsequently perform chemical analysis on these molecules.
3. Employ a genome–scanning based approach on a bacterial strain which displays an-
tibiotic activity to help identify the bioactive compounds being produced together with
the potential biosynthetic pathway for these metabolites.
4. Develop and validate a high–throughput assay to identify novel calcineurin inhibitors
using yeast as a model system. The aim is to use this assay to screen chemical libraries
of microbial extracts, libraries of known compounds and also metagenomic libraries.
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
x Lekha Menon Margassery
Chapter 1
Introduction
1.1 Natural Products as drugs
Chemical compounds produced by a natural or biological source such as microbes, plants
or animals are scientically termed as natural products (NP). Natural products have always
played an important role in the treatment and prevention of diseases. Crude extracts from
animals, plants and microbes have historically been used as medicines. This opened a new
arena for the pharmaceutical industries (Ganesan, 2008), who began to investigate NP as
a valuable source of therapeutics; resulting in the discovery of 877 new chemical entities
between 1981 and 2002 of which 49% were NP (Koehn & Carter, 2005). This conrmed the
widely held view that NP are good lead compounds for drug discovery.
1.1.1 Natural products for drug discovery
The number of new NP coming to market has declined over the last decade because the phar-
maceutical companies have focused their attention on the production of synthetic molecules
(Koehn & Carter, 2005). The reasons for this recent trend in the industry are both commercial
and scientic. Eli Lilly and Company, one of the pioneers in the area, who started developing
many β–lactam based antibiotics such as vancomycin, erythromycin, capreomycin amongst
others; ceased their NP based research because of low–throughput screening and decreasing
returns on their investment (Baltz, 2008).
Some of the limitations of the natural products for drug discovery are:
• The NP is often synthesized in small quantities and is required on a larger scale from
a product development time line perspective. Indeed the bottleneck in drug discovery
has always been the developmental process (Powledge, 2004).
• Rediscovery of known compounds.
• NP are often complex in structure.
1
1. Introduction 1.1 Natural Products as drugs
Due to these limitations, the screening of drugs from natural products has been revolutionized
to a larger extent in recent years (Lam, 2007). For a successful NP drug discovery programme
the following measures have to be implemented:
1.1.1.1 Streamlining the screening process of NP
Innovative and rapid screening techniques such as automating the extract preparation and
bioassay–guided fractionation is essential. Scientists from the US and China have devel-
oped an automated high–throughput system to fractionate NP from plants for drug discov-
ery. The study has yielded multiple hits for dierent assays (Tu et al., 2010). Separation
technologies such as high–pressure liquid chromatography (HPLC), solid–phase extraction
(SPE) with mass spectroscopy (MS) and nuclear magnetic resonance (NMR) are then used for
the purication, separation of extracts and also detection of bioactive compound from NP.
Scientists from Denmark recently developed a method called the “explorative solid–phase
extraction” (E–SPE) where a solid–phase column with orthogonal selectivities is used to ex-
plore the purication strategy. Dereplication of the metabolites is facilitated by feeding the
liquid chromatography–mass spectrometry (LCMS) with ionizable functional groups. This
method is compatible with a wide array of bioassays and also transferable between dierent
bioactives and organisms (Månsson et al., 2010). Cubist Pharmaceuticals recently launched a
program to scale–down their fermentations by using calcium–alginate macrodroplet beads in
their modied fermentation vessels with an engineered E. coli strain which contained multiple
antibiotic resistance markers to screen for the known antibiotics. This automation increased
the screening process enormously and this was scalable too (Baltz, 2008).
1.1.1.2 Improvement of NP sources
For a successful drug discovery from NP the source of the compound plays an important
role. Many of the compounds that have been launched on the market recently are mostly
microbial in origin. Additionally, there are more in various stages of clinical trials that have
anti–bacterial, anti–viral, anti–cancer and other activities. Hence narrowing the focus to-
wards microbes as a source of novel bioactivites could prove fruitful in future drug discovery
processes. A novel isolation technique would not only be helpful in the identication of novel
isolates but also in the identication of novel metabolites. With the resistance developing in
pathogens, there is an urgent need to develop new classes of antibiotics as many of the deaths
from clinical infections are currently associated with multi–drug resistant bacteria. There is
therefore a potential to curb this trend by focusing on bacteria from novel habitats (Coates
et al., 2011); (Kurtböke, 2010). Some of these could include marine habitats and the human
microbiome amongst others (Schmitt et al., 2011).
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1.1.1.3 Synthetic organic methodologies
NP are indeed quite complex in structure and it is this complexity that plays a critical role
in their development as drugs (Hong, 2011). Recently, many NP have been modied by total
synthesises resulting in a number of FDA approved drugs that are currently available on the
market. Some of the best examples include the development of the glycopeptide antibiotics
oritavacin and telavancin (Van Bambeke, 2006). For example: oritavacin is an analogue of
vancomycin that is currently under clinical trials (Tice, 2012).
Many industrial laboratories employ protocols involving mutation of the production strain
and subsequent screens to identify production strains with a higher yield of the required
product. For example scientists from Pakistan has shown an increase in the yield of alkaline
protease for leather dehairing by mutating the strain Bacillus licheniformis N–2. The strain
was then tested on goat skins and complete dehairing was observed and this coupled with
the fact that the skin was also intact indicated that the mutant had not modied the collagen
structure (Nadeem et al., 2010).
Industries also typically employ approaches which involve the redirection of primary metabo-
lic uxes by the introduction of genetic modications using recombinant DNA technologies.
Some of the genetic approaches that are used for the improvement of the secondary metabo-
lites especially produced by Actinobacteria include altering the metabolic ux, genome shuf-
ing, overexpressing structural genes and inducing resistance to several antibiotics (Olano
et al., 2008). With the combination of classical and molecular genetics, many new strains of
bioactive producing bacteria have been isolated and identied (Davies, 2011). The classica-
tion of the strains has also aided in dening the phylogenetic clades that helped in dening
the antibiotic classes.
With the advancement of many of the aforementioned new technologies and approaches, a
number of pharmaceutical industries has begun to refocus their drug discovery programmes
by targeting NP (Mishra & Tiwari, 2011). Some of these companies are listed in Table 1.1.
Table 1.1 : Natural products discovered by the pharmaceutical companies and their
present clinical status.
Adapted from (Sheridan, 2012).
Company Product sources Lead compound Indication Clinical status
Merlion Microbial, fungal, plant Finaoxacin Infection Phase 2
AnalytiCon Plant, microbes Libraries Not applicable Not applicable
Noscira Marine Tideglusib (NP–12) CNS Phase 2
Optimer Microbes Fidaxomicin Infection Approved
Recent reports indicate that there are around 100 NP derived compounds (Harvey, 2008) with
various biopharmaceutical applications with potential use as anti–cancer agents, immunosup-
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
3 Lekha Menon Margassery
1. Introduction 1.2 Systematics of the Phyla Actinobacteria
pressants, anti–infective, anti–inammatory, neuropharmacological, vaccine adjuvants (Rey-
Ladino et al., 2011) amongst others. Some examples and their mode of action are listed in Table
1.2 (Vaishnav & Demain, 2011); (Chin et al., 2006) .
Table 1.2 : Examples of natural products developed during these years showing their
phase of development.
Drugs Mode of action Clinical trials Product sources
CuracinA Antimitotic Pre–clinical Marine bacterium
Platensimycin Antibiotic Pre–clinical Whole cell screening
Tacrolimus Immunosuppressant Market Soil sample
Dolastatin10 Anti–cancer Phase II Marine bacteria
A recent survey indicates that over the past thirty years that NP comprise about 41% of the
newly approved drugs by the FDA (Figure 1.1). This has been possible due primarily to recent
developments both in the combinatorial chemistry and the molecular biology areas (Newman
& Cragg, 2012).
Figure 1.1 : Newly approved drugs.
N–Natural Product (biological, plant or NP derived drug), S–Synthetic drug, S/NM–Synthetic/NP-
mimic, S*–Made by total synthetis/pharmacore is a NP,V–Vaccine.
Data obtained from a recent study by Newman and Cragg (Newman & Cragg, 2012).
1.2 Systematics of the Phyla Actinobacteria
Microbes play a signicant role in the discovery of NP and it has been estimated that of the
23,000 currently known secondary metabolites, 42% are from Actinobacteria, 16% are from
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other bacteria and the rest are from fungi (Onkarappa & Kekuda, 2010); (Kurtböke, 2012). Thus
Actinobacteria are a phylum with an abundance of bioactives. Actinobacteria were initially
described as being morphologically similar to a fungus–like branching laments and so was
called the “ray fungi”. The dierent genera exhibit diversity in morphology, physiology and
metabolism. Their morphologies vary from coccoid (eg., Micrococcus) to fragmenting hyphal
forms (eg., Nocardia) or highly branched mycelia (eg., Streptomyces). Spore formation is not
ubiquitous and can range from zoospores to propagules. It is evident that the observed physi-
ological diversity may account for the production of extracellular enzymes and the numerous
metabolic products that they synthesize and excrete (Gao & Gupta, 2012).
Figure 1.2 : Phylogenetic tree for 98 actinobacterial specieswhose genomes have been
sequenced, based upon concatenated sequences for 35 conserved proteins.
The tree shown is based on neighbor–joining (NJ) analysis, and the numbers at the nodes represent
the bootstrap scores of the nodes.
Adapted from (Gao & Gupta, 2012).
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The members of this phyla are gram–positive with a high G+C content (>55mol% in genomic
DNA), which makes this strikingly distinguishable from the rest of the bacterial community
(Chater, 2006). They are free–living microbes that live in both terrestrial and marine habitat.
Some of the taxonomically important features that are importance while screening for novel
organisms that produce novel metabolites would be the cellular morphology, the shape and
colour of the mycelium, the presence of heat–resistant spore formers and distinguishable 16S
rRNA signatures (Adegboye & Babalola, 2012); (Ventura et al., 2007).
Currently there are 15 suborders and according to Watve and co workers predictive modelling
suggests that there may be up to 150000 bioactive molecules still to be discovered just from
Streptomyces genus alone (Watve et al., 2001). The phenotypic diversity is reected in the
genotypes (Manivasagan et al., 2010); (Zhang et al., 2008). Current taxonomical data suggests
that there are species of at least 4 of the genera which have linear chromosomes, including
Streptomyces, Rhodococcus, Gordonibacter and Kineococcus. They are distantly related to each
other and this suggests that this linearization may have evolved more than once during the
evolution of Actinobacteria (Figure 1.2).
1.2.1 Antibiotics produced by Actinobacteria
There are currently around 157 complete genomes which have been sequenced and 474which
are currently being sequenced from this phylum which will provide an abundant resource to
data. The genomic data reveals the genomic size diers signicantly within the same genus.
For example, the genome of M. smegmatis strain MC2155 is 7.0 Mb whereas the genome of
the pathogen M. leprae is only 3.27 Mb. However, the theory that the genome sizes may vary
to facilitate adaptations to environmental changes is debatable. The molecular marker that
is widely available to detect the branching patterns among dierent species is the 16S rRNA
gene. However, there is no unique feature that is characteristic among the taxa. Hence it is
essential to determine the unique properties of this phyla so that the species can be precisely
dened. Studies have shown traits such as conserved indels (insertions or deletions) in protein
sequences that is characteristic of the dierent groups of bacteria and are also helpful in
understanding their relationships. The presence of novel signatures in cytochrome–c oxidase
subunit I (CoxI), glutamyl–tRNA synthetase (GluRS), CTP synthetase and 23S rRNA in all
Actinobacteria species are distinctive indicating that these could be useful future molecular
markers (Gao & Gupta, 2005); (Gao et al., 2006).
The discovery of the rst Streptomyces antibiotic, Streptomycin in 1940s sparked much ini-
tial interest in this phylum. Since then Actinobacteria have been the source of many new
antibiotics and were particularly important in the period between 1940 and 1986 which is
often considered as the ‘golden age of antibiotics’ (Mahajan & Balachandran, 2012). A broad
spectrum of compounds are produced as secondary metabolites by Actinobacteria includ-
ing antibiotics, pigments, toxins, regulators and inhibitors of a signalling pathway, immuno–
suppressants, immuno–modulating agents, antitumor agents, pesticides, insecticides and en-
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zymes which nd utility in various bioconversions (Vaishnav & Demain, 2011); (Matsui et al.,
2012). The major genera that produce these wide range of biological activity are Streptomyces,
Saccharopolyspora, Micromonospora, Amycolatopsis and Actinoplanes (Onkarappa & Kekuda,
2010). A spectrum of biological applications are listed in Table 1.3.
Table 1.3 : Drugs produced by Actinobacteria.
Biological activities Name of the drugs Organism
Anti–bacterial Rosaramicin Micromonospora
Anti–fungal Brasilinolide A Nocardia brasiliensis
Anti–viral AM–2604 A Streptomyces A
Anti–protozoal Coronamycin Streptomyces sp.
Anti–helminthic Ivermectin Streptomyces avermectinius
It is clear that the biosynthetic pathways in this phylum have been evolving for about a billion
years and the possibility exists to harness the vast metabolic capabilities of these microbes
particularly targeting their ability to produce novel secondary metabolites (Baltz, 2008). This
phyla has always been attractive as cell factories or bioreactors for industrial, agricultural,
environmental and pharmaceutical applications. Recent advancement in the eld of biotech-
nology have resulted in the development of a number of host–vector systems for Actinobacte-
ria which allows for the highly reproducible production of recombinant proteins (Nakashima
et al., 2005). This has been possible due to two distinguishable characteristic features of this
phylum:
• They exhibit a unique metabolic diversity and enzymatic capabilities.
• They have a dierent genetic composition (eg., high GC content) unlike the conven-
tional host cells such as E. coli.
Some examples of currently available host–vector systems are shown in Table 1.4.
Table 1.4 : Expression vectors in Actinomycetes.
Adapted from (Nakashima et al., 2005).
Vectors Organism Inducers Location Levels of expression
pSH19 Streptomyces –caprolactum cytoplasm High–level
pTip Rhodococcus thiostrepton cytoplasm Expression at low temperature
pJAM2 Low level Mycobacterium acetomide cytoplasm Low level
Studies have shown that heterologous expression can provide the possibility for the produc-
tion of novel bioactives (Alduina & Gallo, 2012). For example, deletion of host gene clusters
in S. coelicolor induced overexpression of actinorhodin biosynthetic clusters in laboratory
strains (Zhou et al., 2012), while point mutations in the rpoB and rpsL genes are known to
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result in increased levels of antibiotic production (Talà et al., 2009). This indicates that gene
clusters may prove to be attractive targets for modulating heterologous expression levels in
Actinobacterial host systems, thereby facilitating the future development of streptomycete
hosts for high–level heterologous expression of novel products.
1.2.2 Secondary metabolism
The diversity of secondary metabolism in Actinobacteria is driven by a number of dier-
ent biological processes including horizontal gene transfer, point mutations, homologous
recombination, gene duplications/deletions/replacements and transposition events. As pre-
viously mentioned the genome of Actinobacteria range from 3–10 MB with 5–10% of their
coding capacity being devoted to Polyketide synthase (PKS) and Non Ribosmal Peptide Syn-
thetase (NRPS) genes which are involved in secondary metabolism. In addition, recombina-
tion events involving these functional gene clusters could have resulted in the production of
novel metabolites, some of which have bioactivity. One such example is the evolution of the
avermectin (an anthelmintic agent) biosynthetic pathway which appears to have occurred
by gene duplication and domain exchange with other PKS pathways present in S. avermitilis
(Baltz, 2008). Genome mining of this Streptomyces sp. subsequently revealed the presence of
24 additional PKS and NRPS clusters, the vast majority of which are yet unidentied. Some
antibiotics that involve PKS and NRPS enzymes in their biosynthesis include actinomycin,
bleomycin, antibiotic TA (myxovirescin) (Figure 1.3) (Walsh, 2004).
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Figure 1.3 : Examples of PKS/NRPS Antibiotics.
a) PKS–antibiotic TA (anti–bacterial agent), b) NRPS–actinomycin D (anti–cancer agent), c) Hybrid–
Bleomycin (anti–cancer agent). All these antibiotics are produced by the phyla Actinobacteria.
1.2.2.1 Polyketides
Polyketides are the products that are synthesised by a large family of multifunctional proteins
that are involved in the production of secondary metabolites. Some examples of metabolites
that originate via a polyketide pathway are erythromycin, nystatin, and doxorubicin. Polyke-
tide architectures are quite diverse resulting in a broad spectrum of compounds such as aro-
matic compounds, fatty acids, macrolides and many more.
PKS are structurally and functionally similar to fatty acid synthases (FAS) as both classes
catalyse the condensation of primary metabolites to form β–ketoacyl polymers that are linked
to the enzyme by thioester bonds. In FAS the condensation is followed by β–ketoreduction,
dehydration and enoyl reduction to yield a fully reduced fatty acid product but in PKS the
reduction steps are partly or completely avoided in a controlled fashion, resulting in a highly
diverse polyketide chain. PKS are categorized into three main groups, type I, type II and type
III based on the enzyme structure.
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Type I PKS
Type I PKS consist of multifunctional proteins with several individual functional do-
mains and are similar to eukaryotic fatty acid synthase. The mechanism involved is
described in Figure 1.4. Some of the compounds that are produced by Type I PKS in-
clude erythromycin, rapamycin, rifamycin amongst others. They are generally found in
bacteria and fungi (Cox, 2007). They typically contain seven dierent catalytic domains
namely acyltransferase (AT), acyl carrier protein (ACP), keto-synthase (KS), ketoreduc-
tase (KR), dehydratase (DH), enoylreductase (ER), and thioesterase (TE). Type I PKS are
further subdivided into iterative and modular type I PKS systems.
1. Iterative PKS
This type of PKS systems, typically found in fungi, have only a single set of do-
mains on a single polypeptide in which the active sites are reused repeatedly, as in
the case of eukayotic fatty acid synthesis. The iterative PKS are divided into nonre-
ducing PKS whose products are true polyketides such as aatoxins (Crawford
et al., 2008), partially–reducing PKS such as in asperlactone (Garson & Staunton,
1981) and highly–reducing PKS, such as the lovastatin PKS (Chiang et al., 2010).
2. Modular PKS
Modular PKSs are the most widely studied PKS system and they possess multi-
ple catalytic domains in which each active site is used only once. This class of
PKS is commonly found in bacterial systems. The two main modular PKS are the
AT-containing (cis) modular PKS, in which the AT domain is integrated into the
modules and AT–less (trans) modular PKS in which the AT activity is provided
by a separate enzyme. The trans–ATs so far identied are: free–AT, tandem ATs,
tandem AT with ER and AT coupled with ER (Keatinge-Clay, 2012) . The basic
steps involved in a modular PKS (cis and trans) are represented in Figure 1.4.
The simplest functional PKS consists of a KS, an AT, an ACP and a TE domain. The
domains that are responsible for the addition of a single ketide unit to the growing
polyketide and the following modication are termed as modules. The modules
observed in a PKS system are: a starter or a loading module that consists of AT–
ACP– which is usually acetyl–CoA or malonyl–CoA, followed by elongation by
repetitive decarboxylative condensations and modications such as ketoreduction
(ketoreductase (KR) domain), dehydration (dehydratase (DH) domain) and enoyl
reduction (enoyl reductase (ER) domain) by the elongation or extending module
–KS–AT–[DH–ER–KR]–ACP– where the elongation module is usually malonyl–
CoA, methylmalonyl–CoA or ethyl–malonyl–CoA that is loaded onto the current
ACP domain catalyzed by the current AT domain (the cycle is repeated for each
elongation step) and nally the release or the termination module catalysed by the
thioesterase domain–TE that hydrolyses the completed chain of polyketide from
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the ACP domain of the previous module.
Figure 1.4 : Biosynthesis of poyketides by Type I modular PKS (cis and
trans).
Adapted from (Piel, 2010).
This gure shows the biosynthesis of a hypothetical polyketide. Black lled circles rep-
resent the ACP domains. Biosynthesis is initiated when the AT selects the extender unit
and loads on to the ACP domain that forms a thioester bond. Biosynthesis proceeds by
the decarboxylation caused by the KS domain between the ACP and the polyketide inter-
mediate bound to ACP domain of the preceeding module. The chain elongates by loading
another ACP and the cycle continues. Some other modications such as dehydration, ke-
toreduction and enoylreduction caused by DH, KR and ER domains respectively are also
involved in the elongation process. All elongating modules have the core domains while
the loading module lacks a KS and the last module contains an additional TE domain that
releases the nished polyketide. All the AT domains in cis PKS systems are integrated
within the modules whereas for the trans–AT PKS, the architecture can dier substan-
tially from the one shown. In the gure, two trans ATs are represented: free AT and AT
coupled with ER. An additional (optional) domain MT (methyltransferase) is observed in
the trans AT pathway and loads a methyl group to the growing chain. KS: decarboxylat-
ing KS present in many loading modules; GNAT: acetyl-loading AT of the GCN5-related
N-acetyl transferase superfamily.
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Type II PKS
Type II PKS consist of an assembly of discrete enzymes analogous to bacterial type II
fatty acid synthases. The chain-length factor (CLF) homologous to a KS which forms a
heterodimer with the KS, the ACP and the malonyl CoA: ACP-transacylase (AT) forms
the minimal PKS (Watanabe & Ebizuka, 2004). Type II PKS catalyse the formation of
compounds that typically require aromatization and cyclization to complete the biosyn-
thesis, but not extensive reduction or reduction/dehydration cycles. Type II PKS sys-
tems are involved in the biosynthesis of bacterial aromatic natural products such as
actinorhodin, tetracenomycin and doxorubicin. They are mainly restricted to bacteria.
Type III PKS
Type III PKS are distinct in both structure and mechanism from the bacterial modular
Type I PKS and the dissociated Type II PKS. Type III PKS catalyses the assembly of PKS
by transfer of an acyl–group to the catalytic Cys, resulting in acyl-PKS complex (the
starter substrate) which then undergoes decarboxylative condensations with acyl–CoA
extender substrates (malonyl CoA) but without the involvement of ACPs. This is fol-
lowed by Claisen condensation of the active anion with the acyl moiety to generate an
acyl–CoA having an additional two-carbon unit followed by the extension of the PKS
chain by repetitive reactions of the steps mentioned above. Finally, the chain elonga-
tion of a CoA-linked starter substrate is usually followed by cyclization of the linear
intermediate in the same active-site cavity to generate various polyketide scaolds (Ri-
mando et al., 2007); (Savic & Vasiljevic, 2006); (Abe & Morita, 2010). The amino residues
that are important to Type III PKS and that form a catalytic triad are Cys, His, Asn. This
class of PKS do not have a phosphopantetheinyl group on which the growing polyke-
tide chains are tethered. The diverse Type III products are formed due to the specicity
in the starter and the extender units, the number of incorporated extender substrates
and the cyclization pattern of the intermediate (Katsuyama et al., 2011). Some examples
of molecules produced by Type III PKS include the synthesis chalcones and stilbenes in
plants and polyhydroxy phenols in bacteria. Type III PKS systems are found in plants,
bacteria and fungi.
1.2.2.2 Nonribosomal Peptides
Nonribosmal peptide derived natural products are another important family that are organ-
ised in a similar manner as the modular Type I PKS systems with multiple enzymatic domains
located on a single polypeptide chain. As with PKSs the growing peptide chain is tethered to
the NRPS protein via a thiol domain (T) of the peptidyl protein (Figure 1.5). Some of the phar-
maceutically important drugs that are biosynthesised by this mechanism include vancomycin,
bleomycin, and cyclosporin A. NRPS systems can be found in both fungi and bacteria (Rausch
et al., 2007).
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Figure 1.5 : Basic steps during synthesis of Nonribosomal peptides.
Adapted from (Donadio et al., 2007).
This gure shows the biosynthesis of a hypothetical nonribosomal peptide. Biosynthesis is initiated
when the A (adenylation) domain recognises and activates the amino acid and loads it onto the thiol
(T) domain of the peptidyl carrier protein (PCP). The condensation domain catalyses the formation
of a peptide bond amino acid and the chain elongates. The TE (thioesterase) domain terminates the
process by releasing the completed peptide chain, sometimes accompanied by cyclisation.
NRPS are organised into modules that use amino acids as their building blocks to catalyse
the formation of amide bonds. The order and specicities of domains within the modules
determines the sequence of the nal product presenting an assembly line biosynthetic system.
The adenylation (A) domain is responsible for substrate selection, this domain recognises an
amino acid which it activates through the formation of an aminoacyl adenylate through ATP
hydrolysis and then a covalent bond is formed between the activated amino acid and the thiol
(T) of the phoshopantetheinyl cofactor of the peptidyl carrier protein (PCP). The third domain
is the condensation domain (C) that catalyses the formation of the peptide bonds resulting in
the elongation of the peptidyl chain. Chain elongation is terminated by the thioesterase (TE)
domain. This is the last module that is involved in the hydrolysis or the cyclisation of the
peptide chain yielding the nal product (Weber & Marahiel, 2001). Additional domains such
as the epimerization (E) domain (Rausch et al., 2007) for the conversion of L–amino acids to
D–amino acids seen in cyclosporin A and tyrocidine A (Du & Lou, 2010), the N–methylation
(NMT) domain in pyochelin biosynthesis, the heterocyclic ring formation (Cy) domain as
seen in bacitracin and vibriobactin, the formylation (F) domain observed in oxazolomycin, the
oxidation (Ox) domain in epothilone biosynthesis and the reduction (R) domain in pyochelin
have also been identied. The nal peptide products can be cyclic, linear or have a branched
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structure. Once released, the products can further undergo modications by the action of
glycosyltransferases, halogenases and oxygenases (Hur et al., 2012).
1.2.2.3 Siderophores
Siderophores have long been of interest to researchers due to their ability to scavenge iron.
Iron is essential for the growth of all microbes and is required for electron transport pathways
and for oxygen transport in higher animals. Many microorganisms produce small molecules
called siderophores that have high anity for ferric iron and they are released into the envi-
ronment to scavenge iron. The siderophore–iron complex is recognized by specic receptors
on the cell surface and is transported into the cell. Many siderophores function as virulence
factors in pathogens and hence the enzymes that are involved in their biosynthesis are poten-
tial targets for antimicrobial therapies. Siderophores can be classied into two groups based
on their biosynthetic origin: NRPS–dependent and NRPS–independent. In NRPS-dependent
pathways the siderophore is produced via a NRPS system, examples include mycobactins,
microcin E-492, coelichelin, and fusachelin. NRPS-independent siderophore (NIS) involve a
family of synthetase enzymes that catalyses the oligomerization and macrocyclization of ω-
aminocarboxylic acid that form amide bonds by several rounds as observed in desferrioxam-
ine E. The second group involves a pair of synthetases and forms a unique hybrid NIS-NRPS
pathway. This kind of mechanism is observed in petrobactin biosynthesis (Barry & Challis,
2009).
1.2.2.4 Ribosomal Peptides
Ribosomal peptide derived natural products are another class of bioactive agents that has been
of recent research interest. They are usually short peptides and are post–translationally mod-
ied by various enzymes that catalyze the formation of a large number of chemical groups.
The pre–peptide usually consists of a conserved leader sequence that is responsible for recog-
nition by the modifying enzymes and the carboxyl terminus of the precursor encodes the
sequence that is enzyme modied which forms the active peptide. The leader sequence is
cleaved from the carboxyl terminus after modication that results in a peptide product. This
kind of machinery is usually found in bacteria, fungi and in cone snails. Some of the examples
are patellamides, microcin B17 and lantibiotics (Schmidt, 2010).
1.2.2.5 Terpenes
Streptomyces also produce terpene natural products that are industrially important as avours,
plant hormones and as antibiotics. The biosynthetic pathways of these have recently been
identied in actinomycetes. All isoprenoid compounds, including terpenes, are derived from
a ve-carbon precursor called isopentyl diphosphates (IPP). Recently, it has been shown that
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IPP is synthesised through the 2–C–methyl–D–erythritol 4–phosphate (MEP) pathway in
most bacteria, green algae and in the chloroplasts of higher plants. Most Streptomyces have
only the MEP pathway but some also have the mevalonate pathway (MV) for IPP biosynthesis.
The rst step in the MEP pathway involves the catalysation of polyprenyl diphosphate syn-
thase (PDS) that condenses IPP into allylic diphoshates to produce linear polyprenyl diphos-
phates with specic chain lengths. In many cases, the polyprenyl diphosphates undergo a
range of cyclizations to produce the parent skeletons–mono (C10), sesquiterpenes (C15) and
diterpenes (C20) followed by a variety of modications involving hydroxylation, methyla-
tion and glycosylation to produce diverse isoprenoids (Dairi, 2005). Some examples of bioac-
tive isoprenoids include longestin (Hayashi et al., 2007), which acts as a selective inhibitor
of calmodulin-dependent cyclic nucleotide phosphodiesterase (Ichimura et al., 1996), brasili-
cardin A, a potent immunosuppressive agent (Shigemori et al., 1998) and pentalenolactone
(You et al., 2006) which is a sesquiterpenoid antibiotic.
1.2.3 Regulation of secondary metabolism
The complexity and diversity of secondary metabolism is quite a distinguishable feature of
Actinobacteria. The secondary metabolite gene clusters respond to various physiological sig-
nals and stresses which mediates a wide array of signalling cascade systems. Genes involved
in the production of secondary metabolites are generally arranged in clusters that vary in
size from a few kilobases to 100s of kb and most of these contain specic regulatory genes
for a particular pathway which are normally required for the production of these metabolites.
The best known example is (p)ppGpp, a highly phosphorylated guanosine nucleotide which
appears to be required for antibiotic production under nitrogen limiting conditions in Strep-
tomyces coelicolor A3. However, the direct role of this ppGpp synthetase (relA) in antibiotic
production is still unclear (Bibb, 2005).
One of the key factors that are known to contribute to antibiotic production is nutrient depri-
vation. Recent studies have reported that carbon catabolite control also plays an important
role in morphological development thereby directly aecting antibiotic production. The util-
isation of various carbon sources and exiting from the vegetative stage of growth are clearly
linked. The best example is the bldB gene which is a DNA–binding protein only found in acti-
nomycetes. The overproduction of this gene aects the sporulation and cell–division stage
within the antibiotic producing strain as well as overall antibiotic production. In general,
mutations that block sporulation seem to have a lesser eect on antibiotic production than
known bld mutations. The reason for this is that the switch to secondary metabolism is closely
connected to the early stages of morphological dierentiation (Wezel & McDowall, 2011).
Additional physiological triggers/factors which are also known to inuence the production
of secondary metabolites in Actinobacteria include pH, temperature and oxygenation. These
factors have been employed in fermentation based approaches to increase the yield of dierent
secondary metabolites and coupled novel screening strategies have played an important role
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in the isolation and development of new metabolites (Olano et al., 2008).
1.3 Screening strategies
Since the discovery of drugs such as penicillin and streptomycin, many NP have been in-
troduced to the market by industry but the number of new drugs which have discovered has
fallen markedly since the 1990s. As previously mentioned there has been a dramatic increase
in the emergence of drug–resistant pathogens and hence the identication of new classes of
antibiotics is now more important than ever before. Since 1990 the pharmaceutical industry
has only introduced three new classes of antibiotics to the market, namely oxazolidinones,
lipopeptides and mutilins (Figure 1.6) (Fischbach & Walsh, 2009); (Coates & Hu, 2007); (Liv-
ermore et al., 2011).
Figure 1.6 : Antibiotics discovered between 1930 and 2010.
First classes of antibiotics discovered between 1930s and 40s but after 1960s, no new classes were
discovered until 2000. New screening strategies revolutionized the drug discovery.
Adapted from (Fischbach & Walsh, 2009).
The strategies that can be employed to identify novel bioactives mainly focus on the com-
pounds, nucleotide sequences and the uncultured microbial communities (Figure 1.7).
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Figure 1.7 : Screening strategies in drug discovery.
1.3.1 Target–based approach
A target–based approach is the most ecient and least ambiguous method in isolating an
active molecule for the target that is responsible for a pathological process or a disease that is
thought to be a single gene product or group of products in a system. This approach is often
referred to as the “reductionist” approach (Kenakin, 2009). The rst step in this approach
is mainly the identication of molecular targets followed by specic chemical– or antibody
based small molecule modulators or inhibitors of the target. Theoretically, a single molecular
mechanism is sucient to have a therapeutic eect however it has to date been ineective
in treating cancer and diseases aecting several multiple cell types (Aggarwal et al., 2007).
The conventional phases of drug discovery can be divided into three stages: the rst being
the discovery phase that involves the identication of a valid target, the second being the
lead optimization phase where the molecules are synthesised and tested and the third phase
is the clinical development phase (Figure 1.8). In terms of strategies for drug development,
the latter two steps are common however, the target validation step is unique to target–based
drug discovery.
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Figure 1.8 : Target–based drug discovery.
This approach involves novel targets and once validated it moves to the next process of the drug
development until it reaches the market.
Adapted from (Cong et al., 2012).
The concept of cell–based assays is that because of the high–throughput strategies that have
been developed, thousands of compounds can be screened in a day. There is always however
a possibility of missing promising drug candidates (Crowther et al., 2012). The reporter assays
can also lead to the false identication of the molecules. For example, in G–protein coupled
receptor (GPCR) assays, fusion proteins are used. Preliminary screening of a compound which
shows an eect on GPCR activation may be subsequently hard to conrm if the activation is
due to the eect of the compound on the protein rather than the actual protein itself (Kotz,
2012).
Some of these limitations can be overcome by modifying the existing methods. The best ex-
ample is the ADME/Tox assays. This system involves the examination of the eects of an
organism, tissue or cell on a compound as well as the eect the compound has on an or-
ganism, cell or tissue (Larson et al., 2011). The introduction of Mass–Spectrometry (MS) and
Nuclear Magnetic Resonance (NMR) Imaging has helped scientists to determine the mass and
also elucidate the structure of the drug respectively (Capon, 2010). MS based assays can de-
tect direct eects of drugs without manipulating cells and also quantitatively identify true
changes in the metabolites. Techniques such as fragment–based drug design provides leads
for previously known targets and works only on small soluble targets and has been success-
ful in anti–infective research. The three–dimensional structure of the binding mode of the
fragments is determined by X–ray crystallography or NMR to determine the properties of the
drugs (Murray & Rees, 2009); (Sun et al., 2011).
The chemical genetics–based target identication represents a powerful and a more recent
approach that involves the identication of a novel and validated target in a more ecient
and unbiased manner. With this approach, the biological activities and a target potential is
assessed earlier in the discovery process which improves the eciency of the drug discovery.
Exploring new approaches such as using various biochemical and bioinformatics tools may
provide possible solutions in the discovery of new metabolites.
1.3.2 Genomic analysis of Streptomycetes
As previously mentioned the genus Streptomyces is of interest because of its ability to pro-
duce numerous bioactives that have found utility in human and veterinary medicine and
agricultural based applications. The era of genome sequencing has resulted in the identi-
cation of gene clusters which not only encode novel antibiotics but also other small bioactive
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molecules; and this has opened up a new strategy in the eld of drug discovery. The rst
antibiotic–producing actinomycete genomes to be sequenced were initially reported in the
early 21st century from Streptomyces coelicolor and Streptomyces avermitilis (Challis & Ravel,
2000). Both these genomes were found to contain an abundance of genes that encoded for
enzymes involved in secondary metabolism with numerous NRPS and PKS being present.
The genome analysis of S. coelicolor revealed the presence of two dozen clusters encoding for
pigments, complex lipids, signalling molecules and iron–scavenging siderophores (Borodina
et al., 2005) and 30 clusters from S. avermitilis (Ikeda et al., 2003); (Omura et al., 2001). Re-
markably, nearly all the clusters from both the genomes probably encode dierent compounds
in the two species.
Gradually, many other genus of this phyla were sequenced and many novel clusters were
subsequently identied. A high–throughput genome scanning was undertaken by Ecopia
Biosciences wherein they identied several gene clusters and predicted the structures which
were likely to be produced by these clusters using the signature PKS/NRPS sequences (Chal-
lis, 2008). They grew these actinomycetes in dierent media and found a novel anti–fungal
agent being produced by Streptomyces aizunensis and a novel anti–bacterial agent by Amy-
colatopsis orientalis (McAlpine et al., 2005). Seven complete genomes of Actinobacteria are
now available: two Mycobacterium tuberculosis strains, H37Rv (Cole et al., 1998) and CDC1551
(Fleischmann et al., 2002); Mycobacterium leprae (Cole et al., 2001), Corynebacterium diph-
theriae, Corynebacterium glutamicum, S. coelicolor (Bentley et al., 2002) and S. avermitilis. In
addition there are around 60 genomes which have been submitted to the NCBI from the Strep-
tomyces genus alone. This provides scientists with the opportunity to exploit these genomes
by decoding the metabolic pathways and to potentially identify novel metabolites that does
not possess any conserved PKS/NRPS signatures (Davies, 2011).
Genomic based studies can also provide a possible route whereby variants of already existing
drugs can be produced by the construction of large genomic libraries with various PKS, NRPS
and hybrid clusters (rapamycin, FK506 for example) (Bode & Müller, 2005). These types of ge-
netic alterations coupled with the feeding in of dierent monomers to actinobacterial cultures
can thus lead to novel natural–product–derived variants (Clardy & Walsh, 2004). Studies by
scientists in Japan have shown the presence of at least 25 secondary metabolite clusters in S.
avermitilis which displayed homology to polypeptides of known function. Another example
is of the proteasome inhibitor, salinosporamide A from Salinospora tropica where the biosyn-
thetic gene cluster was identied for the compound in the absence of the compound being
observed following analyses of fermentation broths (Udwary et al., 2007). Recent studies in
a Streptomyces sp. strain S4 identied multiple potential antibiotic biosynthetic pathways
and several novel clusters that may lead to the potential novel bioactives (Seipke et al., 2011).
Halometabolites have recently been identied in a variety of marine microorganisms follow-
ing in silico mining of genomes (Zhao, 2011). In addition screening for genes that encode
targeted enzymes such as halogenase in the biosynthetic pathway has identied some novel
putative genes.
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Other genome mining based approaches have also resulted in the identication of several
cryptic gene clusters that may produce novel bioactives. The strategies employed have either
involved induction of expression in the natural host or heterologous expression in the sur-
rogate strain. The rst approach involves the use of dierent media and/or if possible, the
genetic manipulation of the strain. The second involves the heterologous expression of clus-
ters in surrogate hosts (Gomez-Escribano & Bibb, 2011). Expression of an identied pathway
in a heterologous host has been successfully employed with known compounds such as the
macrolides. This approach not only helped in the identication of the gene clusters but also
facilitated their cloning into cosmid or BAC vectors and the subsequent transfer to a strain
which grows at a faster rate than the parent strain or is known to produce larger levels of
the secondary metabolites (Penn et al., 2009). The popular heterologous expression host E.
coli has never been a good host for the expression of actinomycetes gene clusters. For ex-
ample, studies have reported enhanced heterologous expression of two Streptomyces griseolus
cytochrome P450s and Streptomyces coelicolor ferredoxin reductase enzymes with hydroxy-
lation activity in S. lividans; while these activities were not observed when E. coli was used
as a surrogate host (Hussain & Ward, 2003). S. coelicolor and S. lividans has been widely used
as heterologous hosts (Alduina & Gallo, 2012); (Jones et al., 2012). Many new constructs for
eective expression of gene clusters in heterologous hosts has been improved by removing
competing pathways (Davies, 2011); (Komatsu et al., 2010). All the above examples of com-
binatorial biosynthesis indicate that the PKS and NRPS pathways can be applied to produce
novel and highly active compounds (Baltz, 2008). Structural scaolds and docking on to the
protein targets with a combination of chemical modication has proven successful in some
studies (Izumizono et al., 2011).
With the exponential increase of genome sequencing and genome mining analyses, many
NP are now becoming therapeutic agents. The divergence from the pure chemical analyses
to a combinatorial approach of both chemical and genomic approaches is the future for e-
cient drug discovery. These examples prove that genome–based studies can be useful in the
identication of novel NP (Kurtböke, 2012).
1.3.3 Metagenomic approach
This is a term which is used to describe the study of entire communities of microbial or-
ganisms using shotgun sequencing technology rather than the clonal culture of individual
strains (Handelsman et al., 1998). It generally implies mixed samples of genomes from multi-
ple species. Some other terms that are often used to describe this approach are environmental
genomics, ecogenomics, community genomics and megagenomics (Chistoserdova, 2010). The
approach mainly bypasses the problems of bacterial sampling and culturing and hence it is
commonly referred to as a culture–independent approach (Juengst & Huss, 2009). The ini-
tial shotgun sequencing projects involving metagenomic DNA from seawater and soil sam-
ples provided insights into the enormous levels of microbial biodiversity present within these
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ecosystems as well as their huge biotechnological potential particularly as a “treasure trove”
of genes with not only potential novel functionalities but also of new genes that were only
remotely similar to existing genes with known function (Venter et al., 2004); (Tringe et al.,
2005); (Tyson et al., 2004).
The construction of metagenomic libraries has proven to be a powerful tool for exploring
the diversity of microbes in an uncultured system and thereby forming the basis of genomic
studies linking the phylogenetic and functional relationships between microbes and their en-
vironment (Singh et al., 2009). The technique involves isolating the genomic DNA of approx-
imately 40–200 kb in size from an environment, and subsequently cloning it into a suitable
large cloning vector such as a cosmid, fosmid or BAC based system and transformation into a
heterologous cultured organism that can be used for further analysis and long–term preser-
vation (Figure 1.9). E. coli is typically used as a heterologous host strain but due to its some-
what limited ability to express DNA, a number of other host strains including Streptomyces
lividans, Rhizobium leguminosarum, Pseudomonas aeruginosa, and Ralstonia metallidurans to-
gether with additional shuttle vectors are beginning to be increasingly used for the detection
of both secondary metabolites and novel bioactive compounds (Courtois et al., 2003); (Wexler
& Johnston, 2010). These clones can be used for phylogenetic analyses or screening for enzy-
matic activity (Walter et al., 2005); (Selvin et al., 2012) or for antibiotic production (Md. et al.,
2009). A signicant problem that can occur during the construction of a metagenomic library
is that fragmentation of the DNA can occur thereby causing a signicant loss of the total gene
complement. To overcome the fragmentation, an alternative approach is to employ blunt–end
or T–A ligation to clone randomly sheared metagenomic fragments (Wilkinson et al., 2002).
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Figure 1.9 : Metagenomic Mining for Novel enzymes.
DNA is extracted from the environment samples and then it is subjected to either sequence–based
or function–based approaches or both. This would help in the speciation of novel microbes or in the
identication of novel bioactives.
Several bioinformatics based tools and databases have been developed to help process the
large datasets being generated from the large number of metagenomic studies currently being
undertaken. These methodologies have largely focused on attempts to capture the as yet
unexplored microbial diversity as well as overcoming the existing barriers in estimation of
diversity. In addition new screening methods continue to be developed to help select for
specic functional genes within metagenomic libraries.
To analyse the metagenomic data, two approaches which are routinely employed to analyse
metagenomic derived data, namely sequence–based and function–based approaches will now
be discussed.
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• sequence–based approach
• function–based approach
1.3.3.1 Sequence–based approach
Sequence based approaches involves targeting the presence of specic genes encoding pro-
teins of interest being targeted by using either PCR primers or hybridization probes for these
genes. Since this approach involves the design of primers or DNA probes which are derived
from conserved regions of already well characterized genes or protein families, thus these ap-
proaches typically lead to the identication of new variants of known classes of proteins; and
usually result in very few really novel genes being detected. Notwithstanding this however,
such homology based strategy have led to the identication of genes encoding a variety of
novel enzymes. Using the homology based approach, PCR amplication is performed follow-
ing which the putative gene is sequenced and then subsequently cloned into an appropriate
expression vector where the heterologously expressed protein is then puried and biochem-
ically characterized to ascertain its function.
From a marine bioactive standpoint the power of data generated from the sequencing of
metagenomic DNA from marine environments is clearly demonstrated in the recent report
from the Sherman group (Rath et al., 2011). This group sequenced DNA from the microbial
symbiont community associated with the tunicate Ecteinascidia turbinata which resulted in
the identication of twenty ve genes which were then found to comprise the core Non Ri-
bosomal Peptide Synthase (NRPS) biosynthetic pathway cluster which is involved in the syn-
thesis of the anti–cancer agent ET–743 (Yondelis). The group subsequently demonstrated that
the γ–proteobacterium Candidatis Endoecteinascidia frumentensis a symbiont of the tunicate
produces the tetrahydroisoquinoline core of the ET–743 molecule (Rath et al., 2011).
Exploration and analysis of the microbial diversity from environmental samples is termed as
“taxonomical binning”. The approach can be based on sequence similarities, sequence compo-
sition or both. The binning methodology depends on various factors such as the complexity
of the microbial community, available reference sequences and resources (Mande et al., 2012).
The initial steps involve the assembly of the reads into consensus sequences called contigs
which is then followed by the prediction of the genes. There are many web servers such
as MG–RAST (http://metagenomics.anl.gov/), IMG–M (https://img.jgi.doe.gov/
m/) or CAMERA (http://camera.calit2.net/) that oer computational resources (Dröge
& McHardy, 2012) for this type of metagenomic analysis (Mande et al., 2012). MetaProdigal, a
metagenomic version of the gene prediction program Prodigal that can identify genes in short,
anonymous coding sequences with a high degree of accuracy was recently launched to over-
come the limitations of the current sequencing technologies. The novel method consists of
enhanced translation initiation site identication, an ability to identify sequences that use al-
ternate genetic codes and condence values for each gene call. The program can analyse frag-
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ments independently as it utilizes multiple processors (Hyatt et al., 2012). Once the sequence
data has been generated then it can be analysed for taxonomical classication using RDPII
(Cole et al., 2003), greengenes (http://greengenes.lbl.gov/cgi-bin/nph-index.cgi)
or ARB–SILVA (http://www.arb-silva.de/). The advent of metagenomic approaches not
only provides information about the uncultured bacteria but also about their metabolic po-
tential (Heidelberg et al., 2010).
1.3.3.2 Function–based approach
Function–based approaches involve the screening of clones for a specic activity resulting
from the expression of a particular function by the clone, followed by the subsequent se-
quencing of the clone to identify the gene(s) involved. These screens are based on the activity
being exhibited by the metagenomic clones resulting in the generation of a readily identi-
able phenotypic change. For example metagenomic clones displaying lipolytic activity can
be observed as zones of clearing on LB agar supplemented with 1% tributyrin. This approach
has successfully been employed to identify a variety of dierent genes and proteins including
proteins that inactivate antibiotics, genes conferring resistance, Na+(Li+)/H+ transporters
(Majerník et al., 2001) and genes encoding multidrug eux pumps that plays a major role
in the development of drug–resistant microbes (Schmieder & Edwards, 2012). Another ap-
proach involves the induction of gene–expression for the identication of novel catabolite
genes. Some of the function–based approaches are listed in Table 1.5.
Table 1.5 : Examples of enzymes identied by functional metagenomic approaches.
Adapted from (Simon & Daniel, 2009).
Target Source Sampling site Screening approach
Lipase Fosmids Baltic sea sediment Phenotypical detection
Lipase/Esterase Plasmids Soil from a meadow Phenotypical detection
Cellulase Phagemids Crater Lake enrichments Phenotypical detection
Antibiotics Cosmids Tank Water Phenotypical detection
One of the major problems with functional based screening approaches is that expression
of genes in heterologous hosts is often sub optimal. This lack of ecient transcription of
genes derived from the metagenome coupled with poor secretion of the foreign protein, a
misfolding of the desired protein owing to a lack of essential chaperones, a lack of cofactor
synthesis or insertion into the recombinant metagenomic protein and a dierent codon usage
of the expression host strain can lead to a low frequency of clones displaying the desired
activities. Several studies has recently addressed some of these problems by constructing
novel vectors, novel host strains and transposable promoters (Troeschel et al., 2010), thereby
facilitating more ecient transcription of metagenomic DNA.
Coupled with the development of approaches to increase the eciency of gene transcription,
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there have also been advances in the development of various high throughput screening meth-
ods such as the metabolite–related expression (METREX) system in which the activity sensor
is in the same cell as the metagenomic DNA. This method has resulted in the identication of
clones which produce a quorum–sensing inducer for expression of green uorescent protein
(GFP) (Tyson et al., 2004). Another intracellular screening system which has been successfully
developed is substrate–induced gene expression screening (SIGEX) for the isolation of catabo-
lite genes (Uchiyama et al., 2005). This system is based on the expression which is generally
induced by relevant substrates, or controlled by promoters present near the catabolic genes.
The construction of an operon–trap GFP–expression vector available for shotgun cloning that
allows the selection of positive clones in liquid cultures by uorescence–activated cell sorting
made SIGEX a high–throughput screening method. This approach has been implemented in
the cloning of aromatic hydrocarbon–induced genes from a groundwater metagenome library
and subsequent genome–informatics analysis was performed (Uchiyama & Miyazaki, 2010).
The use of an engineered host strain to detect particular cellular pathways using reporter
gene strategy coupled with high–throughput assays has recently proven successful. For ex-
ample scientists from France employed a high–throughput assay using a reporter–gene based
strategy to allow rapid detection of NF–κB modulation to screen a metagenomic library from
the human intestinal microbiota of patients suering from Crohn’s disease, allowing the iden-
tication of NF–κB modulating clones. They employed a human colorectal cell line HT–29
containing the secreted alkaline phosphatase (SEAP) reporter gene and identied excellent
candidate metagenomic clones that can be used to further study novel host–commensal in-
teraction mechanisms (Lakhdari et al., 2010).
1.4 The Marine Environment as a source of Natural Products
As previously mentioned NP have historically been a rich source for drug development For
example from 1981 to 2002, of the 1031 new candidate drugs approved by the FDA; 23%
were natural–product–derived drugs and 5% were from NP themselves (Clardy & Walsh,
2004). Many of the natural product based drugs currently on the market originated from
soil based sources and by continuing to screen terrestrial based ecosystems the likelihood is
that the same classes of antibiotics will continue to re–discovered, thus it make sense that
other environments such as marine ecosystems should be screened as a potential source for
new microorganism that produce bioactive compounds with potential biopharmaceutical ap-
plications (Baker et al., 2007).
1.4.1 Isolation strategies for novel bacteria
It is now well established that over 70% of the earth’s surface is covered with water and
that life evolved in the seas billions of years ago. The marine environment is as yet largely
underexplored from a biotechnological perspective, it is widely believed that the diversity of
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the marine environment is such that it is likely to be a rich source of microbial biodiversity
(Thakur et al., 2008); (Imho et al., 2011). However molecular analyses of marine environments
suggest that many marine microbes remain uncharacterised and are not prone to cultivation.
If the natural microbial biodiversity is to be assessed and ultimately exploited then traditional
culturing techniques will need to be augmented with culturing conditions that mimic more
closely the natural environment from which the bacterium was originally isolated. There
have been some recent advances in the regard with new experimental new culture conditions
such as GigaMatrix (Laerty & Dycaico, 2004) and Microdish (Ingham et al., 2007), being
employed which has led to the identication of novel species and genera. Some of the newly
described genera which have been isolated from the marine environment include Salinospora,
Demequina and Lamerjespora (Bull & Stach, 2007). Hence innovative techniques such as the
aforementioned high–throughput cultivation (HTC) approaches combined with the use of
components of the natural environment in the isolation media has resulted in some recent
progress in the cultivation of marine bacteria (Connon & Giovannoni, 2002). For example a
research group in Turkey has recently (Hames-Kocabas & Uzel, 2012), separated bacteria in
samples and incubated them individually (Taylor et al., 2009); (Ishøy et al., 2006) thus avoiding
repression of the slow–growing strains. They also provided them with minimal media thus
allowing the recovery of bacteria that need low nutrient concentrations and long–term incu-
bation to be isolated. Studies have also shown that bacteria grown at low temperatures allow
for the recovery of new isolates (Song et al., 2009) while other groups have used microbial
entrapment methodologies resulting in an increased recovery of actinomycetes (Kaeberlein
et al., 2002).
1.4.2 Molecular strategies for determining microbial diversity
Molecular techniques based on DNA or RNA analyses are typically employed in accessing
the microbial biodiversity in marine samples (Hentschel et al., 2001). Molecular tools such
as Denaturating Gradient Gel Electrophoresis (DGGE) which is used to separate the ampli-
ed 16S rRNA products has been widely used as a tool to detect the phylogenetic “nger-
print” of diverse marine organisms (Li et al., 2006). The biochemical and the ecological role of
the microbes that are unknown can be characterised by tracing back the functional genes to
genes that are similar in well–known species using uorescence in situ hybridization (FISH)
(Friedrich et al., 2001). Numerous variations in the sequence–based techniques and high–
throughput strategies (Werner et al., 2012) for accessing the diversity of marine ecosystems
have evolved in recent years. Thus it has been possible to gain a greater understanding of the
dynamics and overall structure of marine microbial communities, using small subunit riboso-
mal RNA (SSU rRNA) in conjunction with high–throughput sequencing technologies such as
pyrosequencing (Fierer & Lennon, 2011); (Zengler, 2009); (Lozupone & Knight, 2008); (Huse
et al., 2008). Scientists from Ireland used pyrosequencing technology and obtained long aver-
age read lengths of ~430 bp (V1–V3 region of 16S rRNA gene) that allowed robust resolution
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of sequences to genus level (Jackson et al., 2012).
In addition, innovative combinations of employing microarrays together with other molecular
based tools have become increasingly useful for predicting the structure–function relation-
ships of complex microbial communities (Wagner et al., 2007). Studies have also identied
non–fermenting bacteria using matrix–assisted laser desorption ionization–time–of–ight
mass spectrometry (MALDI–TOF MS) for species identication allowing comparisons with
16S rRNA analysis (Mellmann et al., 2008). In addition as previously mentioned genomic
(Zhao, 2011) and metagenomic based approaches (Kennedy et al., 2010) have successfully been
employed to identify potential gene clusters encoding novel enzymes involved in the biosyn-
thesis of secondary metabolites which will further facilitate the eld of marine based drug–
discovery (Dionisi et al., 2012).
1.4.3 Marine natural products
In a previous section of this introduction NP were discussed, but the focus here will speci-
cally be on marine based NP. While about 60% of NP which have been discovered to date can
be traced back to the marine environment the success rate from a successful clinical applica-
tion standpoint has been low due to the somewhat limited access to various marine areas and
also security of supply (Lam, 2006). The problem of access has however been largely over-
come through the use of remotely operated underwater vehicles (ROVs) (Leal et al., 2012).
While many earlier studies were based on samples from coastal areas, the use of ROVs has
meant that samples can now be obtained from deep sea studies which increase the possibil-
ity of uncovering unique microbial diversity, thereby increasing the likelihood of discovering
more novel lead drug molecules (Schauer et al., 2010); (Xu et al., 2010).
Given the fact that actinobacteria are known to be a rich source, it is perhaps not surprising
therefore that marine actinomycetes have been the focus of many research groups involved in
marine biodiscovery (Gulder & Moore, 2009); (Olano et al., 2009). Relatively recently, repre-
sentatives from 13 new genera of Actinobacteria of marine origin have been isolated, which
could prove to be a source of many novel compounds (Fenical & Jensen, 2006); (Sibanda et al.,
2010). Some of the structural features of marine NP are unique and hence it is not surpris-
ing that their modes of action are unique as well (Zotchev, 2012). Some of the bioactivities
which are displayed by marine based NP include anti–bacterial, anticancer, anti–malarial and
anti–viral activities amongst others (Prudhomme et al., 2008).
Currently, there are 13 marine NP which are in various phases of the clinical development
(Glaser & Mayer, 2009). Table 1.6 provides a list of NP (marine sources) that are currently
undergoing pre–clinical and clinical trials.
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Table 1.6 : Examples of Marine natural products undergoing clinical trials.
This table is adapted from (Mayer et al., 2010).
Name of the compound Source Activity Company/ Institution
Cytarabine, Ara–C Marine sponge Anti–cancer/ Approved Bedford, Enzon
Vidarabine, Ara–A Marine sponge Anti–cancer/Approved King Pharmaceuticals
Eribulin Mesylate (E7389) Marine sponge Anti–cancer/Phase III Eisai Inc.
Hemiasterlin (E7974) Marine sponge Anti–cancer/Phase I Eisai Inc.
Hemiasterlin Marine sponge Anti–cancer/Phase I Eisai Inc.
1.5 Marine sponges
Marine sponges are one of the ancient multicellular cellular metazoans which have been re-
siding in the oceans since the Precambian era. They are quite simple organisms and occupy
80% of known water bodies. Sponges pump up to 25 m3 of water one kg sponge per day
through their aquiferous system. They have an epidermal layer called the pinacoderm which
is composed of pinacocytes (Figure 1.10). Seawater is drawn through porocytes into an area
located between the outer and inner cell layers– the so called mesophyl layer of the sponge;
which is composed of a network of canal–like structures. The interior body of the sponge is
lined by choanocytes which are agellated cells that create the sponge’s water current and
use microvilli to lter out particles from the water. Bacteria within the seawater when they
are transferred into the mesohyl tissue are either ingested by archaeocytes or survive and
become established as part of the sponge–specic microbiota which become enclosed within
the mesohyl matrix. In this way marine sponges play host to signicant microbial populations
which include bacteria, single–celled eukaryotes (microalgae and fungi) and archaea, which
play crucial roles in the biology of the host.
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Figure 1.10 : Movement of water ow from a typical marine sponge.
Bacteria along with water enters through the porocytes in the pinocoderm and exists through the
osculum.
Adapted from (Taylor et al., 2007).
The sponge microbiota can be symbiotic, pathogenic, act as a food source or be transiently
associated with the animal. In some instances, it has been estimated that up to 40–60% of the
total biomass of the sponges may comprise endosymbiotic microorganisms, reaching densities
as high as between 108 and 1010 bacteria per gram of sponge wet weight. These are known
as high–microbial–abundance (HMA) sponges or bacteriosponges, with a classic example be-
ing the Caribbean great barrel sponge Xestospongia muta which is believed to contain around
8×109 bacteria per gram of sponge tissue. This exceeds the number of bacteria which are typ-
ically found in seawater by at least two to four orders of magnitude. Marine sponges are a very
good source of NP which many believe may have evolved as a chemical defense mechanism
against potential predators and/or to prevent biofouling. More novel bioactive metabolites are
obtained annually from sponges than from any other marine taxon. Over 7,000 bioactive
compounds have to date been isolated from sponges, many of which have proven to be bi-
ologically active and pharmacologically valuable, with anti–cancer, anti–infective and other
bioactivities. Many of these NP are structurally very similar and in some cases identical to
bacterially derived compounds and it is now widely believed that many of these products are
in fact produced by bacterial symbionts of the sponges. Thus understandably there has been
a lot of interest in studying the microbiota associated with marine sponges not only from
the perspective of potential biotechnological exploitation but also from a microbial ecology
perspective, thereby gaining insights into the diverse microbial communities present within
the sponge ecosystem.
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1.5.1 Microbial diversity associated with sponges
Recent molecular studies has shown that there is a diverse assemblage of bacteria and archae
within sponges (Na et al., 2008), while recent pyrosequencing based analysis of sponge mi-
crobial communities have revealed diverse sponge–specic microbial communities (Lee et al.,
2012); (Jackson et al., 2012). The microbial diversity of sea sponges has recently been described
as containing the following 35 bacterial phyla: Acidobacter, Actinobacteria, Bacteroidetes,
Chloroexi, Cyanobacteria, Nitrospira, Proteobacteria (α, β, γ, δ and ε), Deinococcus–Therm-
us, Firmicutes, Gemmatimonadetes, Planctomycetes, Spirochaetes, Poribacteria, Verrucomi-
crobia, TM6, Lentisphaerae, BRC1, Chlamydiae, Fibrobacteres, Fusobacteria, Tenericutes,-
WS3, Aquicae, Deferribacters, Dictyoglomi, TM7, Chloribi, Chrysiogenetes, OD1, Thermod-
esulfobacteria, OP10, OS–K, Thermotogae, Synergistetes and Elusimicrobia (Fieseler et al.,
2004); (Taylor et al., 2007); (Hardoim et al., 2009); (Webster et al., 2010); (Lee et al., 2011);
(Schmitt et al., 2012); (Trindade-Silva et al., 2012).
Several eukaryotes are also known to occur in sponges such as dinoagellates, parasitic di-
atoms (Bavestrello et al., 2000), microalgae (primarily zoochlorellae) and some fungi (Aspergill-
us sp. and Penicillium sp.), with the fungi in particular representing novel biotechnological
potential.
1.5.2 Metabolites from sponges and their microbes
The major breakthrough which sparked much of the recent research interest in sponges from
a biopharmaceutical perspective was the discovery of the nucleosides spongothymidine and
spongouridine from the marine sponge Cryptotethia crypta. These subsequently formed the
basis for Ara–C, the anticancer drug and the anti–viral drug, Ara–A (Sipkema et al., 2005).
Recent studies has also reported brominated indole alkaloids, sesquiterpene quinones and
hydroxyquinones isolated from two sponges–V. rigida and S. aurea. These compounds are
potential leads for anti–depressant drugs (Kochanowska et al., 2008). The structures of many
sponge–derived NP, and in particular many of the complex polyketides and modied pep-
tides, structurally resemble bacterial compounds. Thus it is a widely held belief that many of
these products are in fact produced by bacterial symbionts of the sponges. Examples include
cyclodepsipeptide chondramide D isolated from the myxobacterium Chondromyces crocatus
and jaspamide from the sponge Jaspis spp. as well as the myxobacterial metabolite apicularen
A which is almost identical to salicylihamide A from Haliclona sp. (Erickson et al., 1997).
Many of these sponge–derived bacterial metabolites appear to exhibit several interesting
bioactivities such as anti–yeast, anti–fouling, antiangiogenic, antimicrobial and cytotoxic ef-
fects. One such example is a metabolite from a novel Pseudomonas sp. associated with the
sponge Suberites domuncula, which is known to produce an antiangiogenic, antimicrobial, and
cytotoxic compound (Thakur et al., 2005). Other recent studies have identied a large number
of microbes which are associated with sponges which display anti–bacterial and anti–fungal
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activities against clinical pathogens (O’Halloran et al., 2011); (Phelan et al., 2012); (Margassery
et al., 2012); (Flemer et al., 2012).
1.6 Prospects of Natural Products for drug discovery
If NP are to increase their potential as a possible source of new bioactive molecules with bio-
pharmaceutical potential then a number of obstacles remain to be overcome. Firstly, it will
be important to create a more diverse range of compound libraries in order to identify new
metabolites from new environments. In addition the genomic and metagenomic experimental
datasets which are currently available should be dissected and various bioinformatics based
tools (Glöckner & Joint, 2010) should be employed to discover not only potential compounds
but also potential new metabolic pathways (Cong et al., 2012). In this respect microbes asso-
ciated with marine sponges may prove to be a useful starting point for these types of studies,
given the track record of success to date in this area. It is also clear that culture based exploita-
tion of marine actinomycetes in particular is likely to lead to the discovery of many potential
novel bioactives. New approaches such as the recent mass spectrometry–guided genome min-
ing method that can identify NP and their biosynthetic gene clusters will greatly aid in this
respect (Kersten et al., 2011). Cho and co–workers have suggested the use of a combined target
and genome–based approach that would help to identify small molecules and their target pro-
tein (Cho & Kwon, 2012). While the rediscovery of known compounds (dereplication) will also
continue to be a potential problem, modern NMR and MS based methodologies involving data
integration software using predicted spectra for many known NP are being developed, which
will greatly aid in this process. In addition, early stage dereplication informed by microbial
systematics is also now proving to be successful (Vynne et al., 2012).
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Chapter 2
Diversity and antibacterial activity
of bacteria isolated from the coastal
marine sponges Amphilectus
fucorum and Eurypon major 1
2.1 Abstract
The aim of this study is to access the bacterial diversity and antimicrobial activity of cultur-
able bacteria associated with two temperate–water marine sponges, Amphilectus fucorum and
Euryponmajor. It was found that Proteobacteria were the dominant group of bacteria cultured
from both sponges, but overall, the bacterial composition was diverse and distinct between
the sponges. The most notable features were the higher proportion of rmicutes in E. major
and the low frequency of Actinobacteria in both sponges. Four bacterial isolates were iden-
tied as potentially novel species and will be characterised in future studies. Approximately
400 cultured bacteria were screened for antimicrobial activity against a collection of indica-
tor strains, with only eight strains, all Pseudovibrio spp. displaying any such activity. These
strains were active against Escherichia coli and Bacillus subtilis but not Staphylococcus aureus
or a selection of fungal strains.
2.2 Introduction
Sponges are primitive metazoans in the order Porifera and are a part of the benthic community
that plays a vital role in marine ecology. They are common and widely dispersed in most
marine waters and have been considered a source of bioactive metabolites with therapeutic
1Published: (Margassery et al., 2012)
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potential for some time (Radjasa et al., 2011). Sponges form close associations with a wide
variety of bacteria (Webster & Taylor, 2012), which can in some cases constitute up to 40%
of the sponge biomass (Grozdanov & Hentschel, 2007). These sponge–associated bacterial
symbionts have been postulated to perform a number of roles in the biology of the sponge
including the elimination of toxic metabolic by–products, increased structural rigidity, and the
production of bioactive metabolites, which may be of use to the host (Taylor et al., 2007). Some
of the bioactive compounds that have been isolated from sponges are believed to originate
from resident bacteria rather than from the sponge, a fact that has led to a large increase in
studies that explore the diversity and ecology of sponge–associated bacteria (Taylor et al.,
2007). The microbial diversity in sponges has recently been reported to comprise of at least
35 phyla and a number of studies have been performed in which sponge–associated bacteria
were cultured and screened for the production of bioactive compounds (Anand et al., 2006);
(Grozdanov & Hentschel, 2007); (Cragg et al., 2009); (Kennedy et al., 2009); (Abdelmohsen
et al., 2010); (O’Halloran et al., 2011). The aim of this study was to culture and identify bacteria
associated with the Irish coastal sponges, Amphilectus fucorum and Eurypon major, and to
assess the diversity and bioactive potential of these bacteria.
2.3 Materials and Methods
2.3.1 Sponge collection and processing
The sponges Amphilectus fucorum and Eurypon major were collected by scuba diving from
Lough Hyne, a sea lough on the south–west coast of County Cork, Ireland (51°30’N 9°18´W),
at depths of 8 m and 15 m respectively, in August 2008 (Kennedy et al., 2009). Detailed de-
scriptions of this Lough and its sponge ecology have previously been published (Bell & Barnes,
2003).
2.3.2 Isolation of bacteria
To remove the contaminants from sea water, the sponge sample was washed in sterile articial
sea water (ASW). On site, 1 g of sponge sample was chopped nely and vortexed with 3 mm
glass beads. The sponge homogenate was then serially diluted using ASW and 100 µl aliquots
were plated out on isolation media supplemented with 30 µg amphotericin B/ml to inhibit
fungal growth. Three dierent media were used: SYP–SW medium (10 g starch/l, 4 g yeast
extract/l, 2 g peptone/l, 33.3 g Instant Ocean/l (Atkinson & Bingman, 1998), 15 g agar/l); Chitin
medium (4 g colloidal chitin/l, 33.3 g Instant Ocean/l, 15 g agar/ l; MMA medium (50 µg yeast
extract/l, 500 µg tryptone/l, 100 µg sodium glycerol phosphate/l, 33.3 g Instant Ocean/l, 15
g/l). These plates were incubated at 18°C for 4–6 weeks, with colonies subsequently selected
for culturing based on morphological features such as colony colour and appearance. Pure
cultures were then sub–cultured on SYP–SW plates and stocks were stored at -80°C for long
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term usage. All chemicals were purchased from Sigma with the exception of Instant Ocean
(Fish Antics, Dublin, Ireland).
2.3.3 Antimicrobial assays
A deferred antagonism assay was used to determine whether bacteria isolated from sponges
possessed antimicrobial activity (Kennedy et al., 2009). In brief, bacteria to be tested were
grown in SYP–SW agar media at 28ºC to a colony size of 0.5–1cm in diameter and then over-
laid with soft agar seeded with bacterial or fungal indicator strains. The bacterial test strains
were grown overnight and 50 µl of the culture was added to the LB soft agar. All the bacterial
strains was diluted to a nal OD600=0.1. For the fungal test strains, similar procedure was
followed but 50 µl of the culture was added on to YEPD soft agar. Incubation was continued
at 28°C and a zone of clearance around the bacteria indicates that it is producing an antimi-
crobial compound to which the test strain is sensitive. The fungal test strains, which were
pre–grown in standard YEPD (10 g yeast extract/l, 20 g peptone/l and 20 g dextrose/l) broth
at 30°C, were Candida albicans SC5314, Candida glabrata CBS138, Saccharomyces cerevisiae
BY4741, Kluyveromyces marxianus CBS6556 and Aspergillus fumigatus Af293). The bacterial
test strains, which were pre–grown in standard LB broth at 37°C, were Bacillus subtilis IE32,
E. coli 12210 and Staphylococcus aureus NC000949.
2.3.4 DNA extraction and PCR Analysis
Bacterial genomic DNA was isolated from fresh colonies or frozen glycerol stocks as follows:
either 25 µl of glycerol stock cultures or a single colony was picked and added to 100 µl TE
buer, which was then heated at 98°C for 30 min. The mixture was then centrifuged at 3913×g
in an eppendorf microfuge for 15 min at 4°C and 3 µl of the supernatant was used to provide
template DNA for PCR. PCR was performed with a total volume of 30 µl containing sterile
water, 1X Taq buer, 2 mM dNTPs, template DNA, Taq DNA polymerase (0.75 U) (Fermentas),
and the universal primers (10 µM each) 27F (5´ AGAGTTTGATCCTGGCTCAG 3´), 1492R (5’
GGTTACCTTGTTACGACTT 3’) (Turner et al., 1999). These primers amplify the 16S rRNA
gene, generating a 1.5 kb PCR product. The conditions were as follows: initial denaturation
(95°C for 5 min), followed by 36 cycles of denaturation (94°C for 30 sec), primer annealing (50°C
for 30sec) and primer extension (72°C for 2 min), completed with a nal primer extension step
(72°C for 10 min).
2.3.5 DNA Sequencing and Phylogenetic analysis
The amplied PCR products were concentrated using an evaporator (GeneVac–MiVac Duo
Concentrator) and sequencing was performed by Macrogen Inc. Korea. Sequences were
trimmed (to between 400 and 600 nt depending on the dataset) using FinchTV (http://
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www.geospiza.com/Products/finchtv.shtml) and then dereplicated using the fastgroup
database with a cut–o value of 98.5% (Seguritan & Rohwer, 2001). Sequence similarity
searches were performed using BLAST with reference sequences being downloaded from the
Ribosomal Database Project (Wang et al., 2007). Sequences were then aligned using MEGA4
software and a phylogenetic tree was constructed using this software (Tamura et al., 2007).
The evolutionary history was inferred using the Neighbour–Joining method (Saitou & Nei,
1987). The bootstrap consensus tree inferred from 1000 replicates is taken to represent the
evolutionary history of the taxa analysed (Felsenstein, 1985). The evolutionary distances were
computed using the Maximum Composite Likelihood method (Tamura et al., 2004) and are
in the units of the number of base substitutions per site. All positions containing gaps and
missing data were eliminated from the dataset (complete deletion option). The 16S rRNA gene
sequences for the isolates were deposited in GenBank under the accession numbers JN039179–
JN039214 for Amphilectus fucorum and JN040567–JN040606, JN616284 for Eurypon major.
2.4 Results
2.4.1 Microbial diversity of the sponges
To try to assess a broad spectrum of bacterial diversity in the two sponges Amphilectus fu-
corum and Eurypon major, tissue extracts from these sponges were inoculated onto three
dierent media, namely SYP–SW, Chitin medium and MMA. 335 strains were selected based
on morphological dierences and microbial diversity was subsequently analysed using 16S
rRNA gene sequencing to identify species and genera. Using Fastgroup algorithm (methods),
these strains were grouped into 76 taxa (based on a 98.5% 16S rRNA cut o) and one repre-
sentative from each group was selected for further analysis. The overall culturable microbial
diversity of the two sponges is shown in pie chart format (Figure 2.1).
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Figure 2.1 : Distribution of the bacterial phyla cultured from a)Amphilectus fucorum
and b) Eurypon major.
16S rRNA sequencing of 335 bacterial strains cultured from the two sponges identied 257 unique 16S
rRNA sequences (110 A. fucorum isolates and 147 E. major isolates). These were grouped using the
Fastgroup programme used to classify bacteria by phylum. The relative distribution (as a percentage)
of phyla in each sponge is illustrated.
For both sponges, Proteobacteria were the dominant group by far: 89% of the Amphilectus
isolates (Figure 2.1a) and 68% of the Eurypon isolates (Figure 2.1b). The Proteobacterial di-
versity was studied in more detail by aligning sequences with references and construction
of a phylogenetic tree (Figure 2.2). The bulk of strains cultured were α and γ Proteobacteria
and although isolates with identical 16S rRNA sequences were not recovered from sponges,
there were not striking dierences in the patterns or groups of Proteobacteria isolated from
both sponges. The most notable feature was the recovery of just one β–Proteobacteria taxon
from Amphilectus, with no β–Proteobacteria recovered from Eurypon. This β–Proteobacteria
taxon was recovered 8 times and the phylogeny indicates that it is likely to represent a species
within the genus Ralstonia (Figure 2.2).
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Figure 2.2 : Phylogenetic tree representing Proteobacteria phyla cultured from both
sponges.
The evolutionary relationships of the Proteobacterial taxa identied among Proteobacteria cultured in
both sponges are shown with reference sequences from RDP and Genbank included. The analysis is
based on the 16S rDNA sequence and aligns a single representative sequence for each group identied
by the Fastgroup program (methods). The number of similar sequences that is represented by each
sequence is shown in brackets, as is the media in which the species was isolated (methods). Cultured
isolates from Amphilectus fucorum and Eurypon major are represented by Nand  respectively. The
neighbour–joining tree was drawn using the MEGA program and bootstrapping percentages (1000
replicates) above 50% are shown. Sequences that may represent novel species are highlighted in bold.
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When comparing other groups, it was seen that Bacteriodetes were isolated at similar frequen-
cies in both sponges (7–8%) whereas the proportion of Firmicutes was considerably higher in
Eurypon (23%) than Amphilectus (3%). Actinobacteria were rarely isolated from either sponge
(~1%). As with the Proteobacteria, detailed phylogenetic analysis does not identify any specic
patterns within other bacterial phyla, although the much higher representation of Firmicutes
in Eurypon is apparent (Figure 2.3).
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Figure 2.3 : Phylogenetic tree representing the non–Proteobacteria phyla cultured
from both sponges
The evolutionary relationships of the the Firmicutes, Actinobacteria and Bacteriodetes taxa identied
in both sponges are shown with reference sequences from RDP and Genbank included. The analysis is
based on the 16S rDNA sequence and aligns a single representative sequence for each group identied
by the Fastgroup program (methods). The number of similar sequences that is represented by each
sequence is shown in brackets, as is the media in which the species was isolated (methods). Cultured
isolates from Amphilectus fucorum and Eurypon major are represented by N and  respectively. The
neighbour–joining tree was drawn using the MEGA program and bootstrapping percentages (1000
replicates) above 50% are shown. Sequences that may represent novel species are highlighted in bold.
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Multiple dierent Bacilli sequence–types are present, suggesting that these spore–forming
bacteria may be common in Eurypon. Most of the bacterial isolates displayed 100% identity to
their related species in BLAST searches indicating that they are isolates of established species.
There were four exceptions to this, with two of the Amphilectus fucorum isolates and two of
the Eurypon major isolates (represented in bold in Figure 2.2 and Figure 2.3) showed 97%
or less identity to their nearest neighbours. These may represent novel species and further
studies are being carried out to classify and characterise these bacteria.
2.4.2 Antimicrobial activity of sponge–associated bacteria
A total of 409 bacterial isolates were tested for anti–fungal activity against C. albicans, C.
glabrata, S. cerevisiae, K. marxianus and A. fumigatus and for anti–bacterial activity against
E. coli, B. subtilis and S. aureus using a deferred antagonism assay. None of the isolates dis-
played any anti–fungal activity but ve of the isolates from Amphilectus fucorum and three
isolates from Eurypon major displayed activity (Table 2.1). Isolates 113V, 107L, 108L and 109L
inhibited both E. coli and B. subtilus and a further four strains inhibited one or the other of
these test bacteria. None of the isolates displayed anti–staphylococcal activity under these
assay conditions. Interestingly, all the active isolates were Pseudovibrio sp. and in fact, 8 of
the 12 Pseudovibrio strains isolated in this study displayed anti–bacterial activity, indicating
that such activity is common in the genus.
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Table 2.1 : Isolates showing antimicrobial activity against test bacterial strains1
Name of the sponge Sponge isolates Test strains
E. coli 12210 B. subtilis IE32 S. aureus NC000949 Fungal strains2
Amphilectus fucorum 117V + – – –
113V + + – –
115V + – – –
112V + – – –
83V1 – + – –
Eurypon major 107L + + – –
108L + + – –
109L + + – –
1Activity detected using a deferred antagonism assay.
2Five fungal strains tested as described in methods.
2.5 Discussion
In this study, it has been seen that in overall terms, the diversity of culturable bacteria, and
dominance of Proteobacteria is similar to that which has been reported for other Irish ma-
rine sponges such as Haliclona simulans (Kennedy et al., 2009). Actinobacteria were rarely
isolated from either sponge (~1%), a nding that contrasts with studies with other sponges
such as Haliclona simulans (Kennedy et al., 2009). This low frequency of Actinobacteria could
indicate that this group is less frequently found in Amphilectus fucorum and Eurypon major
than Haliclona simulans but it should be noted that the methodology for isolating bacteria
was not the same in both studies: in particular, this study did not use any medium that was
specically selective for Actinobacteria, such as SYP with Nalidixic acid (Kennedy et al., 2009).
It must be considered that the medium used will inuence the cultured diversity; for example,
in this study, whereas α and γ Proteobacteria were isolated on all 3 media used, Firmicutes
were only recovered on SYP–SW medium (Figure 2.4, Table 2.2).
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Figure 2.4 : Phyla isolation from dierent media.
The chart shows the phyla distribution from each of the three media SYP, MMA and Chitin. Inter-
estingly, although Proteobacteria were isolated on all three media, no Bacteriodetes were isolated on
chitin agar and Firmicutes and Actinobacteria were isolated only from SYP.
Table 2.2 : Number of isolates recovered from each phyla.
Phyla Media Number of isolates
Actinobacteria SYP 3
Firmicutes SYP 37
Bacteriodetes
SYP 15
MMA 9
γ Proteobacteria
SYP 90
MMA 2
Chitin 20
β Proteobacteria SYP 9
α Proteobacteria
SYP 45
MMA 3
Chitin 28
It was observed that 8 of the 12 Pseudovibrio isolates from the sponges showed anti–bacterial
activity which is in accordance with the previous studies which also reported anti–bacterial
activity from Pseudovibrio sp. against E. coli, B. subtilis, B. cereus and S. aureus (Sertan-de Guz-
man et al., 2007); (Kennedy et al., 2009); (Santos et al., 2010) as well as Pseudomonas aeruginosa,
Acinetobacter calcoaceticus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Entero-
coccus faecium and Enterococcus faecalis (Santos et al., 2010). Furthermore, Pseudovibrio sp.
isolated from three Irish marine sponges, Polymastia boletiformis, Axinella dissimilis and Hal-
iclona simulans, have also previously been reported to display activity against a number of
important pathogens includingClostridium perfringens and Yersenia enterocolitica (O’Halloran
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
63 Lekha Menon Margassery
2. Diversity and antibacterial activity of bacteria
isolated from the coastal marine sponges Amphilectus
fucorum and Eurypon major 2.5 Discussion
et al., 2011). Studies have reported that the roseobacter from the order Rhodobacterales pro-
duces a novel tropolone antibiotic, tropodithietic acid (TDA) that maintain symbiosis with
their algal hosts. Recently, scientists from the US have identied that the expression of this
antibiotic is controlled by a novel autoinducer and the genes that are important for the pro-
duction of TDA was also identied in Pseudovibro sp. suggesting that the marine Pseudovibrio
strains isolated from this study could also be producing TDA (Geng & Belas, 2010). It is in-
teresting that all the Pseudovibrio were recovered in chitin agar (Figure 2.4). Furthermore,
production of secondary metabolites or other antimicrobials is often tightly regulated, and
thus it may be that, for some bacteria, the conditions in this particular assay did not induce
their synthesis.
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Chapter 3
Aquimarina amphilectae sp. nov.,
isolated from the Irish sponge
Amphilectus fucorum 1
3.1 Abstract
A gram negative, rod–shaped orange–coloured, catalase and oxidase positive, non–motile
bacterium designated as 92VT was isolated from the marine sponge, Amphilectus fucorum,
collected from Lough Hyne, Co. Cork, Ireland. 16S rRNA gene sequence analysis revealed
that strain 92VTclustered with members of the family Flavobacteriaceae, the closest mem-
ber being Aquimarina latercula, with a gene sequence similarity of 97%. The dominant fatty
acids were iso–C17:0 3–OH (38.4%), iso–C17:1 ω9c (11.8%) and iso–C15:0 3–OH (10.1%). Com-
bined phenotypic dierences and phylogenetic analysis indicates that 92VT represents a novel
species of the genus Aquimarina, for which the name Aquimarina amphilectae sp. nov is pro-
posed with 92VT as the type strain (=NCIMB 14726, DSM25232). The GenBank/EMBL/DDBJ
accession number for the partial 16S rRNA gene sequence of strain 92VT is JN039190.
3.2 Introduction
The genus Aquimarina, rst described in 2005, is classied as yellow pigmented, gram–
negative, aerobic, heterotrophic bacteria in the family Flavobacteriaceae (Nedashkovskaya
et al., 2005); (Bernardet & Nakagawa, 2006). There has been nine species of Aquimarina so far
identied from dierent studies (Nedashkovskaya et al., 2005); (Nedashkovskaya et al., 2006);
(Yoon et al., 2006); (Miyazaki et al., 2010); (Yoon et al., 2011); (Yi & Chun, 2011); (Lin et al., 2011);
(Park et al., 2011). In this study we report a new strain of Aquimarina–like bacterium isolated
1Under review
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from a marine sponge Amphilectus fucorum and the name Aquimarina amphilectae sp. nov.,
is proposed for this novel strain.
3.3 Materials and Methods
3.3.1 Isolation of bacteria
In the study of screening for bioactive producing bacteria, many culturable bacteria were iso-
lated from the marine sponge Amphilectus fucorum collected from the Lough Hyne, Co. Cork,
Ireland (51°30’N 9°18´W). Strain 92VT was initially isolated from sponge extracts inoculated
onto MMA medium (0.005% yeast extract, 0.05% tryptone, 0.01% sodium glycerol phosphate,
3.33% articial sea salts ‘Instant Ocean’ brand, 1.5% agar) and incubated at 18°C for 4–6 weeks
(Margassery et al., 2012). The strain was subsequently sub–cultured on SYP–SW agar (1%
starch, 0.4% yeast extract, 0.2% peptone, 3.33% articial sea salts ‘Instant Ocean’ brand) and
incubated at 28°C.
3.3.2 DNA extraction and PCR amplication
For PCR amplication of the 16S rRNA gene, bacterial genomic DNA was extracted from fresh
colonies to provide template DNA for PCR. PCR amplication was performed with a total vol-
ume of 30 µl using Taq DNA polymerase (Fermentas) the 16S rRNA universal primers (10 µM
each) 27F (5´ AGAGTTTGATCCTGGCTCAG 3´), 1492R (5’ GGTTACCTTGTTACGACTT 3’)
(Turner et al., 1999) to amplify the near complete 16S rRNA gene. PCR reaction conditions
were as follows: initial denaturation (95°C for 5min), followed by 36 cycles of denaturation
(94°C for 30 sec), primer annealing (50°C for 30 sec) and primer extension (72°C for 2 min),
completed with a nal primer extension step (72°C for 10 min). The amplied PCR product was
gel puried and sequenced (GATC Biotech). Sequence similarity searches were performed us-
ing BLAST with reference sequences being downloaded from the Ribosomal Database Project
(Wang, 2006); (Wang et al., 2007). Sequences were then aligned using MEGA4 software and
a phylogenetic tree was constructed using this software (Tamura et al., 2007). The evolution-
ary history was inferred using the Neighbour–Joining method (Saitou & Nei, 1987) and con-
rmed using maximum likelihood analysis. The bootstrap consensus tree inferred from 1000
replicates is taken to represent the evolutionary history of the taxa analysed (Felsenstein,
1985). The evolutionary distances were computed using the Maximum Composite Likelihood
method (Tamura et al., 2004) and are in the units of the number of base substitutions per site.
All positions containing gaps and missing data were eliminated from the dataset (complete
deletion option).
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3.3.3 Phenotypic, Biochemical and Chemotaxoniomal tests
The growth of the strain was monitored both under anaerobic and aerobic conditions. Tem-
perature growth range was determined on 2216 plates (Difco) incubated at temperatures rang-
ing from 4–45°C that were monitored for 6 weeks. pH growth range was monitored in marine
cytophaga broth containing 4% articial sea salts (Sigma) with pH ranging from 4–11 and incu-
bated at 25°C for 6 weeks. Penicillin G susceptibility was tested by spreading the isolate onto
2216 plates with a 1 µg penicillin G being placed on the surface. The plates were incubated at
25°C for 7 days and checked periodically for a zone of inhibition.
API enzyme tests were set up with the following modications. The colonies were suspended
in either 0.85% NaCl and an incubation temperature of 25°C was used. As the API strips did
not show any indication of growth after 24 h, the incubation temperature was prolonged to
48–72 h. The API ZYM was also increased from 4 h to 20 h. Fatty acid proles were performed
by growing the culture on 2216 media and were analysed using the Sherlock Microbial Iden-
tication System by MIDI Inc. The DNA G+C content of the strain 92VT was determined
by HPLC (Mesbah et al., 1989); (Tamaoka & Komagata, 1984); (Visuvanathan et al., 1989). All
the tests were carried out at The National Collection of Industrial, food and Marine Bacteria
(NCIMB).
3.4 Results
3.4.1 Phylogenetic analysis
According to the partial 16S rRNA gene sequence similarity, 92VT was 97% similar to Aquima-
rina latercula strain (Figure 3.1). It was evident that this strain belongs to the Aquimarina
genus and 16S rRNA gene analysis indicated it was a potential new species. The Genbank
accession number for this strain is JN039190.
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Figure 3.1 : Phylogenetic tree based on 16S rRNA gene sequences of strain and
related genera in the family Flavobacteriaceae
The tree was constructed using the neighbour–joining method. Numbers at nodes indicate bootstrap
values (%). All branches were also maintained in the maximum likelihood tree.
3.4.2 Phenotypic characterisation
The determination of exirubin type pigments was carried out as described (Bernardet &
Nakagawa, 2006); (Bernardet et al., 2002). Other tests such as gram–staining, catalase, oxidase,
motility starch and agar hydrolysis, acid production from sugars, hydrolysis of tween80 were
investigated as described in previous studies (Healing, 1993); (Johnson & Chilton, 1966). The
cellular morphology was examined using the Leica Light Microscope (Leica DM3000) and the
cells range from 0.2 µm to 0.25 µm in width and from 2.2 µm to 2.7 µm in length (Figure 3.2).
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Figure 3.2 : Microscopic examination of the strain 92VT.
The width and the length of the cells are measured and labelled using the in–built Leica LMD software.
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The phenotypic, biochemical and chemotaxonomic tests are represented in Table 3.1 and Table
3.2.
Table 3.1 : Phenotypic dierences of strain 92VT with the type strains of other Aqui-
marina species.
Strains: 1, 92VT; 2, A. mytili KCTC 23302; 3, A. brevivitae KCTC 12390; 4, A. intermedia JCM 13506; 5,
A. latercula JCM 8515; 6, A. macrocephali JCM 15542; 7, A. muelleri KCTC 12285; 8, A. spongiae KCTC
22663; 9, A. addita KACC 14156; 10, A. agarilytica NBRC 10695. +, Positive; –, Negative; ND, Not
determined. 1 and 5 are from this study. The rest of the data was taken from previous studies (Yi &
Chun, 2011); (Lin et al., 2011); (Park et al., 2011).
Characteristic 1 2 3 4 5 6 7 8 9 10
Temperature (°C) 10–30 15–37 10–41 4–36 4–34 8–30 4–34 10–35 4–30 4–30
pH 6–10 7–9 5.5–10 ND ND ND ND 6–11 6–8 6–9
NaCl range (%) 2–5 1–4 1–10 1–10 1–5 1–4 1–8 1–5 3–7 1–4
Anaerobic growth – – – – – – – – – –
Catalase activity + + + + – + + + + +
Oxidase activity + + + + + + + + + +
Alkaline phosphatase activity + + ND + + ND + + + +
Gliding motility – + + + – + + – – –
Flexirubin–type pigments – – – + – – – – – –
Nitrate reduction – + + – + + – + + –
H2S production – – – + + – – – – –
Acid production from glucose – – – – – + – – – +
Penicillin G resistance + + + – + + + – ND –
Hydrolysis of:
Agar – – – – + – – – – +
Aesculin + + + + + – – + + ND
Tween 80 – + + + + – + + + –
Starch + + + + – + + + + +
Enzyme activities:
N–Acetyl–β–glucosaminidase + + – – – – – – – ND
α–chymotrypsin + – + – + – + + – ND
Esterase lipase + – + – + – + – – ND
β–galactosidase + – – + + – – – – +
β–glucosidase + – + – – – – – – ND
Trypsin + – + – – – – – + ND
Valine arylamidase + + + + + – + + + ND
DNA G+C content (mol %) 36.1 37.9 36 37.1 34 33.1 31.9 36.9 35 32.8
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Table 3.2 : Fatty acid compositions (%) of strain 92VT compared to the other Aquima-
rina strains.
Strains: 1, 92VT; 2, A. mytili KCTC 23302; 3, A.brevivitae KCTC 12390; 4, A.intermedia JCM 13506;
5, A.latercula JCM 8515; 6, A.macrocephali JCM 15542; 7, A.muelleri KCTC 12285; 8, A.spongiae KCTC
22663; 9, A.addita KACC 14156; 10, A.agarilytica NBRC 10695. +, Positive; –, Negative; ND, Not deter-
mined; Tr– Trace. 1 and 5 are from this study. The rest of the data was taken from previous studies (Yi
& Chun, 2011); (Lin et al., 2011); (Park et al., 2011).
Fatty acid 1 2 3 4 5 6 7 8 9 10
C16:0 0.8 3.3 1.0 4.4 1.59 3.9 10.2 1.9 – 5.1
C18:0 – 1.7 Tr 3.3 – – 6.7 1.0 1.8 ND
C17:1 ω6c 3.4 – – Tr 1.77 – – – 1.5 ND
iso–C13:0 0.4 Tr Tr Tr – 4.4 1.9 Tr – Tr
iso–C15:0 12.2 34 21.5 27.1 18.64 16.8 21.1 38.1 13.3 21.6
iso–C16:0 3.5 1.4 2.5 1.6 6.85 Tr – 1.3 1.1 ND
iso–C15:1 G 2.6 12.6 12.3 12.5 7.49 8.7 6.1 15.5 5.4 4.3
iso–C16:1 H 1.3 – 1.6 1.2 – – – – – ND
iso–C17:1ω9c 11.8 7.6 5.9 9.2 7.8 6.0 9.4 8.2 – ND
C16:0 3–OH 1.7 Tr 1.5 Tr 2.85 14.5 1.5 0.7 1.2 5.4
iso–C15:0 3–OH 10.1 – 4.9 4.5 5.24 4.8 4.7 5.3 6.1 2.4
iso–C16:0 2.6 – 2.4 1.1 2.16 – – Tr 1.2 Tr
iso–C17:0 3–OH 38.4 22.3 30.4 23.3 27.44 24.4 28.8 18.1 30 15.4
Phylogenetic analysis indicated that 92VT was a member of the genus Aquimarina. The level
of 16S rRNA sequence similarity (94–97%) to the other members of this genus indicated that it
could be a novel species. Phenotypic analysis testing clearly indicated 92VT had all the typical
characteristics of the genus Aquimarina but a unique phenotypic prole compared to other
members of this genus. The dierences in enzyme reactions as well as the higher percentage
of the fatty acid iso–C17:0 3–OH and the various other fatty acids mentioned in Table 3.2
clearly dierentiated the new isolate from recognized species of the genus Aquimarina.
3.4.3 Description of Aquimarina amphilectae sp. nov.
The strain is strictly aerobic, gram–negative, non–sporulating, non–motile rods with parallel
ends. Colonies, on 2216 agar plates were shiny, smooth, translucent and raised, and produced
a non–diusible orange pigment (exirubin negative). The strain grows at 10–30°C (optimum,
25°C) and at pH 6–10 (optimum, pH 6–7). The strain requires sea salt for its growth and it
grows on media with articial sea salts but not on media supplemented with only NaCl.
The strain is catalase, oxidase and alkaline phosphatase positive, is able to hydrolyse starch
and aesculin and is resistant to penicillin G. There is no nitrite or nitrate reduction, nor hy-
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drolysis of casein, agar or Tween80. Results for indole production, gelatinase, β–galactosidase
were variable. The major fatty acid present is iso 3–OH C17:0 (38.4 %). Other acids greater
than 10% are iso–C15:0 (12.2%), iso 3–OH C15:0 (10.1%) and iso–C17:1 ω9c (11.8%). The DNA
G+C content of the type strain 92VT is 36.1 mol%. The type strain, 92VT (= NCIMB 14726),
was isolated from the marine sponge, Amphilectus fucorum.
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Chapter 4
A high–throughput screen to
identify novel calcineurin
inhibitors 1
4.1 Abstract
Calcineurin is a eukaryotic protein phosphatase important for many signalling and develop-
mental processes in cells. Inhibitors of this enzyme are used clinically and there is interest
in identifying novel inhibitors for therapeutic applications. This report describes a high–
throughput assay that can be used to screen natural or chemical libraries of compounds to
identify new calcineurin inhibitors. The microtitre plate assay is based on a yeast reporter
strain and was validated with known inhibitors and tested in a pilot screen of bacterial ex-
tracts and a sponge metagenomic library.
4.2 Introduction
Calcineurin is a highly conserved, eukaryotic calmodulin–dependent serine/threonine phos-
phatase type 3CA (formerly PP2B). In mammalian cells, it participates in diverse cellular
processes such as signal transduction, cell–cycle regulation, stress response and apoptosis
(Rusnak & Mertz, 2000) and has recently been implicated in several important neurodegen-
erative disorders, including schizophrenia (Kvajo et al., 2010); (Tabarés-Seisdedos & Ruben-
stein, 2009). In the immune system, calcineurin is centrally involved in maturation of T cells
and, for this reason, most immunosuppressive therapies involve the use of calcineurin in-
hibitors (CNI) (Castroagudín et al., 2011). The most widely used CNIs are cyclosporin A and
tacrolimus (FK506), both of which are natural microbial metabolites that bind to intracellu-
1Published: (Margassery et al., 2012)
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lar receptors known as immunophilins, which then block calcineurin function. The mode of
action of and history of these CNIs has been extensively studied and very well–documented
(Liu et al., 1991); (Pritchard, 2005). Interestingly, the main details of the mechanism of action
of both cylcosporin A and FK506 were rst determined in the budding yeast, S. cerevisiae,
something made possible by the strong conservation of calcium signalling pathways and cal-
cineurin across the Eukarya (Fox & Heitman, 2002). Although CNI are extensively used for
immunosuppressive therapy, most notably in organ transplantation, there are cardiovascular,
renal and other side–eects that can occur with long–term use (Rezzani, 2006); (Fung et al.,
1991) and thus there is interest in identifying novel calcineurin inhibitors. Furthermore, such
molecules may also have potential as novel anti–fungal agents (Steinbach et al., 2007) and
applications even as cell biology reagents to study calcium signalling and homeostasis are
possible.
The most prolic reservoir of bioactive molecules has always been the natural world and the
majority of molecules used in medicine are derived from microbes or plants. Many antibi-
otics, as well as important drugs such as CsA, tacrolimus (FK506) and sirolimus (rapamycin),
are of microbial origin and in the new current of genome biology there is renewed interest
in bioprospecting to identify new microbial metabolites with therapeutic applications. The
challenge of developing screens to identify specic inhibitory activities remains, however,
and modern requirements stipulate that any methods are specic, rapid, high–throughput
and automatable in so far as is possible. Current methods to screen for calcineurin inhibitors
are limited and do not satisfy these requirements (Fruman et al., 1992); (Enz et al., 1994); (Sellar
et al., 2006). The aim of this study was to develop a new screen for calcineurin inhibitors that
would be compatible with robotic handling systems for screening large numbers of microbial
extracts, metagenomic libraries or combinatorial chemistry libraries.
The screen was developed using yeast reporter strains. In yeast, as in mammalian cells, var-
ious extracellular signals lead to a transient increase in calcium ions in the cytoplasm. The
cytoplasmic protein calmodulin binds calcium and then activates calcineurin. The targets of
calcineurin dier among organisms, with the transcription factor Crz1p, the main target in
yeast. Following dephosphorylation by calcineurin, Crz1p translocates to the nucleus where
it activates transcription of target genes by binding to a promoter sequence known as the
CDRE element (Kraus & Heitman, 2003); (Cyert, 2003). The conservation of calcineurin in
Eukarya facilitated the development of this yeast screen.
4.3 Materials and Methods
4.3.1 Strains and growth conditions
Saccharomyces cerevisiae BY4741 was used as the standard strain for all assays. Typically,
yeast strains were grown in YNB medium at 30°C with appropriate auxotrophic selection to
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maintain plasmids (Sherman, 1991). Routine lithium acetate transformation (Gietz et al., 1992)
was used to introduce the reporter plasmids pMRK212, which carries a CRZ1::lacZ fusion
(Serrano et al., 2002), and pRSP97, which carries a GFP::CRZ1 fusion (Polizotto & Cyert, 2001).
4.3.2 Development of the assay
To prepare yeast cells for the assay, the strain carrying the CRZ1::lacZ fusion was grown
overnight and inoculated into fresh medium at an A600 of 0.1. The fresh culture was allowed
to undergo 2–3 doublings (approximately 5 h) before cells were harvested by centrifugation
and resuspended at an A600 of 0.4. 25 µl of this cell suspension followed by 25 µl of the test
reagent (or control solution) was added to each well of a 96–well polystyrene micro titre at
bottomed plate and the plate incubated at 30°C for 30 min. Next, alkaline stress is provided by
adding 25 µl of TAPS (N–Tris(hydroxymethyl)methyl–3–aminopropanesulfonic acid) pH 8.1
(100 mM stock, nal concentration, 33.3 mM) and incubating at 30°C for 1 h. A β–galactosidase
activity assay was then performed as follows. 75 µl of Z–buer of pH 7.0 (60 mM disodium
hydrogen phosphate, 40 mM Sodium dihydrogen phosphate, 10 mM KCl, 1 mM Magnesium
sulphate heptahydrate) was added. Cell lysis was by addition 75 µl of lysis buer (1% N–
lauroylsarcosine and 0.5% β–mercaptoethanol in Z–buer) and incubation for 30 min at 30°C.
The use of N–Lauroyl sarcosine for cell lysis was to avoid the eect of chloroform on the
plastic microtitre plates (Kippert, 1995). Lysis was followed by the addition of 25 µl ONPG
solution to each well and incubation at 30°C until a yellow colour developed in the positive
control (typically 20 mins). The time was recorded and the reaction stopped by addition of 60
µl of 1 M Na2CO3. The A405 was then measured in a plate reader (Thermo Multiskan FC) and
units calculated. Arbitrary units were dened as follows: Activity = [A405×1000] / [Time (min)
× Volume of the cells (ml)]. The A600 of the cells is not included in the formula as experience
showed that although the assay is highly reproducible with respect to the relative values of
positive and negative controls, absolute values can vary and all data must be compared to
these controls within an experiment. For comparison, all values were then normalised with
the negative control (typically ~150 units) given a value of 1.
4.3.3 Testing and validation of the assay
All assays include a well to which no TAPS is added and this serves as the base–line from
which an increase in expression following alkaline stress is observed. All other wells have
TAPS added as described above and so should see an increase in expression of the CDRE::lacZ
reporter. One well simply has 25 µl control solution (medium or organic solvent as appro-
priate to the test) and this is the positive control for the assay, whereas all the test wells
have solutions or metabolites pre–added in advance of the TAPS (above). To validate the sys-
tem, the eects of three known calcineurin inhibitors: FK–506 (Tacrolimus), Cyclosporin A
and Ascomycin as well as three other inhibitors/anti–fungal metabolites: Okadaic acid, Ra-
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pamycin (Sirolimus) and uconazole, were tested. Each of these reagents prepared in appro-
priate stocks and added to a nal concentration as follows: FK–506 (1.5 µg/ml) Cyclosporin A
(25 µM), Ascomcyin (0.004 µM), Rapamycin (0.78 µM) and Okadaic acid (1.56 µM), Fluconazole
(0.125 mM). With the exception of uconazole (Sigma), all other test reagents were purchased
from LC Laboratories, USA. Following validation, a pilot screen was performed with 81 bac-
terial extracts. The bacteria used were largely marine–sponge associated bacteria cultured as
part of a larger marine biodiscovery project (Kennedy et al., 2009). The bacteria were cul-
tured for 7–14 days in SYP broth (10 g starch/l, 4 g yeast extract/l, 2 g peptone/l, 33.3 g Instant
Ocean/l) to obtain supernatant. These extracts were prepared from bacterial culture super-
natant by treating cell–free supernatant with amberlite XAD–16 resin for 2–4 h, which was
then washed with water and eluted with methanol. This concentrated methanol extract was
diluted 1 in 10 with YNB media for the assay. All experiments are carried out in triplicate.
4.3.4 Screening of calcineurin inhibitors from a sponge metagenomic li-
brary
The metagenomic library of the marine sponge, Haliclona simulans was constructed as de-
scribed previously (Lejon et al., 2011). The total community DNA was extracted from the
microbiota associated with the sponge Haliclona simulans which was collected from from the
Kilkieran bay, Galway coast on the west coast of Ireland, at a depth of 15 m (N 53°18.944´,
W 09°40.140´) in August 2007. It was size–fractionated using pulse–eld–gel–electrophoresis
and an insert of ~40kb was cloned into a fosmid Copy Control pCC1FOS™ vector to construct
a metagenomic library. The library constituted approximately 48,000 clones. The clones
were transferred to 384–well plates containing the storage media (10 g tryptone/l, 5 g yeast
extract/l, 5 g NaCl/l, 6.3 g KH2PO4/l, 1.8 g KH2PO4/l, 0.5 g trisodium citrate/l, 0.9g ammonium
sulphate/l, 0.09 g MgSO4.7H2O/l, 60 ml glyerol/l) using the QPIX2–XT robot after an in vitro
packaging of lambda phages and infection of E. coli TransforMax™ EPI300™. The clones that
were stored in –80°C in a 384–well plate were thawed and replicated onto another 384–well
plate using the robot containing LB supplemented with 12.5 µg chloramphenicol/ml. Follow-
ing overnight incubation 37°C, the clones were replicated on to 96 deep–well plates contain-
ing LB supplemented with 12.5 µg chloramphenicol/ml and 0.01% arabinose for increasing the
copy number and incubated at 37°C overnight. Approximately 3840 clones were screened by
the high–throughput assay described above to determine whether they carried genes encod-
ing proteins that were able to inhibit the calcineurin pathway.
To prepare the extract, clones were lysed in situ by treating with 1 mg lysozyme/ml for 15
min followed by three freeze–thaw cycles at an interval of 15 min for each step. The plates
were then centrifuged at 6104×g for 15 min and the supernatant was taken as the test extract
for the calcineurin assay. The calcineurin assay was performed by adding 25 µl as mentioned
above. Simultaneously, a control E. coli strain with no insert was treated as above.
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4.3.5 Characterisation of metagenomic clones
Eight fosmids (HS02P13, HS03E21, HS03I9, HS04F24, HS07C7, HS07F21, HS07N21, HS88E5)
were sequenced using 454 pyrosequencing (Roche, GS FLX+ system) with the pool of other
clones. Both the sequencing and assembly were done at the University of Liverpool, Centre
for Genomic Research. The contigs for all the fosmids were assembled using the RAMMCAP
pipeline (Li, 2009) hosted by CAMERA (Sun et al., 2011). ORF predictions were analysed and
rened by blastp hosted by NCBI.
The clone HS02P13 was studied in detail to identify the genes that were responsible for the
inhibition of the calcineurin pathway. Conventional gene cloning using restriction enzymes
BsiWI, HindIII, PmlI, NheI and AatII were performed. The fosmids were self–ligated and indi-
vidual inserts were transformed into an E. coli strain EPI300 and selected in LB supplemented
with 12.5 µg chloramphenicol/ml. The genes of interest (predicted protein, phosphatidyl ser-
ine decarboxylase, NADH:ubiquinone oxidoredcutase M and N subunit, NADH:ubiquinone
oxidoredcutase N subunit and NADH:ubiquinone oxidoredcutase L subunit) were digested
with KasI, EcoRI, BglII and SphI respectively. Sub–cloning of the various genes into pLIT-
MUS 39 (Evans et al., 1995) was performed by linearizing the vector (KasI, EcoRI, BamHI and
SphI) and treating with alkaline phosphatase (New England Biolabs) to prevent the recir-
cularization of the vector. Each of the plasmid containing various genes were transformed
into XL–10 Gold Ultracompetent E. coli cells (Stratagene), and the clones were selected in
LB supplemented with 100 µg carbenicillin/ml. The plasmids from 10 individual clones from
each of the sub–cloning experiments were isolated using the alkali–lysis method (Fermentas
kit). These were analysed using restriction digestion with the restriction enzymes mentioned
above to ascertain if the genes were properly inserted. Two clones from each experiment com-
prising the genes mentioned above were screened for anti–calcineurin activity as described
in Section 4.3.2. The gene that was not screened initially was the hypothetical protein (as
conrmed by blastp). Hence an additional sub–cloning was done by digesting the gene us-
ing MfeI and linearizing the vector using the same enzyme. Cloning was done as mentioned
above and two clones were tested for anti–calcineurin activity. All the restriction enzymes
were purchased from Fermentas.
4.3.6 Fluorescence Microscopy
Epiuorescent microscopy was used to visualize the GFP::Crz1p fusion protein in yeast cells
with or without alkaline stress and with or without inhibition of calcineurin. Strain BY4741
carrying the pRSP97 reporter plasmid was grown to mid–log phase (A600= ~0.8) in YNB media
at 30°C. Cultures were split and exposed to alkaline stress by treating with 30 mM KOH (or
control treatment). Individual cultures were also contemporaneously treated with FK506 or
putative calcineurin inhibitors to observe the eect on Crz1p localization. Following addition
of KOH and the putative drug incubation followed for 15–30 min at 30°C in a dark room
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before cells were visualised by epiuorescent microscopy. For visualization, 25 µl of each
sample is taken and visualized with DIC and GFP using an I3 lter (emission of 450–490
nm and excitation of 510 nm). The image is then visualized and captured by using the Leica
Florescence Microscope.
4.4 Results
4.4.1 Development of a high–throughput assay of calcineurin activity
The basis of the high–throughput assay to identify calcineurin inhibitors developed in this
study is that calcineurin activity can be detected by the activity of a CDRE::lacZ gene fusion,
which is carried on the pMRK212 plasmid. A cytoplasmic calcium spike is triggered by alkaline
stress (addition of TAPS buer at pH 8.1) and this in turn activates calmodulin, calcineurin and
Crz1p, which then binds to the CDRE element on the reporter construct activating expression.
Expression of the CDRE::lacZ gene fusion can be detected using a modied assay for the β–
galactosidase enzyme. A major criterion for the assay was that it could be performed in a 96
well microtitre plate, thereby being amenable to HT robotic methods if desired. Although all
individual aspects of the system are routine in yeast, integration into a single assay required
various modication and optimizations mentioned in the methods. This culminated in the
high–throughput assay illustrated in Figure 4.1.
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Figure 4.1 : Overview of a scalable assay to identify calcineurin inhibitors.
The diagram provides an overview of the method used to assay for calcineurin inhibitors. The key fea-
ture is that calcium–mediated induction of β–galactosidase in the reporter strain requires calcineurin
activity. Any molecule that inhibits this activity will prevent the alkali shock (TAPS)–mediated induc-
tion of expression and this is detected by an enzymatic assay. All steps of the assay can be performed
by a robotic system.
The specicity of the assay was validated by assessing the eects of known calcineurin in-
hibitors as well as inhibitors of other classes of phosphatase and anti–fungal compounds (Fig-
ure 4.2). The induction of CDRE::lacZ expression by alkali stimulation is seen by the increase
from lane 1 to lane 2. The inclusion of the calcineurin inhibitors FK506 (lane 3), ascomycin
(lane 4) or cyclosporin A (lane 5) prevents the induction, thereby demonstrating how cal-
cineurin inhibitors can be identied. It is important for the assay that the eect is specic
to calcineurin inhibition, therefore Rapamycin, an immunosuppressive drug with a distinct
mode of action from CNIs (lane 6) and Okadaic acid, which inhibits the class of PP2A phos-
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phatases (lane 7) and were also tested. Neither of these potent molecules prevented induc-
tion of CDRE::lacZ expression. In addition, it was conrmed that the assay is independent
of inhibitory eects on yeast growth; for example, inhibitory eects of the anti–fungal drug
uconazole has no eect on the assay (data not shown).
Figure 4.2 : Validation of the calcineurin inhibition assay.
The calcineurin inhibition assay was carried out in a microtite plate as indicated in Figure 4.1. Dierent
treatments, including known calcineurin inhibitors and other classes of inhibitory molecules, were
included as indicated in each lane. With the exception of lane 1 (negative control), all treatments
included stimulation by addition of TAPS, pH 8.1. Lane 1, negative control, no stimulation; lane 2,
positive control; lane 3, FK–506; lane 4, ascomycin; lane 5, cyclosporin A; lane 6, rapamycin; lane 7,
okadaic acid. The eect of the known calcineurin inhibitors is seen in lanes 3–5, whereas unrelated
inhibitors have no eect on the assay (lanes 6 & 7). Assays were carried out in triplicate.
4.4.2 Application of the calcineurin inhibition assay in a pilot screen
A pilot screen was carried out to validate the assay and to demonstrate its applicability for
high–throughput approaches. A library of extracts of marine sponge–associated bacteria was
available for this. One microtitre plate that contained methanol extracts from 81 dierent bac-
teria was tested to identify candidate calcineurin inhibitors. From this assay, three candidate
extracts with potential calcineurin inhibition were identied. This is illustrated in Figure 4.3,
where data for examples of two non–inhibitory extracts (lanes 3 and 4) as well as the three
inhibitory extracts (lanes 5–7) are presented. The other 76 non–inhibitory extracts followed
the pattern seen in lanes 3 and 4 (data not shown).
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Figure 4.3 : Pilot screen to identify calcineurin inhibitors in a library of bacterial
extracts.
A library of 81 bacterial extracts was tested in a pilot screen to identify candidate calcineurin inhibitors.
The assay was as described in Figure 4.1, with controls as described in Figure 4.2. With the exception
of lane 1 (negative control), all treatments included TAPS alkaline shock and all treatments included
the same solvent (10% methanol). 78 extracts that were negative are represented by lanes 3 and 4, and
data from the three positive extracts are shown in lanes 5–7. Extracts are denoted by library numbers.
Lane 1, negative control, no stimulation; lane 2, positive control; lane 3, 24 N; lane 4, 20; lane 5, SM8;
lane 6, FMK7A; lane 7, FMK1B. It is seen that the relative expression in lanes 3 and 4, exceeds that
of the positive control (lane 2) whereas relative expression in lanes 5–7 is more similar to that of the
negative control (lane 1). Assays were carried out in triplicate.
4.4.3 Metagenomic library screening
A second pilot screen was carried out to determine whether the method was suitable for
screening metagenomic libraries (Figure 4.4). A metagenomic library that constituted of
48,000 clones of Haliclona simulans was constructed as mentioned previously (Lejon et al.,
2011).
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Figure 4.4 : Strategy to identify putative calcineurin inhibitor genes in a sponge
metagenomic library.
The metagenomic library of microbiota associated with H. simulans was screened to identify potential
inhibitors that block the calcineurin pathway. Eight putative clones were identied and sequenced.
The clone HS02P13 that showed the best inhibition was subjected to cloning strategies and a hypo-
thetical protein was identied as a putative candidate.
Approximately 3840 clones from this metagenomic library were screened for anti–calcineurin
activity using the high–throughput screen developed. Eight clones were found to inhibit the
calcineurin pathway in S. cerevisiae (Figure 4.5).
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Figure 4.5 : Metagenomic sponge library screening.
A sponge metagenomic library of approximately 3840 clones was screened to identify putative clones
that showed calcineurin inhibition. The assay was as described in Figure 4.1, with controls containing
the lysate from an E. coli strain without any insert represented in lanes 1 and 2. With the exception
of lane 1 (negative control), all treatments included TAPS alkaline shock. 3832 clones are represented
by lane 3 and data from the eight positive clones are shown in lanes 4–11. The extracts are denoted
by library numbers. Lane 1 negative control, no stimulation; lane 2, positive control; lane 3, HS01M5;
lane 4–11 (HS02P13, HS03E21, HS03I9, HS04F24, HS07C7, HS07F21, HS07N21, HS88E5) respectively. It
is seen that the relative expression in lane 3 is similar to that of the positive control (lane 2) whereas
relative expression in lanes 4–11 is more similar to that of the negative control (lane 1). Assays were
carried out in triplicate.
These fosmid clones were sequenced using 454 pyrosequencing and were assembled using
the RAMMCAP pipeline hosted by CAMERA. The annotation was obtained only from four
of the fosmids and among the data obtained, the clone that showed the most anti–calcineurin
activity from the assay was HS02P13 (Figure 4.5, lane4). Hence this was selected for analysis.
Gene prediction was carried out with GeneMark™ (http://exon.gatech.edu/GeneMark/
metagenome/), a gene prediction software that uses rened heuristic models (Zhu et al., 2010).
This resulted in the identication of 27 coding regions. A BLAST search was done to predict
the putative proteins encoded by these genes (Table 4.1).
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Table 4.1 : Predicted genes and proteins in clone HS02P13.
Gene ID Start Stop Name of the protein
1 1693 2 Xanthine dehydrogenase family protein (large)
2 2184 1690 Xanthine dehydrogenase family protein (small)
3 3041 2181 Xanthine dehydrogenase family protein (medium)
4 3329 3715 Transposase
5 4074 3712 Putative PLP–dependent enzyme
6 5227 5093 Conserved hypothetical protein
7 5226 6989 Hypothetical protein
8 7633 8616 Phosphatidyl serine decaroboxylase
9 9071 10276 Carbamoyl phosphate synthase, small subunit
10 10726 13356 Carbamoyl phosphate synthase, large subunit
11 15356 13899 NADH–quinone oxidoreductase, N subunit
12 15421 15353 Hypothetical protein
13 16968 15424 NADH–quinone oxidoreductase, M subunit
14 18945 16981 NADH–quinone oxidoreductase, L subunit
15 19316 19011 NADH–quinone oxidoreductase, K subunit
16 19933 19313 NADH–ubiquinone/plastoquinone oxidoreductase chain 6
17 19933 20421 NADH–quinone oxidoreductase, chain I
18 21482 20430 NADH–quinone oxidoreductase, H subunit
19 23953 21497 NADH–quinone oxidoreductase, G subunit
20 25305 23983 NADH–quinone oxidoreductase, F subunit
21 25932 25387 NADH–quinone oxidoreductase, E subunit
22 27185 25932 NADH–quinone oxidoreductase, D subunit
23 27960 27178 NADH–quinone oxidoreductase, C subunit
24 28500 28024 NADH–quinone oxidoreductase, β subunit
25 28847 28491 NADH–quinone oxidoreductase subunit 3
26 29364 28987 NADH–quinone oxidoreductase subunit 1
27 34564 29687 Hypothetical protein, partial
4.4.3.1 Random cloning of HS02P13
Conventional gene cloning using restriction enzymes BsiWI, HindIII, PmlI, NheI and AatII
was performed. The fosmids were self–ligated and individual inserts were transformed into
an E. coli strain. Five clones were then screened for anti–calcineurin activity. The region of
interest was between 3866 and 17499 bp (Figure 4.6).
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Figure 4.6 : Linear map of the clone HS02P13 highlighting the region of interest.
The clone was analysed both by single (AatII, PmlI and NheI) and double digestions (NheI/PmlI,
HindIII/BSiWI) and the region that showed calcineurin inhibition was between 3866 and 17499bp.
4.4.3.2 Sub–cloning strategy
Virtual mapping was carried out for all regions using the Lasergene software (Figure 4.7).
The promoter was predicted using the bioinformatics software called Softberry BPROM that
can be accessed online (http://linux1.softberry.com/berry.phtml). These fragments
were cloned into pLITMUS 39 as described in the methods (Section 4.3.5).
Figure 4.7 : Various genes encoded in the region that showed calcineurin inhibition.
The blue arrow indicates the direction in which the genes are transcribed. Restriction enzymes are
designed to clone the fragments individually and screen them for calcineurin inhibition. From left to
right, the proteins that are cloned are: conserved hypothetical protein, hypothetical protein, carbamoyl
phosphate synthase, NADH–quinone oxidoreductase N subunit, NADH–quinone oxidoreductase M
and N subunit and NADH–quinone oxidoreductase L subunit.
The clones were isolated and restriction analysis was performed to check the inserts and it
was tested using the calcineurin assay. The only region that showed inhibition in the assay
was a hypothetical protein (Figure 4.8).
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Figure 4.8 : Hypothetical protein showing calcineurin inhibition.
The assay was as described in Figure 4.1, with controls as described in Figure 4.5. With the excep-
tion of lane 1 (negative control), all treatments included TAPS alkaline shock. Lane 1 negative control,
no stimulation; lane 2, positive control; lane 3, HS02P13 (positive control); lane 4, lysate from hy-
pothetical protein; lane 5, lysate from conserved hypothetical protein; lane 6, lysate from carbamoyl
phosphate synthase; lane 7, lysate from phosphatidyl serine decarboxylase; lane 8–10, lysates from
NADH::ubiquinone oxidoredcutase (M and N, N and L subunits) respectively. It is seen that the relative
expression in lanes 5–10 was similar to that of the positive control (lane 2) whereas relative expression
in lanes 3 and 4 are more similar to that of the negative control (lane 1). Assays were carried out in
triplicate.
The protein was re–analysed using blastp and it showed 29% identity to a Na+/Ca2+ exchanger
protein. The query coverage in the blastp to the Na+/Ca2+ exchanger protein (YP_001635005.1)
was 67% with an E–value of 4e–15. An alignment was done using ClustalX (http://www.
clustal.org/clustal2/), (Figure 4.9), (Larkin et al., 2007).
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Figure 4.9 : Alignment of HS02P13 with Na+/Ca2+ exchanger protein
(YP_001635005.1).
The alignment of the hypothetical protein of the clone HS02P13 was done using ClustalX with the
Na+/Ca2+ exchanger protein.
4.4.4 Localisation assay of Crz1p following calcineurin inhibition
The principle of the screen is that inhibition of calcineurin prevents the translocation of Crz1p
to the nucleus that normally follows alkaline stress. To demonstrate that this is in fact the
case, and to conrm that the putative inhibitors identied in the pilot screen described above
have this eect, another reporter was used. This construct is a GFP::CRZ1 fusion that has been
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demonstrated to accurately report the sub–cellular localization of the Crz1p protein (Polizotto
& Cyert, 2001). Crz1p is normally cytoplasmic but following alkaline treatment the protein is
dephosphorylated by calcineurin and translocates to the nucleus (Figure 4.10, panels A and B).
Addition of either the known calcineurin inhibitor FK–506 (Figure 4.10, panel C) or one of the
extracts containing a putative inhibitor (Figure 4.10, panel D) prevents eective translocation
and GFP uoresence throughout the cell was seen. These data demonstrate that the microtitre
assay using the CDRE::lacZ fusion (Figures 4.2 and 4.3) does successfully identify inhibitors
of calcineurin activity. As mentioned above, restricting growth does not have this eect but
it is possible that interfering with calcium signalling in another way (e.g. channel blocking
or calmodulin impairment) could have similar eects.
Figure 4.10 : Inhibition of calcineurin prevents Crz1p nuclear localisation.
A yeast reporter strain expressing the GFP–Crz1p fusion protein was stimulated by alkaline stress
(KOH) and the localisation of the fusion protein monitored by epiuorescent microscopy. Panel A
shows cytoplasmic localisation of the protein in unstimulated cells. Panel B shows nuclear localisation
following stimulation. As a control, methanol is added in the same concentration and volume as panels
C and D. Panel C (FK–506) and panel D (extract from bacterial strain SM8) include metabolites that
are known (FK–506) or suspected (SM8) to inhibit calcineurin activity. In both cases, uorescence is
cytoplasmic and the GFP–Crz1p fusion fails to localise to the nucleus.
4.5 Discussion
We developed a high–throughput reporter gene based assay that would be compatible with
the robotic handling systems for screening. The assay developed is a target–based approach
that helps in the identication of new drugs in a shorter duration. This method is simple,
reproducible, sensitive and capable of handling large amount of extracts. The limitations of
other assays such as the exposure of radioactives in the radioactive–based assay and the time
consumption in the colorimetric assay has been overcome by the high–throughput assay.
The metagenomic library screening resulted only in a success rate of 0.2%. The reason be-
hind such low success rate is because the library is maintained in an E. coli host. Studies
have revealed that the functional expression of environmental genes in heterologous hosts
are poor due to the inecient transcription of genes therefore an improper assembly of the
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corresponding enzymes. Hence for the identication of novel proteins, an ecient expression
system is required. The reason behind the inhibition observed by the clone in the metage-
nomic library is unclear and hence further investigation with the protein should be carried
out. As it is an exchanger protein, there is a possibility that this would be sequestering cal-
cium from the cells even before the calcineurin pathway is initiated and hence the result of
the inhibition in cells.
Recently, a transposon based method called MuExpress was developed to enhance the expres-
sion of protein in E. coli. The recombinant transposon randomly inserts into the environmen-
tal DNA that facilitates the gene expression from its inducible promoters (Troeschel et al.,
2010). Researchers in the USA have constructed tools for functional screening the metage-
nomic library in S. lividans (McMahon et al., 2012). According to their analysis, the bioactive
clones were functional only in S. lividans but not in E. coli which suggests that new surrogate
hosts must be constructed and screened for various assay to identify novel bioactive clones.
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Chapter 5
Identication of bioactive
metabolites from a Streptomyces
strain 1
5.1 Abstract
Marine sponges are a known source of bioactive metabolites but it is predicted that many
sponge–derived metabolites are in fact produced by symbiotic microbes. The purpose of this
study was to identify bioactives from the bacterial extracts associated with marine sponges
obtained from Irish waters. In a screen of 120 bacterial isolates cultured from the sponge
Haliclona simulans, 25 isolates that inhibited fungi in both deferred–antagonism and disc
diusion assays were identied. Following preliminary analysis, one particular marine spe-
cic Streptomyces strain, SM8 that produces a low molecular weight metabolite(s) and that
can be extracted by organic solvent was selected for further studies. This strain secretes an
activity that is inhibitory to yeasts and fungi, including the pathogens C. albicans and A. fu-
migatus. These metabolites were puried by solid–phase extraction and reverse–phase HPLC
with fractions assayed for antimicrobial activity using the NCCLS assay. NMR analysis led
to the identication of butenolides exhibiting anti–calcineurin activity. This would be the
rst report of a butenolide from any source showing this activity. A number of antimycin–
like molecules, uncharacterised anti–bacterial metabolites and a hydroxylated saturated fatty
acid were also identied in the extract.
1Manuscript in preparation
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5.2 Introduction
The marine ecosystem is known to have a diverse microbial diversity and biotechnological
potential as 70% of the earth’s surface is occupied by water (Gandhimathi et al., 2008). Ma-
rine sponges play an important role in the benthic community as they act as a reservoir for a
diverse microbial community (Paul et al., 2011). During evolution, these simple, sessile lter
feeders developed resistance to protect them from harmful organisms. Studies have revealed
that they have physical scaolds which can help in the development of bacterial communities
(Friedrich et al., 2001). The reported symbiotic functions of these microbes include stabilisa-
tion of the sponge skeleton, processing metabolic waste, nutrient acquisition and production
of secondary metabolites (Taylor et al., 2007); (Thomas et al., 2010). The secondary metabolites
produced by the microbes may act as a chemical defence for the sponges. Many metabolites
produced by these microbes are known to possess certain biotechnological potential and fur-
ther exploitation of these metabolites may lead to the discovery of new drugs (Sipkema et al.,
2005).
Drug–resistant microbes have become a common cause of death and morbidity in both im-
munocompetent and immunocompromised individuals (Armstrong-James & Harrison, 2012).
The medical eld is facing challenges to treat tumours, organ transplantations and immune
disorders. It has been seen that eective treatments for microbial infections are often lacking
and the nancial costs to these healthcare systems is often staggering (Steinbach et al., 2007).
The increase in antibiotic resistance among clinical microbes has created a need to develop
antimicrobials with novel modes of action. Studies relating to sponge–associated microbes
have often led to the discovery of novel metabolites or even known metabolites with novel
activities. The focus on Streptomyces sp. in several studies has sparked an interest due to its
wide array of metabolites produced by them. For example: Streptomyces sp. strain JBIR–43
exhibited cytotoxic activity and two other strains (JBIR–34 and 35) showed unique chem-
ical skeleton containing non–proteinogenic amino acids and based on the genome mining
it was predicted that these were produced by novel NRPS genes (Khan et al., 2011). Recent
studies have also reported a novel ansamycin, from a commensal Streptomyces sp. showing
severe cytotoxic activities (Lu & Shen 2007); (Yang & Li, 2012). Another study reported de-
oxyuridines from Streptomyces microavus isolated from the marine sponge Hymeniacidon
perlevis (Li et al., 2011). Scientists from Germany reported an anti–parasitic activity in Strep-
tomyces sp. strains isolated from mediterranean sponges (Pimentel-Elardo et al., 2010).
The sponge species that was selected for this study was Haliclona simulans, a member of the
order Haplosclerida which has been known to produce a wide range of secondary metabo-
lites. Studies have reported the identication of novel metabolites showing cytotoxic and
anti–bacterial activity. One of the studies reported novel cyclic metabolite such as dialkylpyri-
diniums that showed moderate cytotoxic and anti–bacterial activities against Gram–positive
strains (Lee et al., 2012). Another group reported two novel cyclic depsipeptides exhibiting
anti–inammatory properties (Randazzo et al., 2001). Scientists from Korea have recently
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
101 Lekha Menon Margassery
5. Identication of bioactive metabolites from a
Streptomyces strain 5.3 Materials and Methods
identied a new macrocyclic diamide from Haliclona sp. from Korean waters that exhibited
moderate cytotoxic and anti–bacterial activity against diverse microbial strains (Jang et al.,
2009). Another study reported the identication of araguspongin C, an anti–fungal compound
from the methanol extract of the sponge, Haliclona exigua (Lakshmi et al., 2010).
The secondary metabolites synthesised byHaliclona sp. are microbial drug candidates isolated
from marine invertebrates with a spectrum of activities such as anti–bacterial, anti–fungal and
anti–cancer (Piel et al., 2004). One of the studies identied several bacterial strains exhibiting
a broad spectrum of activities against both bacterial and fungal test strains (Kennedy et al.,
2009). Another study reported a metabolite, tyrocidine A, isolated from a Vibrio sp. associated
with the Haliclona sp. sponge that showed anti–bacterial activity against methicillin resistant
S. aureus, E. coli and P. aeruginosa (Noro et al., 2012).
The aim of this study was to identify novel bioactives from the bacteria associated with the
marine sponge, Haliclona simulans.
5.3 Materials and Methods
5.3.1 Sponge collection, processing and isolation of bacteria
Isolation of bacteria from the sponge H. simulans was previously reported (Kennedy et al.,
2009). Briey, the sponge Haliclona simulans was collected from the Kilkieran bay, Galway
coast on the west coast of Ireland, at a depth of 15 m (N 53°18.944´, W 09°40.140´) in August
2007. To remove contaminants from sea water, the sponge sample was washed in sterile
articial sea water (ASW). On site, 1g of sponge sample was chopped nely and vortexed
with 3mm glass beads. The sponge homogenate was then serially diluted using ASW and 100
µl aliquots were plated out on isolation media supplemented with 30µg amphotericin B/ml to
inhibit fungal growth. These plates were later incubated at 28°C for 8 weeks in the laboratory,
with colonies subsequently selected for culturing based on morphological features such as
colony colour and appearance. Pure cultures were then sub–cultured on SYP–SW plates. For
long term preservation, the stocks were prepared by growing the culture in SYP–SW broth
at 28°C followed by the addition of 15% glycerol to the culture and stored at –80°C. Spore
suspension of sporulating bacteria were also stored at –80°C by adding 20% glycerol for long
term storage. All chemicals were purchased from Sigma with the exception of Instant Ocean
(Fish Antics, Dublin, Ireland).
5.3.2 Isolation and growth media
Five dierent isolation media were used: SYP–SW medium (10 g starch/l, 4 g yeast extract/l, 2
g peptone/l, 33.3 g Instant Ocean/l (Atkinson & Bingman, 1998), 15 g agar/l); Modied marine
agar medium (50 µg yeast extract/l, 500 µg tryptone/l, 100 µg sodium glycerol phosphate/l,
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33.3 g Instant Ocean/l, 15g agar/l); Marine Agar (1 g yeast extract/l, 5 g tryptone/l, 33.3 g
Instant Ocean/l, 15 g agar/l); Actinomycete isolation seawater agar (22 g Difco actinomycete
isolation agar/l, 5 g glycerol/l, 33.3 g Instant Ocean/l, 15 g agar/l) and NaST21Cx (Magarvey
et al., 2004). The plates were made with and without 25 µg Nalidixic acid/ml. The strains were
isolated after incubating the plates at 28°C for 8 weeks followed by culturing and preservation
of bacterial strains as mentioned in the section above.
For the maximal production of secondary metabolites from one of the Streptomyces sp. strain
SM8, the growth media had to be optimised. Initially, the seed culture was grown in the 410
media (10 g glucose/l, 10 g glycerol/l, 15 g casamino acids/l, 5 g oatmeal/l, 10 g peptone/l, 5
g yeast extract/l, 1 g calcium carbonate/l, 33.3 g Instant Ocean/l) for 7 days at 28°C. Then
1ml of the seed culture was inoculated to 50 ml of the growth media. Five dierent growth
media were used (Goodfellow & Fiedler, 2010): 19 medium (20 g mannitol/l, 20 g peptone/l);
400 medium (10 g glucose/l, 3 g meat extract/l, 3 g peptone/l, 20 g soluble starch/l, 5 g yeast
extract/l, 3 g calcium carbonate/l); MMM medium (10 g glucose/l, 5 g tryptone/l, 20 g soluble
starch/l, 5 g yeast extract/l, 1 g calcium carbonate/l); OM (20 g oatmeal/l); SGG (10 g glucose/l,
10 g glycerol/l, 2.5 g corn steep powder/l, 5 g peptone/l, 10 g soluble starch/l, 2 g yeast extract/l,
3 g calcium carbonate/l, 1 g sodium chloride/l). The media was prepared with and without
Instant Ocean. It should be noted that the strain was able to grow only in the presence of
instant ocean which implies that the strain is marine specic and not a contaminant.
5.3.3 Extraction of the antimicrobial compounds
The SM8 seed culture was grown initially in a 410 media for 7 days at 28°C. 16 ml of the seed
culture were inoculated into 800 ml of OM media with Instant Ocean. It was grown for 12 days
at 28ºC in a shaking incubator at 200 rpm. 16 l of the culture were centrifuged at 12074×g for
15 min in a Beckmann Coulter Avanti J–26 centrifuge. The supernatant was passed through
miracloth (Calbiochem) to remove the debris. 1.6 l of amberlite XAD–16 resin were added and
incubated overnight to increase the eciency of the compound binding to the resin. To the
supernatant, fresh resin was added and incubated for 4 h to allow the residual compound to
bind. The resin was washed with methanol to remove the compound completely that was
bound to the resin (the methanol was added to the resin until the resin turns white). The
methanol extract was concentrated in a Speed Vac. The extract once concentrated was par-
tially puried by a liquid–liquid partitioning with ethyl acetate and water. Using a separating
funnel, both the phases were collected and tested for antimicrobial activity using the NCCLS
assay (National Committee for Clinical Laboratory Standards).
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5.3.4 Antimicrobial assays
5.3.4.1 Deferred antagonism assay
A deferred antagonism assay was used to determine whether bacteria isolated from sponges
possessed antimicrobial activity (Kennedy et al., 2009). In brief, bacteria to be tested were
grown in SYP–SW agar media at 28°C to a colony size of 0.5–1cm in diameter and then over-
laid with soft agar seeded with bacterial or fungal indicator strains. The fungal test strains
were grown overnight and diluted to a nal OD600=0.1. 50 µl of the overnight culture were
seeded to 10 ml of the YEPD soft agar (10 g yeast extract/l, 20 g peptone/l and 20 g dextrose/l,
7 g agar/l). For the bacterial test strains, a similar procedure was followed but 50 µl of the cul-
ture were seeded to 10 ml of the LB soft agar (20 g LB/l, 7 g agar/l). Incubation was continued
at 28°C and a zone of clearance around the bacteria indicates that it is producing an antimi-
crobial compound to which the test strain was sensitive. The fungal test strains, that were
pre–grown in standard YEPD (10 g yeast extract/l, 20 g peptone/l and 20 g dextrose/l) broth
at 28°C, were Candida albicans SC5314, Candida glabrata CBS138, Saccharomyces cerevisiae
BY4741, Kluyveromyces marxianus CBS6556 and Aspergillus fumigatus Af293. The bacterial
test strains, that were pre–grown in standard LB broth at 37°C, were Bacillus subtilis IE32, E.
coli 12210, Staphylococcus aureus NC000949 and P. aeruginosa PA01. All the chemicals were
purchased from Sigma.
5.3.4.2 Well–diusion assay
The bacterial strains that possessed antimicrobial activity in the overlay assay were grown in
SYP–SW broth at 28°C (Kennedy et al., 2009). The culture was centrifuged at 6104×g for 10
min and the supernatant was collected for all 7 days, the only exception being the Streptomyces
sp. as the supernatant was collected daily between 8 and 14 days. The fungal test strains were
streaked on the YEPD media to create a lawn of cells and holes were punched using a cork
borer. The supernatant was added to the respective wells. The plates were then incubated at
28°C. A similar procedure was carried out for the bacterial test strains where the test strains
were streaked on to the LB media and incubated at 37ºC.
5.3.4.3 National Committee for Clinical Laboratory Standards (NCCLS)
NCCLS is a quantitative assay that helps to determine the minimum inhibitory concentration
(MIC) of the extract (Liu et al., 2007). The growth media used for fungal strains was 10.4 g
RPMI–1640/l in 165 mM MOPS and the pH adjusted to 7.0. The principle of the assay is that the
dye, resazurin (blue) gets reduced to resorun (pink) when the cells grow. The dye remains
blue when there is inhibition of growth. The test extracts (cell–free supernatant, bacterial
extract dissolved in methanol or the XAD–broth) were diluted with the media (depending on
the concentration) and added to the rst well of the 96–well plate. The other wells are lled
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
104 Lekha Menon Margassery
5. Identication of bioactive metabolites from a
Streptomyces strain 5.3 Materials and Methods
with 100 µl of the media. The test extracts were serially diluted (1:2) up to 10 columns. The last
two columns would be the growth and the sterility controls (Figure 5.1). The fungal test strains
were initially grown on YEPD agar plates and the colonies were suspended in 2 ml of distilled
water at an OD540=0.12 that corresponds to 1–5×106 CFU/ml. The resazurin cell suspensions
were prepared by mixing 100 µl of cells and 250 µl of resazurin (Stock concentration–20 mg
resazurin/ml) in 50 ml of RPMI media. 100 µl of this suspension was added to the 96–well
plate except to the sterility control. The dye for the sterility control was prepared with a
working concentration of 0.1 mg resazurin/ml in 10 ml of RPMI media. 100 µl of this solution
was added to the sterility control wells. The plates were incubated at 37°C. The procedure
for the bacterial test strains remains the same except the media used for the anti–bacterial
assay would be the isosensitest broth (23.4 g isosensitest broth/l, Purchased from Oxoid). The
bacterial test strains were grown in 5 ml LB overnight at 37°C. The overnight bacterial strains
were then re–inoculated in to 50 ml of LB and grown until the OD600=1. 100 µl of cells were
used for the assay as mentioned above. All chemicals are purchased from Sigma unless stated
otherwise.
Figure 5.1 : Illustration of the NCCLS assay.
This gure illustrates the operation of the NCCLS assay. The test extracts (spent media, resin XAD
treated broth and the methanol extract) from SM8 were tested in the plate assay against C. glabrata.
The dye resazurin (blue) gets reduced to resorun (pink) when the cells grow. The dye remains blue
when there is inhibition of growth. As the extraction was done twice, both the extracts were tested
hence labelled as (1 and 2). The media (SYP–SW) in which the strain was grown initially was the
negative control and amphoterin B, an anti–fungal compound was the positive control. Both sterility
and growth controls were also included in the assay.
5.3.5 Quorum sensing assay
The puried extract was dissolved in methanol at a concentration of 1 mg/ml. The test strains
(Chromobacterium violaceum CV026, Serratia marcescens SP15 and SP19) were grown over-
night in LB at 37°C (Poulter et al., 2010); (McClean et al., 1997). Positive (N–(hexanoy1)–L–
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homo– serine lactone: HHL) and negative (methanol) controls were included in the assay
plate. The test strains were streaked on to the LB to create a lawn of cells. 50 µl of the puried
extract were added to the disc and the plate was incubated overnight at 37°C. The plates were
examined for both stimulation (a violet halo in case of CV026, red halo in both SP15 and SP19)
and antagonistic eect (a white halo in case of CV026, SP15 and SP19).
5.3.6 Calcineurin assay
SM8 crude extract and the puried fractions were screened in a method developed to detect
inhibitors for the calcineurin pathway in yeast. The fractions that were puried were tested
for the anti–calcineurin assay. The method is described in detail in Chapter 4.
5.3.7 Purication techniques
Various purication strategies were followed for the identication of the bioactives. Initially,
the work was carried out at the Department of Microbiology and Pharmacy at University Col-
lege Cork but as this strategy was unable to generate suciently pure compounds, subsequent
work was carried out at the University of Strathclyde, Scotland.
5.3.7.1 Thin layer Chromatography (TLC)
Extracts were tested on a normal phase TLC silica plate. 5 µl of the extract was added to
the plate and dried thoroughly. Meanwhile, the TLC chamber was saturated with the sol-
vent system that varies each time depending on the mobility of the extracts. The plate was
then allowed to run in the solvent system until it reaches three quarters of the plate. The
solvent front was noted and the plate was dried thoroughly. It was then sprayed with the p–
anisaldehyde–sulphuric acid, for the detection of lipids, sugars, phenols, terpenes and steroids
(Serralheiro & Quinta, 1986). The plate was heated to 105°C until the spots are visible.
5.3.7.2 Medium Pressure Liquid Chromatography (MPLC)
Crude extract was fractionated using a VersaPak C18 (Spherical) 23×53 mm (15 g) column
using methanol and water as the mobile phase (Ishihara et al., 2000). The Medium Pressure
Liquid Chromatography instrument (pump manager C615, pump module C601) came from
BUCHI, Switzerland, whereas the columns used and the column stand were purchased from
VersaFlash/Supelco, Sigma Aldrich, Germany. The fraction collector (CF2) was from Spectrum
Labs. The gradient was as follows: 0–5 min at 1% methanol, 5–35 min at 1–50% methanol, 35–
40 min at 50% methanol, 40–65 min at 50–100% methanol. The fractions were collected every
15 sec in a test tube. A total of 264 fractions were collected. The column was then washed
three times with 100% methanol, each washing performed for ve minutes and collected in
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a conical ask. The fractions were pooled by the minute for the antimicrobial assay. 400 µl
from each of four test tubes were combined and dried to give an aliquot of the extract for
one minute. The process was repeated for each of the 65 min. The pooled fractions were
then dried, weighed and tested for anti–fungal and anti–bacterial activities using the NCCLS
assay.
5.3.7.3 Sephadex purication
The crude extract that was prepared by growing the strain in oatmeal in articial sea water
was passed through Sephadex LH–20 that was prepared by soaking it overnight in methanol
to allow it to swell. It was then poured into the column in continuous motion and allowed to
settle and washed by carefully running more methanol through the column. The crude sample
was dissolved in methanol and loaded on to the column. The ow rate was approximately 1
ml/15 min. The fractions were tested for antimicrobial activity using the NCCLS assay. The
active fractions were subsequently pooled based on their activity and similarities in the TLC.
5.3.7.4 Silica column purication
Active fractions were also subjected to a conventional silica column purication with the
following solvent systems: 95:5 hexane:ethyl acetate, 90:10 hexane:ethyl acetate, 80:20 hex-
ane:ethyl acetate, and 50:50 hexane:ethyl acetate, followed by washing of the column with
70:30 dichloromethane:methanol, 50:50 acetone:methanol and 100% methanol. The fractions
collected were pooled following TLC and antimicrobial testing was done using the NCCLS
assay.
5.3.7.5 High–performance Liquid Chromatography (HPLC)
In some cases, the samples were separated using HPLC which was run in an X Bridge C18
5 µm 4.6×150 mm analytical Column attached to an X Bridge C18 5 µm 4.6 ×20 mm guard
column with a gradient of 0–100%ACN (0.1% formic acid) for 0–25 min and 5 min in 100% ACN
(0.1% formic acid) at a ow rate of 1 ml/min. The samples were collected, concentrated and
dissolved in 100 µl of methanol and tested using the NCCLS assay. The active fractions were
further puried using a preparative C18 column with a gradient of 0–100% ACN (0.1% formic
acid) for 0–25 min and 5 min in 100% ACN (0.1% formic acid) at a ow rate of 20 ml/min. The
samples were collected, concentrated and dissolved in 1ml of methanol and tested using the
NCCLS assay. This work was carried out in the Microbiology and Pharmacy Department at
the University College Cork. The samples that were scaled up and extracted were analysed
by low resolution LCMS. The samples were run using the LCQ Deca using the Column: ACE
5 C18 75×3.0 mm with the mobile phase being 0.1% formic acid in water (A) and 0.1% formic
acid in acetonitrile (B). The ow rate was 0.4 ml/min. The gradient was as follows: 0–30 min
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at 10%–100% B, 30–35 min at 100% B, 35–36 min 100%–10% B, 36–40 10% B (equilibration). The
fractions were then pooled based on the similarities of their chromatograms. The separation
of the compounds and the analysis by LCMS was carried out at the University of Strathclyde,
Scotland.
5.3.7.6 High–resolution Mass Spectrometry (HRMS) and NMR
The samples were run on the Ultimate 3000 Exactive (Thermo Scientic, Germany) using the
column: ACE 5 C18 75×3.0 mm (Highchrom Ltd, UK) with the mobile phase being (A) 0.1%
formic acid in water , (B) 0.1% formic acid in acetonitrile and an injection volume of 10 µl.
The gradient used was as follows: 0–30 min at 10–100% B, 30–35 min at 100% B, 35–36 min
at 100%–10% B, 36–40 min at 10% B (equilibration). The ow rate was 0.3 ml/min. This was
performed on the active fractions following which MZMine 2.8 was used to process the data,
after which the data was run through the AntiMarin database to identify any known com-
pounds (http://www.chem.canterbury.ac.nz/marinlit/marinlit.shtml). The sam-
ples were dissolved in 750 µl of deuterated DMSO and subjected to a 1H NMR analysis. The
samples were then lyophilized and redissolved in enough 50:50 methanol (HPLC):pure–grade
water to give a nal concentration of 1 mg/ml. The NMR used was the Jeol LA–400 FT–NMR
spectrometer system with an AS400 magnet at 400MHz and the fractions were dissolved in
DMSO. The purication and the NMR was carried out in University of Strathclyde, Scotland.
5.3.8 Collaboration between University College Cork and University of -
Strathclyde
The following was the work done in UCC and University of Strathclyde, Scotland:
• UCC: Culture grown and crude extraction.
• University of Strathclyde: Purication, LC–MS and NMR analysis.
The collaboration is represented in Figure 5.2.
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Figure 5.2 : Schematic representation of the collaboration between UCC and Strath-
clyde University.
The cultivation, extraction and activity testing was done in UCC and the characterisation of the com-
pounds was done at University of Strathclyde, Scotland.
5.4 Results
5.4.1 Screening the strains for antimicrobial activity
The bacterial strains that were cultured from Haliclona simulans were screened for anti–
fungal activity (Kennedy et al., 2009). 120 strains were initially screened for anti–fungal
activity with all the ve test strains using a deferred antagonism assay and it was observed
that there were 25 strains that had anti–fungal activity. The strains were then grown in a
liquid culture to test for the anti–fungal activity using the well–diusion assay. There were
17 strains that showed anti–fungal activity in well–diusion assay and the anti–fungal com-
pound was extracted from these strains using methanol after it was incubated with the amber-
lite XAD–16 resin. Several studies have shown that organic extraction has been eective for
the isolation of bioactives (Kjer et al., 2010). It was observed that only from 8 strains SM6, SM8,
SM12, SM15, SM17 (Streptomyces spp.), 18A (Halomonas sp.), PA2 and PA4 (Pseudoalteromonas
spp.) the activity was extractable in the organic phase whereas for the other strains SM1, SM2,
SM3, SM4, SM7, SM9 (Streptomyces spp.) and MMA7 (Bacillus sp.) the activity remained in the
broth. There were 2 strains SM5 and SM14 (Streptomyces spp.) that did not show any activity
(Figure 5.3).
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Figure 5.3 : Screening the bacterial isolates for anti–fungal activity from Haliclona
simulans.
The isolates from Haliclona simulans were screened for anti–fungal activities using the overlay assay
that shows a zone of inhibition when incubated at 28°C overnight. The putative isolates were grown
in a liquid media for the production of secondary metabolites. The supernatant collected were tested
and a zone of inhibition indicates that the strain is producing an anti–fungal metabolite. The positive
isolates were cultivated in the liquid media and an organic extraction was done and it was detected
that the activity was extractable for 8 isolates. SM8 strain showed activity against all fungal strains
tested.
It should be noted that eleven isolates that secreted anti–fungal activity were Streptomyces
sp. and in ve of the eight isolates the activity was extracted by the organic solvent (Figure
5.4). This genus is known to produce bioactives and so was of interest to us (Dharmaraj &
Sumantha, 2009). As the isolate SM8 grew well and showed consistent activity, it was selected
for further study. The strain was then tested against bacterial strains such as E. coli, B. subtilis,
S. aureus and P. aeruginosa (data not shown). It was observed that it was active against B.
subtilis and P. aeruginosa. This suggested that the strain has a broad spectrum of activities.
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Figure 5.4 : Phylogenetic tree of the marine actinobacteria isolated from Haliclona
simulans.
Adapted from (Kennedy et al., 2009).
5.4.2 Purication and characterisation of antimicrobial compounds
Dierent purication strategies were employed to identify bioactive molecules from SM8.
Initially, all analyses was in–house between Department of Microbiology and Pharmacy, sub-
sequently a collaboration at University of Strathclyde, Scotland was established. The puri-
cation strategies are summarised in Figure 5.5 and described in detail below.
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Figure 5.5 : Summary of the strategies involved in the identication of the metabo-
lites in SM8.
The strain was grown in SYP–SW media initially and puried by preparative HPLC. As the mate-
rial was insucient for NMR, the media was optimised for maximal production of the metabolites.
The culture was grown in the oatmeal media with articial seawater and was scaled to 6.4 l. After
sephadex purication, the active fractions were tested in the NCCLS assay for antimicrobial activity
and calcineurin assay described in Chapter 4. One of the active anti–bacterial fractions (Fraction 17)
was analysed by NMR and the fraction was identied as a hydroxylated saturated fatty acid. Due to
insucient material, the culture was scaled to 16 l and the extract was puried by MPLC. The fractions
collected were tested for both antimicrobial and calcineurin assay. The active fractions were pooled
based on relative mobilities in TLC and RP–MPLC purication was carried out further to determine
the nature of the active metabolite. Fraction 25 that showed anti–bacterial activity was identied as a
compound having m/z 227 and fraction 3 that was not active was identied as butenolides by NMR.
The anti–fungal fractions were pooled based on relative mobilities in TLC and was puried by silica–
column. The fractions were tested for anti–fungal activity and calcineurin assay. By NMR, one of the
active anti–fungal fractions (Fraction 35) showed antimycin–like compounds. The butenolides were
identied in Fraction 10 of the anti–calcineurin fractions.
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5.4.2.1 Strategy 1: Analytical HPLC
The SM8 culture was scaled up initially in 6.4 l of SYP–SW media and the purication was
done by analytical and preparative HPLC (Step 1). After several rounds of purication and
also assaying the active fractions by the NCCLS assay for anti–fungal activity against C. al-
bicans, the production of the compound was insucient for determining the structure of the
molecule. Hence a dierent strategy had to be followed so that metabolites can be produced
enough to predict the structure of the compounds.
5.4.2.2 Strategy 2 : Sephadex Purication
The media (SYP–SW) that the strain was initially grown on did not produce enough for the
structural elucidation and hence the media had to be optimised. It has been observed in several
studies that the variation in the carbon and nitrogen sources in the media can inuence the
production of the secondary metabolites (Haritha et al., 2012). Goodfellow and Fiedler in
their studies have recently optimised several media for the cultivation of the Actinobacteria
(Goodfellow & Fiedler, 2010). Hence the strain was grown in 5 dierent media and it was
observed that the oatmeal media with the articial seawater produced 3 fold more of the
active compound when tested in the NCCLS assay for anti–fungal activity against C. albicans.
It was initially scaled to 6.4 l and the active compound was extracted as mentioned in Section
5.3.5.3. The crude extract was tested by the NCCLS for both anti–fungal against C. albicans
and anti–bacterial activity against B. subtilis (data not shown). The crude extract of about
343.7 mg was puried using Sephadex column (Step 2b) and the fractions were tested for anti–
bacterial, anti–fungal and anti–calcineurin activities. The active fractions (Step 2c) were then
subjected to LCMS and NMR and it was observed that one of the anti–bacterial fraction was
a hydroxylated saturated fatty acid (Figure 5.6). Due to the insucient material, the structure
could not be elucidated.
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Figure 5.6 : NMR of the saturated hydroxylated fatty acid
1H NMR of Fraction 17. The peak at 0.86 is the terminal methyl group. The peak at 1.24 represents
the –CH2– groups. The peak at 2.5 is the solvent peak, DMSO and that at 3.34 is a water peak. The
peak at 3.51 represents the hydrogens attached to carbons bearing hydroxyl groups. The peak at 2.18
represents the CH2 attached to the carboxylic acid carbon.
5.4.2.3 Strategy 3 : MPLC Purication
The culture of SM8 was grown in 16 l of OM in articial seawater media (Step 3) and the crude
extract that weighed about 810.3 mg was sent for the purication and the identication of the
metabolites. Initially the crude extract was puried using Sephadex LH20 using methanol as
the mobile phase with a ow rate of 1 ml for every 15 min. 1 mg of each of these fractions were
tested by the NCCLS for both anti–fungal and anti–bacterial activities. SM8 crude extract
had shown calcineurin inhibition in the assay described in detail in Chapter 4. Hence the
puried fractions were also tested for calcineurin inhibition. The active fractions were pooled
based on their relative mobilities and the colour observed in TLC. Fractions 110–126 were
pooled and taken for further analysis as it showed all three types of activity and also had
the greatest quantity (170.9 mg). Hence these were separated further by reverse–phase MPLC
using a C18 column with water and methanol as the mobile phase and a ow rate of 15 ml/min.
The fractions were pooled based on the relative mobilities and the colour observed in TLC
and tested for antimicrobial activities. Anti–fungal activity and anti–calcineurin activity was
absent.
High–resolution Liquid Chromatography Mass Spectroscopy (HRLCMS) was performed on
the active fractions (Step 3d) and the data was processed using MZMine 2.8. The data was then
run through the AntiMarin database to identify any known compounds. Fraction 25 that had
mild anti–bacterial activity against B. subtilis showed m/z 227 that was similar to medelamine
B. 2D NMR was done to conrm the structure but the spectra did not match medelamine B
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
114 Lekha Menon Margassery
5. Identication of bioactive metabolites from a
Streptomyces strain 5.4 Results
and so it could be an isomer or related compound. Due to the insucient material, further
analysis was not possible.
Fraction 3 which was relatively pure (Step 3d) though not active against B. subtilis was anal-
ysed for NMR. This resulted in the identication of two known furanone isomers. The chem-
ical formula was C13H22O3 and the exact mass was deduced as 226.16. The structures were
also conrmed by 2D NMR experiments. The ROSEY spectrum aided in ascertaining the rela-
tive stereochemistry of the second compound. Recent studies have reported these butenolides
as quorum sensing molecules (Husain et al., 2010) ; (Chernin et al., 2011). These furanones were
then tested for quorum sensing assays as mentioned in Section 5.3.6. The quorum sensing
assay did not show any stimulation of antagonistic eects in any of the test strains indicat-
ing that the butenolides could be inactive. Hence the biological property of these furanones
(butenolides) were unknown.
In parallel, the anti–fungal fractions (127–156) that were obtained from the Sephadex sepa-
ration were puried using a conventional silica column (Step 4e). It was observed that 43
fractions were active when tested (Table 5.1).
Table 5.1 : Fractions exhibiting anti–fungal and anti–calcineurin activity afterMPLC
purication.
Fraction number 33 is highlighted in bold as it weighs the most and was fractionated further to identify
the metabolite.
Fraction Nos. Weight (mg) Anti–fungal activity (C. albicans) Anti–calcineurin activity
Specic activity (mg/ml)
23 7 – +
25 3 – ++
26 2.2 0.00625 +++
27 2.6 0.003125 ++
28 6.2 0.00625 +
29 3.5 0.00625 +
30 6.5 0.0125 ++
31 2 0.025 +
32 2.2 0.0125 +
33 46.2 0.025 +
34 10.7 0.025 +
35 2.3 0.025 +
36 3.5 0.05 +
37 12.4 0.05 +
38 6.6 – +
Fraction 35 was run through LCMS (as it was relatively pure) and was identied as antimycin
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by the AntiMarin database. Hence a comparison was done to the standard Antimycin A that
detects four isomers of antimycins (A1–A4) by NMR. The sample showed the presence of
compounds having similar m/z, indicating that the sample could possibly be antimycin A
derivatives. However, the retention times were dierent indicating that the compounds may
just be the isomers of antimycins. The total ion chromatograms after LCMS shows clearly that
most of the compounds in fraction 35 elute within 25 min whereas the standard Antimycin A
has retention times between 20 and 30 min (Figure 5.7). The fragmentation data obtained from
LCMS from the standard showed the most common fragments of m/z 237 and 265. However,
these were not observed in the sample. This data suggests that the anti–fungal metabolite(s)
were antimycin analogues but it is unclear if the antimycins identied in SM8 are known or
unknown. Due to the insucient material, the structural elucidation of the antimycin was
not possible.
Figure 5.7 : Total Ion Chromatograms of Antimycin A standard (A) and fraction 35
from SM8 sample (B).
The retention times of the antimycin A derivatives evidently elute between 20 and 30 min whereas
most compounds in the sample elute before 25 minutes.
Among the anti–fungal fractions, fraction 33 weighed 46.2 mg and was puried using the
Biotage Flash Purication system as a mobile phase of hexane (A) and ethyl acetate (B) with a
ow rate of 25 ml/min. After fractionation (Step 3f), the resulting fractions were pooled on the
basis of the relative mobilities and the colour on the TLC. The fractions were then tested for
both anti–fungal and anti–calcineurin activity. It was observed that fractions 2 –8 and 17–24
showed anti–fungal activity in the NCCLS (Table 5.2). It should be noted that the fractions 20–
28 were the eluates collected while washing the column with dierent organic solvents. Both
anti–fungal and anti–calcineurin activities were present in those eluates. Hence a fraction
of the compound was not bound to the column. Further work has to be done to identify the
metabolite(s) causing anti–fungal activity.
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Table 5.2 : Anti–fungal and anti–calcineurin fractions obtained after purication of
fraction 33.
Fraction Nos. Anti–fungal activity (C. albicans) Anti–calcineurin activity
Specic activity (mg/ml)
2 0.0125 –
3 0.025 –
4 0.05 –
5 0.05 –
6 0.025 –
7 0.05 –
8 0.05 –
9 – –
10 – +
11 – –
12 – –
17 0.05 –
18 0.05 –
19 0.05 –
20 0.05 –
21 0.025 –
22 0.05 –
23 0.05 +
24 0.05 +
25 – +
Fraction 10 that showed only anti–calcineurin activity was relatively pure and hence 1H NMR
was done to determine the structure. The same furanone isomers that had been identied in
Step 3d was obtained in fraction 10 (Figure 5.9 a, b). The calcineurin assay was performed
as discussed in Chapter 4. It was observed from the assay that four of the fractions showed
calcineurin inhibition (Figure 5.8). The inhibition observed in lanes 6–8 is from the washing
of the column with dierent concentration of ethylacetate and methanol. Fraction 10 that
was relatively pure showed calcineurin inhibition is represented in lane 4. This was the only
fraction from the SM8 fraction that showed only calcineurin inhibition. From the data (lanes
3 and 5), it should be noted that the fractions 9 and 11 did not show any calcineurin inhibition
indicating that the anti–calcineurin is not spread out unlike the anti–fungal fractions (Table
5.2).
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Figure 5.8 : Bacterial extract of puried SM8 from fraction 33 showing calcineurin
inhibition.
The assay was as described in Figure 4.1 of Chapter 4, with methanol as controls. With the exception
of lane 1 (negative control), all treatments included TAPS alkaline shock and all treatments included
the same solvent (10% methanol). Fractions 9 and 11 are represented in lanes 3 and 5 respectively, and
data from the four positive fractions are shown in lanes 4 and 6–8. Fractions are denoted by numbers.
Lane 1, negative control, no stimulation; lane 2, positive control; lane 3, fraction 9; lane 4, fraction 10;
lane 5, fraction 11; lane 6, wash1; lane 7, wash 2; lane 8,wash 3. It is seen that the relative expression
in lane 3 and 5, is the same as the positive control (lane 2) whereas relative expression in lanes 4 and
6–8 is more similar to that of the negative control (lane 1). Assays were carried out in triplicate.
a b
Figure 5.9 : Structure of butenolides.
Two furanone isomers were obtained in fraction 10 :
a) 4,10–dihydroxy–10–methyl–dodec–2–en–1,4–olide.
b) 4,11–dihydroxy–10–methyldodec–2–en–1,4–olide.
From the NMR spectra, the signals at 0.90 ppm and 1.00 ppm were used to estimate the relative
amounts in each butenolide. The red singlet peak at around 0.99 ppm was much taller than
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that of the teal peak, but the two smaller peaks beside it (the doublet at around 0.95 and 0.96
ppm) were about the same. The methyl signals are the only resonance that could dierentiate
both the butenolides. These signals represent the methyl at position 13 in isomer 1 (Figure
5.8a) which was a singlet and the methyl at position 12 in isomer 2 (Figure 5.8b). Those signals
were chosen because they were not overlapping when compared to the methyl at position 12
in isomer 1 which was a triplet and the methyl at position 13 in isomer 2 which was a doublet.
These latter signals found between 0.80 ppm and 0.70 ppm were overlapping and hence will
not be possible to integrate separately (Figure 5.10).
Figure 5.10 : 1H spectra fraction 3 (inactive) is the red spectrum whereas fraction 10
(active) is the teal–coloured spectrum.
The NMR spectra was zoomed in between signals 0.70 ppm and 1.80 ppm. The only dierence between
the two fractions was the ratio between the two butenolides. Both the isomers were present in almost
the same quantity in fraction 10. A certain number of protons were assigned to the peak chosen for
the intergration. From the intergration of the peaks, the percentage of the furanones present in each
of the fraction were calculated.
As 1H NMR is quantitative, the integral peaks between the two isomers were calculated. The
integration was based on the area under the peak and it also represents the number of protons
within a peak (Table 5.3).
Table 5.3 : The percentage of the isomers present in each of the fractions of the
butenolides are tabulated.
Integration 1 Integration 2 Isomer 1 Isomer 2
Fraction 3 1.00 0.40 71.43% 28.57%
Fraction 10 1.00 1.26 44.25% 55.75%
Biodiscovery of Natural Products from Microbes
Associated with Irish Coastal Sponges
119 Lekha Menon Margassery
5. Identication of bioactive metabolites from a
Streptomyces strain 5.5 Discussion
1 mg of the fractions were tested. Fraction 3 was found to be inactive whereas fraction 10 dis-
played anti–calcineurin activity. This activity was dependent on the concentration of isomer
2 when compared to isomer 1 in fraction 10. Further work will involve separating these two
isomers so that the activity of the isomers can be validated.
5.5 Discussion
5.5.1 Purication of bioactive metabolites : strategies and challenges
Dierent purication strategies were employed to identify the bioactives as described in Fig-
ure 5.5. Some of the challenges that had to be faced during the development of the extraction
and the purication strategies was that sample material usually obtained during the crude
extraction contains a mixture of other compounds and the compound of interest present in
them was minimal. As a result, structural elucidation of some of the active compounds was
not possible. The supply problem has always been the bottleneck in the natural product
drug discovery process. The purication strategies requires extensive optimisation to facil-
itate chemical characterisation of compounds (Penesyan et al., 2010). Recently, novel tech-
niques have been employed for rapid detection of compounds. One study has used an ultra–
performance liquid chromatography (UPLC) where the data can be obtained in 1/10th of the
time and the sample used would be less when compared to the traditional HPLC or other pu-
rication strategies (Rowe et al., 2010). Another technique that was developed recently was
Desorption Electrospray Ionisation Mass Spectrometry (DESI–MS) that allows rapid detec-
tion of compounds with minimal eort on data analysis and sample preparation (Nielen et al.,
2009). Scientists from China have recently developed an alternative to chromatographic meth-
ods for separating bioactive compounds in large scale. They employed a high–performance
separation technique to separate sparingly aqua–/lipo–soluble bioactive compounds using an
ionic liquid–based biphasic system (Cao et al., 2012).
5.5.2 Identication of bioactives
This study identied one particular Streptomycete, designated SM8 that synthesised several
distinct bioactive metabolites exhibiting anti–bacterial, anti–fungal and anti–calcineurin ac-
tivities.
5.5.2.1 Anti–bacterial metabolites
The anti–bacterial activity in SM8 was contributed by two distinct class of compounds: a
saturated, hydroxylated fatty acid and an unknown metabolite of m/z 227. The structural
elucidation of both the compounds were not possible due to the insucient material. There
are reports of bioactive fatty acids that are promising as drug candidates (M. Pereira et al.,
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2011); (Mohamad et al., 2009). The fatty acid that has been identied so far from marine were
unsaturated fatty acids. Though the structure of the fatty acid from SM8 could not be iden-
tied due to the supply problem, the NMR spectra reveals that it is a saturated hydroxylated
fatty acid and this is the rst report of a saturated fatty acid isolated from Streptomyces sp.
associated with a marine sponge. The unknown bioactive still has to be characterised by
employing a better purication strategy.
5.5.2.2 Anti–fungal bioactives
The strategies employed to identify anti–fungal metabolites has to be improved as the activity
was spread out (Table 5.1, 5.2) and this could be due to the presence of more than one anti–
fungal metabolite in the extract. The data suggests the presence of antimycins (Figure 5.11) in
the extract and the diversity of antimycins could also be the source of the broad anti–fungal
activity.
Figure 5.11 : Structure of Antimycin A1a.
Molecular weight: 548.625, Molecular formula: C28H40N2O9. This is a representation of one of the
isomers of antimycin present in the standard that was used to compare with the SM8 extract.
Several antimycins have been discovered in recent years from various Streptomyces sp. The
class of antimycins were initially discovered in soil Streptomyces sp. (Barrow et al., 1997).
Recent studies have isolated the initial class (A1–A4) of antimycins in addition to several
other antimycins (A10–A16) from marine–related Streptomyces sp. (Hosotani et al., 2005). Re-
searchers in China have identied two new antimycins from the culture broth of a marine–
derived Streptomyces sp. (Xu et al., 2011). They also observed other classes of antimycins in
the extracts such as A1a, A1b, A2a, A3a and A3b. Two antimycin A analogues were also iden-
tied recently from a marine–derived Streptomyces lusitanus (Han et al., 2012). The diverse
nature of antimycins suggests that in the present study, SM8 strain could be producing known
antimycins or unknown ones as the fragmentation pattern and the retention time varied in
the puried fraction when compared to that of the standard antimycins (A1–A4). Scientists
from UK observed similar results in a Streptomyces sp. strain S4 that was a symbiont of a
farming ant, Acromyrmex octospinosus. They found antimycin gene clusters and after the
knockout, the anti–fungal activity was reduced but not abolished. Their genomic approach
revealed clusters that could possibly produce multiple anti–fungals (Seipke et al., 2011). Hence
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a similar approach can be employed to detect the presence of other anti–fungals in SM8.
5.5.2.3 Anti–calcineurin compound
Anti–calcineurin activity identied in the SM8 strain was a butenolide (furanone) and this
could be the rst report of furanones exhibiting calcineurin inhibition in yeast (Figure 5.9).
Earlier studies have reported these butenolides from a marine sediment (Mukku et al., 2000).
These butenolides have shown cytotoxic activity in recent studies (Olano et al., 2009). There
are no other activities reported to date with respect to these diastereomeric isomers. The
butenolides that exhibited anti–calcineurin can further be analysed by synthesising and sep-
arating the furanones which can allow for a better understanding of the compounds. Scientists
in Germany and Denmark have employed a new technique to isolate individual conforma-
tional isomers from a complex molecule using electrostatic elds at ultracold temperatures
(Filsinger et al., 2009).
5.5.3 Future directions
Dereplication process should be employed earlier in the stages of natural product identi-
cation. An Austrialian Biodiscovery company, Microbial Screening developed a software
called COMET that compiles and analyses co–metabolite patterns in natural product mix-
tures. COMET analyses the data generated by DAD-HPLC and creates compact databases of
the chromatograms and UV spectra. These databases can then be interrogated with exible
analytical tools, which enable rapid understanding of complex natural product extracts. This
can be helpful for the recognition of novel co-metabolite patterns and also in the elimination
of known metabolites producers and replicates early. Further analysis include cytotoxicity
testing, identfying the mode of action and the genetic characterisation of the biosynthetic
pathway of all the compounds identied in the marine Streptomyces strain should be pur-
sued. The butenolides need to be further tested to identify specic eects and in this respect,
a wide array of mutant strains and cell biology reporters available for yeast would be very
useful in performing secondary screens and establishing mechanistic eects. This study has
also yielded other metabolites that have not yet been characterised and may have potential
as new therapeutic leads.
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Chapter 6
Genome Mining of a Streptomyces
strain to identify novel bioactives1
6.1 Abstract
Genetic and genomic approaches were used to identify genes from Streptomyces strain SM8
that are potentially responsible for antimicrobial activities. The SM8 genome was sequenced
from a fragment library using Roche 454 pyrosequencing resulting in 229,280 reads, giving
approximately 13–fold coverage. These reads were quality ltered and assembled using the
meta-assembler hosted by CAMERA 2.0 resulting in a draft genome of 534 contigs and a
predicted genome of approximately 7.15 Mb. The draft genome was annotated by IMG/ER
using the “Prodigal” pipeline. The SM8 genome contains a number of loci that are predicted
to encode polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS) as well
as biosynthetic genes for terpenes and siderophores. Comparative genomic analysis with
other Streptomycetes identied one PKS cluster, likely to direct synthesis of a candicidin-like
molecule; one hybrid PKS/NRPS cluster for antimycin synthesis; two other PKS/NRPS hybrid
clusters of unknown function; and four NRPS clusters of which one is predicted to be involved
in gramicidin synthesis and the functions of the other clusters are as yet unknown. Analyses
of mRNA levels revealed the expression of three hybrid clusters of which one is predicted to
be involved in the synthesis of antimycin and the functions of others are unknown. There
were an additional two NRPS clusters of which one is similar to gramicidin biosynthesis and
the function of the other is as yet unknown. The Whole Genome Shotgun project has been
deposited at DDBJ/EMBL/GenBank under the accession AMPN00000000.
1Manuscript in preparation
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6.2 Introduction
Streptomyces are known to produce bioactive metabolites that include antibiotics such as
streptomycin, tetracycline and vancomycin anti–fungals such as nystatin and natamycin, im-
munosuppressants such as cyclospirin A and many more (Borodina et al., 2005). They are
ubiquitous in nature and have distinguishable characteristic features such as high G+C con-
tent, a large linear chromosomes and a complex life cycle.
The large and complex genomes of Streptomyces are believed to be related to their adaptability
to dierent environmental conditions (van Wezel & McDowall, 2011). Secondary metabolism
genes tend to be located at the distal ends of the chromosome arms whereas the central part of
the chromosome contains a mix of primary and secondary metabolism genes (Chater, 2006).
The metabolites produced by this genus are quite diverse in their structure and function,
for example antimycin, gramicidin, avenolide and many more. The genes for secondary
metabolism pathways are arranged in dened genetic regions or clusters on the chromo-
some. These clusters are typically comprised of genes required for the synthesis of a specic
metabolite including carbon chain assembly, modication, export, resistance and regulation.
The advent of whole-genome sequencing revealed that the number of secondary metabolism
gene clusters in bacteria such as Streptomyces and in fungi outnumbers the known secondary
metabolites produced by these microbes (Scherlach & Hertweck, 2009), as many of these clus-
ters are apparently silent under standard conditions (cryptic clusters). The role of the sec-
ondary metabolites in these microbes remain unclear but many are believed to be produced
as a means of chemical defence, as signalling molecules, as metal scavengers and some are
believed to have a role in microbe–host interaction (Rimando et al., 2007).
In Streptomyces, the diversity of the secondary metabolic pathways is enormous comprising
PKS, NRPS, siderophores, ribosomal peptides and terpenes (Fu et al., 2012). Genome mining
approaches have made it possible to manipulate gene expression and alter the regulation of
secondary metabolism clusters, for example overexpression of a regulatory gene anking the
NRPS genes enhanced the production of daptomycin in Streptomyces roseosporus (Yu, 2012).
In silico tools have helped researchers in the identication of various gene clusters in the
Streptomyces genus. Some of the examples include antiSMASH that helps in the rapid iden-
tication, annotation and analysis of secondary metabolite clusters (Medema et al., 2011),
PKS/NRPS analyser that predicts the specicity of the domains (Bachmann & Ravel, 2009), SB-
SPKS that helps in the prediction of the domains and the structure of the metabolite (Anand
et al., 2010) and ClustScan, a semiautomatic annotation of modular PKS and prediction of
novel structures (Starcevic et al., 2008). The knowledge of the genome sequences of the pro-
ducing strains may pave the way for the manipulation of the biosynthetic genes involved in
the biosynthesis of some of these antibiotics, thereby allowing the biosynthesis of variants
with novel properties against the current drug resistant clinical pathogens; using combina-
torial based approaches. It should be noted however that not all classes of antibiotics can be
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used for such manipulations. An example of one class of antibiotic which are suitable candi-
dates for the combinatorial approach are the peptide–based antibiotics such as vancomycins,
bacitracins which are synthesized on NRPS based assembly lines (Walsh, 2002).
Genome–based approaches have also revealed the presence of various cryptic gene clusters
that could be of clinical importance in the future (Gomez-Escribano & Bibb, 2011); (Komatsu
et al., 2010). One of the best example is the revelation of an uncharacterized Type I polyke-
tide synthase gene cluster (cpk) in S. coelicolor A3(2) showing anti-bacterial activity after the
deletion of a regulatory gene within the cpk cluster (Gottelt et al., 2010). Hence manipulat-
ing regulatory pathways can "awaken" silent gene clusters and lead to the discovery of novel
antimicrobial activities. One of the advantages of the genome mining approach is the reve-
lation of many silent clusters that can be activated to provide potential new compounds. It
can also be employed by researchers to alter specic pathways for the increased production
of bioactives (Bromann et al., 2012).
The aim of this study was to identify gene clusters involved in secondary metabolism in Strep-
tomyces SM8 and to study the expression of genes potentially involved in secondary metabo-
lite production.
6.3 Materials and Methods
6.3.1 Extraction of genomic DNA
Streptomyces strain SM8 was isolated from the marine sponge Haliclona simulans as described
previously (Kennedy et al., 2009). The strain was grown in 50 ml of SYP–SW media in a 250
ml ask for three days at 28°C in a shaker incubator at 200 rpm and the genomic DNA was
extracted using the cetyltrimethylammonium bromide (CTAB) method (Kieser et al., 2000b).
The mycelia was resuspended in 5 ml TE25S (25 mM EDTA, pH 8, 25 mM Tris-HCl, pH 8 and
0.3 M sucrose) and 100 µl of 2 mg lysozyme/ml and incubated for 1 h at 37°C. This was followed
by the addition of 50 µl of 25 mg proteinase K/ml and 300 µl of 10% SDS and incubated for 1
h at 55ºC with occasional mixing. This was followed by the addition of 1ml of 5 M NaCl and
was mixed thoroughly after the addition of 0.65 ml CTAB/NaCl (10% CTAB in 0.7M NaCl) and
incubated at 55°C for 10 min. This was cooled to 37°C and 5 ml of chloroform/isoamyl alcohol
(24:1) was added and mixed for 30 min by inversion. The solution was centrifuged for 30 min
at 12,074×g to precipitate the proteins. The supernatant was transferred to a fresh tube and
the DNA was precipitated by the addition of 0.6 vol. of isopropanol. The DNA was pelleted by
centrifugation at 18,643×g at 4°C for 30 min in Eppendorf 5417R. The DNA was then washed
with 500 µl of 70% ethanol and centrifuged at 18,643×g at 4°C for 15 min in an Eppendorf
5417R centrifuge and the pellet was air-dried. The DNA was then resuspended in 1 ml of
TE buer (10mM Tris-HCl, pH 7.5 and 1mM EDTA, pH 8) at 55°C. This was followed by the
addition of 1 µl of 10 µg RNase A/ml to the DNA and incubated at 37ºC for 30 min. The DNA
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was then recovered by adding 1/10th volume of 3 M sodium acetate of pH 6.8 and 0.6 volumes
of isopropanol. The DNA was recovered as described above. The pellet was resuspended in
1 ml of TE buer. DNA concentration was measured using a Nanodrop spectrophotometer
(ND1000, ThermoFisher Scientic). The concentration was 200 ng/µl and the 260/280 ratio was
found to be 1.8. DNA was analysed by agarose gel electrophoresis and the average fragment
size was found to be ~40kb. The DNA was then sent to the University of Liverpool, Centre for
Genomic Research (http://www.liv.ac.uk/integrative-biology/facilities-and-
services/centre-for-genomic-research/) for genome sequencing.
6.3.2 Genome sequencing
The nucleotide sequence was generated from a fragment library using the GS FLX Titanium
system (Roche) resulting in 229,280 reads and 94,668,678 bp, giving approximately 13–
fold coverage. Assembly was carried out by meta-assembler hosted by CAMERA and anno-
tated by the IMG/ER using the Prodigal pipeline.
6.3.3 Bioinformatics tools
Secondary metabolite genes were identied using antiSMASH (Medema et al., 2011) that rapid-
ly identies a whole range of known secondary metabolite compound classes (polyketides,
non-ribosomal peptides, terpenes, aminoglycosides, aminocoumarins, indolocarbazoles, lan-
tibiotics, bacteriocins, nucleosides, β–lactams, butyrolactones, siderophores, melanins and
others). This online bioinformatics tool also aligns regions at the gene cluster level to their
nearest relatives from a database containing all other known gene clusters. The contigs were
used as queries to scan for functional similarities both in Clusters of Orthologous Groups of
proteins (COGs) and Pfam databases in IMG/ER. The IMG/ER has about 88 COG proteins
and 52 Protein families (Pfam) relating to secondary metabolism and synthesis, catabolism
and transport. The protein sequences corresponding to the secondary metabolite genes were
searched in BLASTp (Altschul et al., 1990), a protein database hosted by National Centre for
Biotechnology Information (NCBI) to identify any functional similarities to other species. A
BLAST search was done using the DNA sequence of the contigs of the secondary metabolism
gene clusters to identify the closest homologues. The contigs were then aligned using Codon-
Code Aligner (http://www.codoncode.com/aligner/) to the best matching homologue in
the corresponding reference genome.
6.3.4 Gap closure of a hybrid cluster
PCR primers were designed to target the predicted gaps between the contigs using Primer3-
plus (Untergasser et al., 2007). Genomic DNA was used as a template to amplify the inter-
contig regions and the products were then puried and sequenced by GATC Biotech (http:
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//www.gatc-biotech.com/en/index.html). The sequences were edited by FinchTv and
then veried by querying in BLASTx. The sequences were then realigned with the contig se-
quences and manually edited using the GeneQuest software (http://www.dnastar.com/t-
sub-products-lasergene-genequest.aspx) and the ORF was predicted by GeneMark
(Besemer & Borodovsky, 1999). The predicted proteins were analysed by BLASTp and the
secondary metabolism genes were analysed by antiSMASH. The domains were analysed by
the PKS/NRPS analyser (O. Bachmann & Ravel, 2009) and SBSPKS (Anand et al., 2010).
The genome analysis was performed by Ciarán O’Brien, an M.Sc. in Bioinformatics student
at University College Cork.
6.3.5 Total RNA isolation
The strain was grown in both the SYP-SW (10 g starch/l, 4 g yeast extract/l, 2 g peptone/l, 33.3
g Instant Ocean/l (Atkinson & Bingman, 1998)) and oatmeal media (OM) (20 g oatmeal/l, 33.3
g Instant Ocean/l) in 50 ml in a 250 ml ask for 12 days at 28°C in a shaker incubator at 200
rpm. The supernatant and the mycelia were collected every second day from day 2 to day 12
and stored at –80°C. To preserve RNA, 2 volumes of RNA protect (Qiagen) reagent were added
to samples immediately after sampling, mixed and incubated for 5 min at room temperature
(15–25°C). The mycelia was then collected by centrifugation at 5000×g for 15 min, then kept
at -80°C for long term preservation. To obtain total RNA from the bacteria several enzymatic
and mechanical disruption of cells were performed. Initially, the cell pellet from a 3 ml culture
was subjected to 100 µl of 15 mg lysozyme/ml in TE buer and 20 µl of 25 mg proteinase K/ml
in water. The pellet was resuspended with the pipette several times and incubated at room
temperature (15–25°C) for 10 min. This was followed by mechanical disruption with the bead
beater for 7 min using 3 mm glass beads. RNA was then puried using the Qiagen RNeasy Mini
Kit. Total RNA was measured using a Nanodrop spectrophotometer (ND1000, ThermoFisher
Scientic). Puried RNA was stored at –80°C until further use.
6.3.6 Preparation of cDNA
To remove residual genomic DNA, RNA concentration of 1 µg was treated with 1 unit of DNase
I (37°C for 30 min) followed by the addition of 1 µl of 50 mM EDTA in a 50 µl reaction and
incubated at 65°C for 10 min. 1 µl of RiboLock™ RNase Inhibitor at 1 u/µl was included in
the reaction mixture to prevent RNA degradation. DNase treated RNA was measured using
a Nanodrop spectrophotometer (ND1000, ThermoFisher Scientic). cDNA was synthesised
by adding 4 µl of 5X reaction mix (reaction buer, dNTPs, oligo (dT)18 and random hexamer
primers) (Fermentas), 2 µl of the Maxima® Enzyme Mix (Maxima® Reverse Transcriptase and
Ribolock™ RNase Inhibitor) to 9 µl of the template RNA (~0.5 µg). The total volume was made
up to 20 µl with nuclease-free water. RT–PCR was done with the following conditions: 10 min
at 25°C followed by 30 min at 50°C and 15 min at 60°C. The reaction was terminated by heat-
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ing at 85°C for 5 min. To conrm that the cDNA was not contaminated with genomic DNA, a
PCR reaction using primers 27F (5´ AGAGTTTGATCCTGGCTCAG 3´), 1492R (5’ GGTTAC-
CTTGTTACGACTT 3’) targeting the 16S rRNA gene was performed for both DNase treated
RNA and cDNA (Turner et al., 1999). The kits and the reagents were purchased from Fermen-
tas (Wiame et al., 2000); (Fleige & Pfa, 2006); (Nolan et al., 2006).
6.3.7 Gene–expression studies
To analyse expression of putative secondary metabolism genes, individual genes from each
cluster were chosen for analysis. Firstly the annotation of the secondary metabolism genes
was checked manually to verify the start and the stop codons. Nine genes (Table 6.1), pre-
dicted to encode biosynthetic enzymes were selected and primers were designed to amplify a
region of 500-1000 bp from each of these using Primer3Plus (Untergasser et al., 2007). The
specicity of the PCR was checked using genomic DNA. PCR was performed with a total
volume of 50 µl containing sterile water, 5 µl of 1 X Taq buer, 5 µl of 2 mM dNTPs, tem-
plate DNA/cDNA (5 µl), Taq DNA polymerase (0.75 U) (Fermentas), and 5 µl of the primers
(Stock concentration of 10 µM each). The conditions were as follows: initial denaturation
(95°C for 5 min), followed by 36 cycles of denaturation (94°C for 30 sec), primer annealing
for 60°C for 30 sec (exceptions being candicidin and unknown NRPS2 in which the annealing
temperature was 59°C) and primer extension (72°C for 2 min), completed with a nal primer
extension step (72°C for 10 min). The PCR products were sent for sequencing to GATC Biotech
(http://www.gatc-biotech.com/en/index.html).
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Table 6.1 : Primers designed for amplication of genes involved in secondary meta-
bolism clusters in Streptomyces SM8.
The primers were designed for specic regions in the contigs and the predicted size of the PCR product
is listed in the table. The contig numbers and the gene ID are assigned by the IMG/ER Prodigal pipeline.
Predicted
cluster
Contig Gene ID Primer
sequences (5´–3´)
Predicted
metabolite
Predicted
size (bp)
Candicidin 183 2512070663 FP–CGAGGAAGCCGGACCAGT
RP–CGTGCGCCGAGGTACT
Candicidin 559
Gramicidin 326 2512072684 FP–GACGAGCAGCTGACCTACG
RP–AGCAGTTCGGTGACGCTGT
Gramicidin 560
Unknown
NRPS1
113 2512069548 FP–CTTCCAGGTCATGCTCAACC
RP–GACGGGAGTGGGTTCCAG
Unknown 640
Unknown
NRPS2
223 2512071193 FP–CGGCGAGCTGTACCTGAC
RP–GACCGGGATGTGGTACGAG
Unknown 853
Unknown
NRPS3
6 2512067507 FP–GCGTACACCGTCGTGGAG
RP–GGGGCCGTAGTGGTTGAC
Unknown 669
Unknown
Hybrid1
271 2512071878 FP–GTGGTGTTGTGCGGGTTAC
RP–CGCAGAGCAGTGTCCTGA
Unknown 670
Antimycin 406 2512073559 FP–ACACCGCCCTCTTCGAGAC
RP–GATGTCCGAGGCCGTACC
Antimycin 755
Unknown
Hybrid2
195 2512070890 FP–AGTTCGAACCGGCCTTCTT
RP–CGGACCAGGGAGATCTGG
Unknown 873
Unknown
Hybrid3
111 2512069504 FP–CTGCTCGACCTCCTCCAC
RP–GGTCACGCACTGGTCCTT
Unknown 661
6.3.8 Antimicrobial assay
The antimicrobial assays were performed as described previously in Chapter 5, Section 5.3.4.
6.3.9 Calcineurin assay
The calcineurin assay was performed on the SM8 fractions as described previously in Chapter
4, Section 4.3.2.
6.3.10 Construction of antimycin knockout strains
To inactivate the antimycin gene cluster, a two–step gene deletion procedure was used. Flank-
ing regions from within the antC gene of approximately 1.4 kb were amplied using the High-
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Fidelity PCR kit (Roche). The primers (region 1–upstream and region 2–downstream) were
engineered at their 5’ ends with restriction sites suitable for cloning into the Streptomyces/E.
coli shuttle vector pKC1139. The primers for the4antC are listed in Table 6.2. The restriction
sites that were used for region 1 (R1) were Hind III/XbaI and for region 2 (R2) were XbaI/EcoR1.
The PCR products were cloned into pJET1.2/blunt using the Fermentas PCR cloning kit giv-
ing pJETA1 and pJETA2 corresponding to the upstream and downstream (R1 and R2) of the
antC gene respectively. Around 10 clones from each were sequenced to verify the inserts and
an error free clone was selected for each. Region 1 was excised from pJETA1 using HindIII
and XbaI and cloned into the similarly digested pKC1139 resulting in pKC1139A1. pJETA2
(pJET1.2/blunt containing region 2) was digested with XbaI and BamHI and the region 2 in-
sert was cloned into similarly digested pKC1139A1 resulting in pKC1139A1A2 which contains
both the anking regions.
The pKC1139A1A2 was conjugated to Streptomyces sp. SM8 strain. Competent cells of E.
coli C2925/pUZ8002 were transformed to apramycin resistance with pKC1139A1A2. Strain
C2925 was used as it is dam and dcm methyltransferase decient as unmethylated DNA was
required for ecient conjugation into Streptomyces SM8. The helper plasmid pUZ8002 can
supply transfer functions to oriT–carrying plasmids, such as pKC1139, but is not eciently
transferred itself because of a mutation in its own oriT (Paget et al., 1999). The E. coli clones
of C2925/pUZ8002/pKC1139A1A2 were grown in 10 ml of LB containing 25 µg kanamycin/ml,
25 µg chloramphenicol/ml and 50 µg apramycin/ml overnight at 37°C. The overnight culture
was diluted (1:10) in LB containing the aforementioned antibiotics and grown at 37°C to an
OD600=0.5. The cells were washed twice with an equal volume of LB to remove antibiotics
that might inhibit the growth of Streptomyces. The cells were resuspended in 0.1 vol. of LB.
Approximately, 108 spores of the SM8 strain was added to 500 µl of 2×YT broth (1.6% peptone,
1% yeast extract and 0.5% NaCl) and subjected to heat shock at 50°C for 10 min. 0.5 ml of E.
coli cells were added to the spores and mixed briey. The pellet was resuspended and plated
on to Mannitol Soya agar (20 g mannitol/l, 20 g soya our/l and 20 g agar/l) containing 10
mM MgCl2 and 33.g Instant Ocean/l. The plates were incubated at 28°C for 20 h. The plates
were overlayered with 1 ml antibiotic solution containing 25 µg nalidixic acid and 100 µg of
apramycin using a spreader. These plates were further incubated at 28°C until potential ex-
conjugants were observed. The transconjugants were plated on to SYP–SW media containing
25 µg nalidixic acid/ml and 100 µg apramycin/ml (Kieser et al., 2000a) and incubated at 28°C
until exconjugants were observed.
The shuttle vector pKC1139A1A2 has a ts ori (pSG5), temperature–sensitive origin of repli-
cation. In Streptomyces it can replicate only at temperatures between 28°C and 30°C. When
potential exconjugants were plated on to SYP–SW containing 100 µg apramycin/ml and incu-
bated at 37°C, the vector stops replicating and apramycin resistance is only maintained when
the plasmid is integrated onto the chromosome by homologous recombination. Apramycin
resistant recombinant clones were allowed to sporulate on SYP–SW agar at 37°C. Spores were
collected and plated out to single colonies at 28°C without selection. Single colonies were
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then picked and screened for the loss of apramycin resistance, a phenotype indicating that
the plasmid has been lost and potentially deletion of the antC gene. Loss of the pKC1139A1A2
plasmid backbone and the mutagenesis of the antC in the4antC was conrmed by PCR using
the primers listed in Table 6.2.
Table 6.2 : Primers designed for the construction and analysis of the antimycin-
knockout strains.
Name of the primers Primer sequences (5´–3´)
antC 1 FP–TATATAAAGCTTGGACGGCTACAGCTACAAGC
RP–TATATATCTAGAATGAGGTATGCGGTGTCGTA
antC 2 FP–TATATATCTAGAGAGGTGGTTCGTGGAGGAG
RP–TATATAGAATTCTGACGATGATGACGTCCTTG
ant1 FP FP–CCCATTCGCTCCTTGAATTA
ant3 FP FP–CCTTCGAACAGCTCGTCCT
ant5 RP RP–GAGTCGACGACGGGAAGAT
6.4 Results
6.4.1 Genome sequencing and analysis
Streptomyces sp. SM8 was isolated from the marine sponge Haliclona simulans collected o
the west coast of Ireland, and initial chemical screening showed that it displayed both antimi-
crobial and anti-calcineurin activity (Chapter 5). The genome was sequenced from a fragment
library using Roche 454 pyrosequencing at the University of Liverpool resulting in 229,280
reads, giving approximately 13–fold coverage. There are 464 contigs with an average size
of 15,411 kb and the N50 value of the genome is ~27 kb (i.e. 50% of the genome is covered
by contigs greater than 27 kb). The N90 value is ~8 kb. These reads were quality ltered and
assembled using the meta-assembler hosted by CAMERA 2.0 (Sun et al., 2011) and quality l-
tered resulting in 539 contigs. The contigs were annotated by IMG/ER (Markowitz et al., 2009)
using the “Prodigal” pipeline (Hyatt et al., 2010). The annotation process removed a further
5 contigs for quality reasons, leaving 534 contigs and a predicted genome of approximately
7.15 Mb. The genome statistics are represented in Table 6.3.
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Table 6.3 : Genome summary of SM8.
The genome statistics are based on those predicted by IMG (http://img.jgi.doe.gov/). PKS
and NRPS tabulated are predicted by COG.
Statistics
Genome size 7.15Mb
Contigs 534
GC content 73.32%
Gene count 6722
Coding genes with function prediction 4625
Coding genes connected to KEGG 1351
Coding genes connected to COGs 4618
Coding genes connected to Pfam 4738
Coding genes connected to TIGRfam 1326
Fused protein coding genes 23
Coding genes coding signal peptides 2100
Coding genes coding transmembrane proteins 1517
NRPS (COG 1020) 20
Type I PKS (COG 3321) 28
Type II PKS (COG 0304) 3
Lantibiotic 1
Terpene 2
The SM8 genome appears to contain several regions coding for potential secondary metabo-
lites, including PKS, NRPS (including PKS/NRPS hybrid clusters), terpenes and siderophores.
Analysis of the genome through a combination of annotation pipelines including RAMMCAP,
RAST and antiSMASH led to the identication of contigs containing these genes. The closest
matches in BLAST were used to align multiple SM8 contigs together to determine whether
a cluster was fully represented. In particular, Streptomyces sp. strain SM8 contains clusters
potentially coding for candicidin–, antimycin– and gramicidin–like compounds, with high
similarity (97-99% nucleotide match) to similar clusters found in other Streptomyces, partic-
ularly Streptomyces sp. S4 (Seipke et al., 2011b); (Seipke et al., 2011a); S. albus J1074 (Unpub-
lished, NCBI accession number ABYC00000000) and Streptomyces sp. strain FR–008 (Chen
et al., 2003). The contigs that correspond to each of the cluster are represented in Table 6.4.
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Table 6.4: List of potential clusters found in SM8 and their closest homologue.
Predicted
cluster
Type Closest
Homologue
Contigs Accession Number
Candicidin PKS I Streptomyces sp.
FR–008
127, 178, 183,
187, 215, 216,
217, 218, 291,
292, 324, 340,
345, 346, 347,
348, 349, 468
AMPN01000122, AMPN01000172,
AMPN01000177, AMPN01000181,
AMPN01000209, AMPN01000210,
AMPN01000211, AMPN01000212,
AMPN01000284, AMPN01000285,
AMPN01000314, AMPN01000330,
AMPN01000335, AMPN01000336,
AMPN01000337, AMPN01000338,
AMPN01000339, AMPN01000455
Unknown NRPS1 NRPS Streptomyces sp. S4 440, 352, 113 AMPN01000427, AMPN01000342,
AMPN01000108
Unknown NRPS2 NRPS Streptomyces sp. S4 223, 151 AMPN01000217, AMPN01000145
Gramicidin NRPS Streptomyces sp. S4 392, 68, 32, 70,
326, 536
AMPN01000380, AMPN01000067,
AMPN01000031, AMPN01000069,
AMPN01000316, AMPN01000511
Unknown NRPS3 NRPS S. albus J1094,
Streptomyces sp. S4
6, 274, 39 AMPN01000006, AMPN01000267,
AMPN01000038
Unknown Hybrid1 Hybrid
PKS/NRPS
Streptomyces sp. S4 180, 271, 424,
406
AMPN01000174, AMPN01000264,
AMPN01000411, AMPN01000393
Antimycin Hybrid
PKS/NRPS
Streptomyces sp. S4 51, 443, 475,
406
AMPN01000050, AMPN01000430,
AMPN01000462, AMPN01000393
Unknown Hybrid2 Hybrid
PKS/NRPS
Streptomyces sp. S4 206, 195 AMPN01000200, AMPN01000189
Unknown Hybrid3 Hybrid
PKS/NRPS
Streptomyces sp. S4 111, 252, 253,
255, 256, 327,
376
AMPN01000106, AMPN01000245,
AMPN01000246, AMPN01000248,
AMPN01000249, AMPN01000317,
AMPN01000364
Unknown PKS II PKS II S. aureofaciens 21 AMPN01000020
Unknown siderophore1 Siderophore Streptomyces sp. S4 99, 229 AMPN01000095, AMPN01000222
Unknown Terpene Terpene S. albus J1094 399 AMPN01000386
Lantibiotic Ribosomal
peptide
S. albus J1094 266, 169, 203 AMPN01000259, AMPN01000163,
AMPN01000197
Unknown siderophore2 Siderophore Streptomyces sp. S4 112, 40 AMPN01000107, AMPN01000039
Unknown Terpene Terpene Streptomyces sp. S4 269 AMPN01000262
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The DNA sequences of the contigs were analysed in BLAST and the closest homologues were
aligned to the contigs using CodonCode aligner. Genome analysis of SM8 identied one Type
I PKS that was predicted to be part of gene cluster for the biosynthesis of candicidin. The can-
dicidin gene cluster in SM8 spans around 18 contigs. Four NRPS gene clusters were identied,
one of which was predicted to be involved in the biosynthesis of gramicidin and contained
up of 6 contigs. The metabolites produced by the other NRPS gene clusters were unknown
and all of the clusters identied were 98% identical to the clusters previously identied in
Streptomyces S4 strain. An entire antimycin biosynthesis gene cluster, synthesised by a hy-
brid PKS/NRPS pathway, was identied in the SM8 genome and comprised four contigs. It is
interesting that the unknown hybrid1 cluster is located immediately adjacent (70 bp apart) to
the antimycin biosynthesis gene cluster, with genes predicted to be involved in the biosynthe-
sis of some other metabolite. The metabolites produced by the other clusters are unknown.
Two siderophore biosynthesis clusters identied are predicted to be synthesised by NIS. One
lantibiotic biosynthesis cluster was also identied in SM8. The secondary metabolism gene
clusters were identied by antiSMASH (Medema et al., 2011).
6.4.2 Transcriptional analyses
The rst nine clusters tabulated in Table 6.4 were selected for transcriptional analyses as
they were predicted to be involved in the production of antibiotic–like compounds. These
clusters were analysed by antiSMASH, PKS/ NRPS analyser and SBSPKS and all of the nine
clusters were found to encode proteins with domain structures typical of enzymes involved
in bioactive secondary metabolite production. In order to analyse the transcription of these
gene clusters a single gene, predicted to encode a biosynthetic enzyme, was selected from
each cluster. PCR primers were designed for each of these genes using Primer3plus and PCR
conditions were optimised using genomic DNA as the template with products validated by
sequencing and comparison to the target sequence.
As described in Chapter 5, SM8 was grown in ve dierent growth media to maximise the
production of dierent secondary metabolites (Goodfellow & Fiedler, 2010). It was observed
that growth in the oatmeal media with the articial seawater produced 3 fold more of the
activity than the SYP–SW when tested in the NCCLS assay for anti–fungal activity against C.
albicans (as discussed in Chapter 5, Section 5.3.4.3). Hence the strain was grown in both SYP–
SW and OM–SW to compare the expression of various clusters. RNA was isolated and cDNA
was synthesised as described in Section 6.3.6. This was followed by PCR using primers in table
6.1 and agarose gel electrophoresis to provide semi–quantitative analysis of transcription of
each of the gene clusters. Transcriptional analyses showed that no transcript was detected for
the putative candicidin biosynthetic genes, unknown NRPS1, unknown NRPS2 and unknown
Hybrid1 under any of the conditions tested. The analysis also revealed expression of the
unknown NRPS3 cluster when SM8 was grown in OM but not in SYP. The unknown NRPS3
was also found to be present in scaold 5 of the Streptomyces S4 genome but was not annotated
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by the group (Seipke et al., 2011a). Our study also identied active transcripts for potential
antimycin, gramicidin and two unknown hybrid clusters (2 and 3) (Figure 6.1).
In an attempt to correlate bioactivity with gene expression data, the supernatants from both
media conditions were collected on days 2, 4, 6, 8, 10 and 12 and analysed for antimicrobial
activities (Figure 6.2) using the NCCLS assay described in Chapter 5, Section 2.4. It was ob-
served that extracts from day 6 showed the highest anti–fungal activity against C. albicans in
both OM and SYP media but the anti–bacterial activity against B. subtilis was highest in day 6
in OM with no anti–bacterial activity being observed after day 4 in SYP. Another interesting
observation was that the relative units varied greatly. Both anti–fungal and anti–bacterial
activities were almost 4–fold higher on day 6 in OM medium compared to that in SYP. This
shows that both the growth medium and timing play an important role in the production of
antibiotics.
Figure 6.1 : Transcriptional analyses of the secondarymetabolism gene clusters iden-
tied in SM8.
RT-PCR analyses were performed on the RNA samples collected on day 2, 4, 6 and 8. cDNA was not
observed for day 10 and day 12 as the quantity of the initial RNA was low. All RNA preparations
were analysed using primers for the 16S rRNA gene to conrm that there was no contamination of
genomic DNA. 16S PCR of the cDNA served as a positive control for the RT reaction. Clear expression
was observed in ve of the nine clusters that were identied in SM8. The dierence in the expression
levels from the two dierent media (SYP and OM) is clearly observed. Lane C is a positive control
(genomic DNA).
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Figure 6.2 : Antimicrobial activities observed in OM and SYP media.
The relative units were expressed as 5 units/well of activity in the NCCLS assay. Hence on day 2 in
OM, the activity was seen in four wells and so it was calculated to be 20. The same is true for the
SYP medium. In OM, both the anti-fungal and the anti-bacterial activities that were observed were the
same. The activities were highest on day 6 and the activity gradually decreased thereafter. In SYP, the
anti–bacterial activity was observed only on days 2 and 4 whereas the anti–fungal activity was the
same on both days 2 and 4 and then it gradually decreased.
6.4.3 Correlation of genomics, bioactivities and chemical analyses
Transcriptional analyses showed clear expression of the antimycin gene cluster and the chem-
ical analyses (Chapter 5, Section 5.4.2.3) also showed antimycin to be present in the anti–
fungal fractions suggesting that at least part of the anti-fungal activity could be due to this
known anti–fungal compound. It can be hypothesised that the metabolites produced by the
other clusters (NRPS3 and Hybrid 2, 3) could also be contributing to the anti–fungal activ-
ity based on the RNA expression levels in OM shown in Figure 6.1. With the anti–bacterial
activity, it appears that the activity is not due to the gramicidin cluster as no expression of
the gramicidin genes was observed on day 6 in any of the conditions tested. Hence it can be
hypothesised that the anti–bacterial activity detected in OM could be due to the product(s) of
one of the other clusters (Unknown NRPS3, Unknown Hybrid3 and antimycin) expressed by
SM8.
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It was observed in Chapter 5, Section 5.4.2.3, that anti–calcineurin activity was exhibited
by a butenolide compound. Butenolides belong to a class of lactones that include a family
of α, β and γ unsaturated lactones. Studies have shown that the butenolides are signaling
molecules that can control pathogenicity and antibiotic production in Streptomyces. It has
been seen that these signaling molecules are autoregulators and the most characterised γ–
butyrolactone autoregulators are A–factor, methylomycin furan (MMF) and avenolide in the
avermectin biosynthetic pathway (Kitani et al., 2011). Recently, SRB1 and SRB2 have also been
identied as signaling molecules for the production of lankacidin and lankamycin in S. rochei
(Arakawa et al., 2012). In most of the Streptomyces species studied to date, the genes involved
in autoregulators biosynthesis and that encode the receptor proteins are often regulated in
the same cluster. Hence we searched for homologs of the γ–butyrolactone autoregulator
receptor protein consisting of avaR1, avaR2, avaR3 and two genes aco and cyp17 in the SM8
genome using BLASTx. However no signicant matches were found in the genome. It should
be noted that the furanones exhibiting anti–calcineurin activity in SM8 belong to a family
ofα, β –unsaturated lactones. There is no known biosynthesis pathway for this family of
butenolides and without further experimental data it is not possible to identify genes that
may be involved in the biosynthetic pathway of this family of butenolide compounds.
6.4.4 Analysis of a novel hybrid cluster
The unknown hybrid cluster3 identied in SM8 was found to be 98% identical to a cluster
in Streptomyces sp. S4 (Seipke et al., 2011a). Due to high and consistent gene-expression lev-
els and the activities that were observed in Figure 6.1 and 6.2, the cluster was selected for
more detailed bioinformatic analysis. The contigs were aligned with the homologous cluster
from Streptomyces sp. S4 using the CodonCode Aligner. Predicted gaps between the con-
tigs ranged from approximately 500 to 700 bp. To conrm and close these gaps primer pairs
were designed to amplify the predicted gaps from genomic DNA. All pairs used resulted in
products of the predicted size and the PCR products were sent for DNA sequencing analy-
sis. The sequences were then manually edited in the GeneQuest software (http://www.
dnastar.com/t-sub-products-lasergene-genequest.aspx) and all gaps in this clus-
ter were closed resulting in a predicted size of ~50kb. The ORFs were predicted by Gene-
Mark (Besemer & Borodovsky, 1999) and then veried by BLASTp. The start and stop codons
for each of the genes were manually veried in Seqbuilder (http://www.dnastar.com/t-
sub-products-lasergene-seqbuilder.aspx). The predicted proteins were analysed by
BLASTp and the secondary metabolism genes by antiSMASH. The PKS/ NRPS domains were
also analysed by PKS/ NRPS analyser (Bachmann & Ravel, 2009). The predicted genes with
the predicted PKS/ NRPS domains are shown in Figure 6.3, Table 6.5.
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Table 6.5 : Predicted genes in the unknown hybrid cluster3 of SM8.
ORF Predicted function Start Stop
1 Subtilisin 32 907
2 Predicted protein/GAF domain 891 1478
3 Integral membrane protein 2083 1553
4 Short-chain dehydrogenase 2245 3042
5 Conserved hypothetical protein 3138 3452
6 Hypothetical protein 3553 4428
7 Monoxygenase FAD binding protein 4969 6210
8 Hypothetical protein 6543 7703
9 NRPS/PKS 7706 16948
10 PKS 16945 25875
11 PKS 25914 32039
12 DNA alkylation repair enzyme 32032 33153
13 PKS 33150 36905
14 Predicted protein 36971 37279
15 Histone deacylase 37276 38424
16 Thioesterase 38417 39249
17 Major facilitator protein 39256 40812
18 Glyoxylase/Bleomycin family protein 41325 40897
19 Glyoxylase family protein 41522 41896
20 Hypothetical protein 41943 42530
21 TetR family transcriptional regulator 43190 42540
22 TetR family transcriptional regulator 43504 44361
23 Conserved hypothetical protein 44431 45324
24 3–hydroxyacyl–CoA dehydrogenase 45351 46382
25 4–hydroxybenzoylCoA–Thioesterase 46379 46858
26 Hypothetical protein 46986 48026
27 Transposase 49493 48879
28 Transposase 49627 49433
29 Conserved hypothetical protein 49779 50246
The hybrid cluster in SM8 appears to contain three PKS genes (ORF 10, 11 and 13) and one
hybrid PKS/NRPS gene (ORF 9) which are predicted to be involved in the biosynthesis of the
metabolite. The presence of a DNA alkylation repair enzyme encoded by ORF 12 could be an
indication of a potential resistance mechanism implying that the active compound could be
DNA alkylating agent. ORF 17 is typical of small molecule transporters often involved in the
export of antibiotic compounds. ORF 21 and 22 appear to encode regulatory genes that one
would predict to be involved in the regulation of antibiotic production by SM8. Studies have
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identied a TetR family transcriptional regulatory gene as a global antibiotic regulatory gene
in a DNA microarray analysis from interspecies Streptomyces (Lee et al., 2010). ORF 27 and
28 are likely pseudogenes. ORF 24 and 25 could be involved in the production of precursor
compounds for use by the NRPS module. Further studies are however needed to understand
the role of each of the genes involved in the cluster.
From a more detailed analyses of the NRPS and PKS modules, it is apparent that the cluster
lacks the AT domain at two PKS modules based on the PKS/NRPS analyser bioinformatic tools
used (Medema et al., 2011); (O. Bachmann & Ravel, 2009). PKS lacking integrated AT domains
typically have a discrete AT that selects extender units. So far, only four types of discrete
ATs have been identied: AT (a free–standing AT), AT–AT (tandem), AT–ER (AT fused with
ER), AT–AT–ER (tandem AT integrated with ER) (Musiol & Weber, 2012); (Piel, 2010). But this
cluster lacks all of the above mentioned architectures with the only ATs present being at the
C–terminus of predicted PKS proteins. Analysis of the genome of SM8 also did not reveal
any likely discrete (or trans) AT domains. Phylogenetic analysis of the AT domains (Figure
6.4) was performed to identify the signature of the AT domains present within the cluster
(Musiol & Weber, 2012) and it was observed that the AT domain in ORF 9 and 11 were not
clearly within either the cis or trans AT clade, forming a separate clade. As this cluster lacks
an identiable discrete AT it may be that the ATs present on ORFs 9 and 11 may act as both
trans and cis ATs.
Figure 6.3 : Gene prediction of the Unknown Hybrid cluster3.
The PKS/NRPS domains of the secondary metabolite genes are labelled above their respective PKS/-
NRPS genes. ORF are designated as numbers and the PKS and the hybrid NRPS/PKS are denoted by
grey colour.
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Figure 6.4 : Phylogenetic analysis of AT domains associated with the polyketide
biosynthesis.
The AT domain of both Kirramycin and the unknown hybrid cluster3 does not belong either to cis
or trans AT clade. The tree was calculated on a dataset representing AT domains associated with
both cis–AT and trans–AT. It is seen clearly that the AT from ORF 9 and ORF 11 can either be in
cis or trans AT clade. All ATs are malonyl–CoA specic exceptions areN are methyl malonylCoA
specic and  ethyl–malonylCoA specic. The evolutionary history was inferred using the Neighbor–
Joining method (Saitou & Nei, 1987). The bootstrap consensus tree inferred from 1000 replicates is
taken to represent the evolutionary history of the taxa analyzed (Felsenstein, 1985). The tree is drawn
to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the
phylogenetic tree. The evolutionary distances were computed using the Poisson correction method
and are in the units of the number of amino acid substitutions per site. All positions containing gaps
and missing data were eliminated from the dataset (Complete deletion option). There were a total of
245 positions in the nal dataset (Zuckerkandl & Pauling, 1965). Phylogenetic analyses were conducted
in MEGA4 (Tamura et al., 2007).
A prediction of the secondary metabolite produced by the hybrid cluster was performed based
on the ORF prediction and domain structure (Figure 6.5). The adenylation unit in module 1 is
predicted to adenylate 3–hydroxy–4–methyl–phenylalanine based upon PKS/NRPS analyser.
An unusual formylation domain in the NRPS is predicted to attach a formyl group to the amine
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that has been so far reported only in the synthesis of oxazolomycins (Zhao et al., 2010). The
remaining PKS catalysed steps proceed using standard PKS steps. In addition to the unusual
arrangement of AT domains, other unusual features of this PKS system are the lack of a KR
domain in module 3 making the DH domain redundant and the terminal aminotransferase
domain in module 4 for which no clear role has been proposed though it is possible that the
biosynthesis is terminated by the addition of an amine to the polyketide.
Figure 6.5 : Prediction of the biosynthetic pathway of the UnknownHybrid cluster3.
Biosynthesis of the metabolite is initiated when the AD (adenylation domain) selects the starter unit,
3–hydroxy 4–methyl phenylalanine and loads on to the ACP. A formyl group in the NRPS module is
added to the growing chain which is catalysed by the formyltransferase. Biosynthesis proceeds by the
decarboxylation caused by the KS domain. The cis AT in module 1 acts in trans in module 2 and the
elongation process proceeds. The same holds good with the cis AT in module 3 acting in trans with
module 4. Finally, the chain stops when the TE domain is recognised. This then releases the nal
product as seen in step 5.
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6.4.5 Mutagenesis of antimycin gene cluster
The expression of the antimycin cluster in SM8 suggested that the anti–fungal activity could
be due to antimycin and the biochemical analyses also showed some antimycin–like com-
pounds in the anti-fungal fraction as discussed in Chapter 5, Section 5.4.2.3. Biosynthetic
(Seipke et al., 2011a) and feeding studies (Schoenian et al., 2012) with labelled precursors have
proposed an enzymatic pathway for the biosynthesis of antimycins. On this basis we selected
the NRPS gene, antC for inactivation (Figure 6.6).
Figure 6.6 : Antimycin gene cluster in Streptomyces SM8.
The two regions (1 and 2) of the NRPS gene, antC that were cloned to construct the deletion cassette
are indicated.
To conrm whether antimycin alone was responsible for the anti–fungal activity, the an-
timycin gene cluster was disrupted by the deletion of part of the NRPS gene, antC (Figure
6.6). The antC gene is present in contig 443 and is ~9 kb in SM8. Two regions of antC (A1, A2)
each ~1.4 kb were PCR amplied and were cloned to an E. coli/Streptomyces shuttle plasmid
(pKC1139). The shuttle vector pKC1139A1A2 containing the ori-T, ts and apR (apramycin re-
sistance gene) was then conjugated to SM8 strain. The apramycin resistant conjugants were
selected after incubating the plates at a higher temperature (37°C) and these were called as
intermediates (IN). The conjugants were then replica plated on to SYP–SW with and with-
out apramycin. ~190 colonies were screened for apramycin sensitivity when incubated at
37°C. Three putative mutant colonies showed apramycin sensitivity indicating the loss of the
plasmid backbone. These mutants were screened using PCR to conrm the deletion in antC.
Primers were designed for specic regions as seen in Figure 6.7. After PCR screening using
primers listed in Table 6.2, one of the strain showed a loss of ~2 kb (using primers 1 and 5)
when compared to the wild–type strain indicating that the strain could be a mutant, 4antC
(Figure 6.8). To verify this, PCR was performed with the other primer pairs for WT, IN and
mutants. PCR using primers 3 and 5 showed a 2 kb product in WT and no bands were ob-
served in the mutant. There was no band observed even in the IN. As variable results were
observed when the intermediates were subjected to PCR screening, it was conrmed that the
strain was a mutant.
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Figure 6.7 : Diagrammatic representation of the wild-type, intermediate and themu-
tant strain.
The primers used are indicated by the arrows. The black circle shows the apramycin resistance gene
present in the plasmid. The rst generation of the conjugants were termed as intermediates. All the
strains were screened for PCR and the expected PCR product is shown in the gure. PCR screening
revealed the loss of the plasmid backbone in the mutant that was not observed in the intermediates
and also the mutant was apramycin sensitive. All the strains were screened using PCR primers as
mentioned in the gure.
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Figure 6.8 : PCR screening of the wild–type and the mutant strain.
PCR screening using primers 1 and 5 showed a product of 5 kb in the WT and a 3 kb in the mutant.
The gel shows a loss of approximately 2 kb in lane 2 compared to the wild-type in lane 1. Lane M is
the DNA marker of 1 kb plus. Lane 3 is negative control.
The mutant was assessed for anti–fungal activity against C. albicans by the NCCLS assay
as described in Chapter 5, Section 5.3.4.3. It was observed that the anti–fungal activity was
much reduced but not completely abolished. Comparative LC–MS analysis was performed
on both wild–type and mutant strains to conrm the absence of antimycin compounds from
the mutant strain (Figure 6.9). The antimycin peaks between 20 and 27 min are completely
absent in the mutant strain when compared to the wild–type and the standard conrming;
that the deletion of the antC gene has eliminated antimycin production and; that the anti–
fungal activity observed by the mutant strain cannot be due to antimycin. Hence the anti–
fungal activity is not solely due to the antimycin compounds but may also be due to some other
metabolite present in the mutant strain. The anti–bacterial NCCLS assay was also performed
using B. subtilis IE32 and P. aeruginosa PA01 indicator strains for the extracts. It was observed
that the anti–bacterial activity was the same against B. subtilis from both the wild–type and
the mutant strains but the activity was reduced 3–fold against P. aeruginosa. This suggested
that antimycin could also be one of the metabolites causing anti–bacterial activity. To conrm
this antimycin standards were tested for anti–bacterial activity against P. aeruginosa PA01 in
the NCCLS assay. It was observed that the antimycin standard showed anti–bacterial activity
with an MIC of 0.05 mg/ml. Several studies have tested the antimycin and several analogues
against P. aeruginosa but none of them has shown anti–bacterial activity (Han et al., 2012);
(Atta & Ahmad, 2009). Thus this is the rst report of an anti-bacterial activity by antimycin–
like compounds.
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Figure 6.9 : LCMS of the extracts from both wild–type and the mutant strain in OM.
LC-MS analysis was performed by Christina Viegelmann, University of Strathclyde, Scot-
land.
Panel A–Mutant, B–Wild–type and C–Antimycin standard. In the mutant in panel A, it is clear that
the peaks between 22 and 27 min corresponding to antimycins (A1-A4) as observed in both the WT
(panel B) and standard (panel C) are missing indicating that the antimycin is completely absent in the
mutant. The antimycin peaks (A1, A2, A3 and A4) are indicated in the standard (panel C).
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Genome mining approaches applied to Streptomyces have in the past revealed an array of novel
natural products exhibiting anti–bacterial, anti–fungal and also new terpene classes (Corre
et al., 2008); (Chou et al., 2010); (Seo et al., 2011); (Nakano et al., 2011). Genomic analysis of SM8
has revealed the presence of several secondary metabolism gene clusters, some of which are
for known metabolites such as antimycin and gramicidin but has also shown clusters whose
functions are as yet unknown. Most of the clusters that were identied were similar to clusters
of unknown function from Streptomyces sp. S4. Transcriptional analyses revealed that several
of these clusters of unknown function were being actively expressed (i.e. not strictly silent
or cryptic). The metabolites of these unknown clusters can in some cases be predicted after
closing the gaps between the contigs as has been described for one of the clusters in SM8.
Two generic approaches that can be employed for determining the function and products of
the other clusters are either gene knockout based approaches or approaches involving het-
erologous gene expression. In SM8, we have used a gene knockout approach to target the an-
timycin cluster and have demonstrated that the observed anti–fungal activity is likely being
contributed not only by antimycin but also by some other metabolites. Hence the same strat-
egy could be employed to allow the identication of metabolites being produced by cryptic
clusters and comparative metabolic proling by LCMS could be used to deduce the metabo-
lites. Such an approach has previously been used by researchers to show the involvement
of a novel Type III PKS in the assembly of germicidin by S. coelicolor. Deletion of one of the
PKS genes from S. coelicolor M145 and comparative LCMS proling showed that the mutant
strain failed to produce germicidin (Song et al., 2006). The heterologous expression approach
involves the cloning of an entire cluster in a BAC or cosmid vector and the introduction of
this cluster into an appropriate heterologous host. LCMS analysis of extracts can then lead to
the identication of new metabolites that are most likely the products of the heterologously
expressed biosynthetic pathways. This approach has previously been successfully employed
to study the production of the antibacterial compound CBS40 (Hornung et al., 2007).
Some additional strategies that can be employed to uncover silent or cryptic biosynthesis clus-
ters involve the so called “genomisotopic approach” and “in vitro reconstitution approach”.
The isotopic approach involves the feeding of the organism with isotope–labelled precursors
and screening extracts using 2D NMR experiments. The labelled metabolites can then be pu-
ried and further characterised. A novel macrocyclic lipopeptide has been identied in P.
uorescens Pf-5 using this approach (Gross et al., 2007). The in vitro approach involves incu-
bating substrates with the recombinant puried enzyme and then determining the structures
of the resulting products. A novel terpene, epi–isozizaene has been determined by using this
strategy (Lin et al., 2006). Both approaches have limitations however, the rst approach being
somewhat limited due to diculties involved with high throughput NMR, whereas the sec-
ond approach requires cloning, expression and purication and may only be useful for simple
one enzyme systems. Hence more generic approaches should be employed for identifying the
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metabolites produced by the cryptic clusters in SM8.
A more recent generic approach includes the overexpression of the regulatory genes. One
study has used constitutive overexpression of a LAL (Large ATP binding of the LuxR) regu-
lator that triggered the expression of a Type I PKS gene cluster in S. ambofaciens that led to
the identication of four 51–membered glycosylated macrolides, subsequently named stam-
bomycins A–D as metabolic products of the gene cluster with anti-tumor activity. This study
represents the largest macrolides ever to be isolated from an actinomycete (Laureti et al.,
2011). Another group has used a deregulation approach where they revealed S. ambofaciens
to be a producer of kanamycin biosynthesis which was known to produce an anti-bacterial
compound. This was achieved by deleting the late regulator AlpW and metabolic proling
concluded that the regulation was by a key late repressor of the cellular control in kinamycin
biosynthesis (Bunet et al., 2011). In addition various factors such as the size of the gene cluster,
the expression of the cluster in laboratory cultures and the accuracy of the products deduced
by the bioinformatics analyses also need to be considered when choosing the best strategy to
identify the metabolites produced by the cryptic clusters.
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Chapter 7
Discussion
Marine Biotechnology is the application of biological knowledge together with cutting–edge
technologies to help develop products and other benets for humans from various marine
sources. The market for marine-related applications is still at its early stages and currently
accounts for only a relatively small percentage of the overall economy in the biotechnol-
ogy market. According to a recent report by Global Industry Analysts, Inc., (http://www.
strategyr.com/), the global marine biotechnology market is estimated to reach US$4.1
billion in 2015. Marine based biosources have the potential to make a signicant impact on
the overall socio-economic status worldwide. Hence many countries have relatively recently
initiated marine biotechnology programmes to explore and ultimately exploit their marine
resources in a sustainable manner. Ireland for example initiated a Marine Biotechnology pro-
gramme in 2008 to develop innovative research by employing Ireland’s extensive marine
biological resources.
Ireland’s seas are potentially a major source of organisms with biotechnology potential and
given that they contain ~90 million hectares of water, the biological diversity likely to be
present within Irish water is quite high. Marine sponges which have been harvested from
Irish waters form the focus of this study, whereby the microbial diversity has been assessed
together with attempts to explore the chemical diversity of these sponges using both culture
dependent and independent approaches.
Marine sponges are ancient metazoans that play a vital role in marine ecology. The microbe-
sponge symbiotic biology is as yet not well understood. Recent studies have however iden-
tied functional genomic signatures such as protein-protein interactions through ankyrin
and tetratricopeptide repeat proteins that begin to explain possible mechanisms by which
sponges may be able to discriminate between bacteria as a potential food source and bacterial
endosymbionts (Thomas et al., 2010).
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Bacteria associated with marine sponges have previously been shown to be a rich source of a
diverse range of chemical classes with bioactive properties including amino acid derivatives,
aromatic compounds, alcohols, fatty acids, lactones, polyacetylenes, polyketides, peptides,
quinones, quinolones, sphingolipids, sterols, terpenoids and terpenes (Cragg et al., 2009);
(Sashidhara et al., 2009); (Leal et al., 2012).
Initial experiments were focused on assessing the bacterial diversity and exploiting the po-
tential of two Irish coastal marine sponges, A. fucorum and E. major as potential sources of
novel chemicals with bioactive properties. Proteobacteria were identied as the dominant
group which is similar to reports from other culture-dependent studies in sponges such as
Haliclona simulans (Kennedy et al., 2008); (Jiang et al., 2007). Culture–dependent studies on
the sponge Ircinia strobilina have revealed the dominance of both α and β-Proteobacteria,
with an increase in the levels of Bacteriodetes being observed when the sponge is cultivated
in an aquaculture system (Mohamed et al., 2008). Another study has reported the dominance
of γ-proteobacteria and Firmicutes in the marine sponge, Gelliodes carnosa, collected from
the waters of South China (Li et al., 2011). Another interesting nding from these studies is
the low number of Actinobacteria isolated from both Ircinia strobilina and Gelliodes carnosa
in comparison with other studies (Kennedy et al., 2009); although it should be noted that
the targeted isolation of Actinobacteria was not carried out here, as in many of the other
studies. For example; Xi and his co–workers recovered 90% of actinobacteria isolates from
the sponges collected from the South China Sea and the Yellow Sea. They also reported that
water agar (M5) medium was the best isolation media in terms of both selectivity and yield
(Xi et al., 2012). One other study used culture-dependent approaches to specically screen
for Gram–positive bacteria associated with Antarctic sponges. They used 10 dierent me-
dia and recovered 52% of isolates belonging to Actinobacteria (Xin et al., 2011). The study
herein also identied eight Pseudovibrio isolates as producers of antibiotics. These ndings
are in keeping with other studies which have identied members of the Pseudovibrio genera
are potentially important future targets for the isolation and identication of novel bioactive
molecules (O’Halloran et al., 2011); (Santos et al., 2010); (Kennedy et al., 2009). Thus a target-
based approach to specically cultivate fast-growing Pseudovibrio sp. may prove useful for
the identication of new metabolites.
The diversity studies resulted in the identication of four potential novel species from both
sponges when the 16S rDNA sequences were analysed with BLAST. It was observed that
the sequences were only 97% or less identical to already known species. Hence phenotypic,
biochemical and phylogenetic studies were subsequently employed on one of these species
which identied that the novel species belongs to the genus Aquimarina isolated from the
sponge Amphilectus fucorum. The major fatty acid present in this type strain is iso 3-OH C17:0
(38.4%) and the percentage of this fatty acid is the highest so far identied in any Aquimarina
type strain. This together with the presence of other fatty acids which were present at levels
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greater than 10% such as iso-C15:0 (12.2%), iso 3-OH C15:0 (10.1%) and iso-C17:1 ω9c (11.8%)
makes the strain a novel species which has now been described as Aquimarina amphilectae
sp. nov. Accessing the bacterial diversity of these marine sponges has therefore provided us
with insights into some novel species, and has also provided further clues whereby we can
learn how best to cultivate novel bacteria from these particular sponges.
Next-generation sequencing techniques can also provide valuable insights into the micro-
bial populations in marine sponges, with pyrosequencing techniques revealing both sponge-
specic novel genera and species. A recent study which compared the use of both culture-
dependent and culture-independent approaches to assess the microbial populations in two
Irish marine sponges namely Raspailia ramosa and Stelligera stuposa reported that while only
four bacterial phyla could be recovered through culture-dependent strategy; ten phyla could
be identied through culture-independent approaches by targeting the V1-V3 region of the
16S rRNA of the sponge metagenomic DNA (Jackson et al., 2012). Another study involving
the spongeAxinella corrugata has also used pyrosequencing technology to identify novel taxa,
with 24% of approximately 65,550 rRNA sequences not matching any bacteria at the class
level indicating they could represent novel taxa (White et al., 2012). Another study has also
shown how pyrosequencing can be applied to identify sponge specic bacterial communities
(Schmitt et al., 2011).
7.2 Calcineurin assay
Work presented in Chapter 4 focussed on the identication of novel inhibitors targeting sig-
nalling pathways in yeast using a high-throughput reporter-gene based assay. The assay
developed was a microtitre plate assay based on a yeast reporter strain, S. cerevisiae. A plas-
mid pMRK212 carrying a CRZ1::lacZ fusion was transformed into the yeast. For the assay,
the transformed strain was grown overnight and the calcineurin pathway was initiated by an
alkaline stress after the cells were incubated with the test extracts. The cells were lysed fol-
lowed by the addition of ONPG. The reaction was stopped by the addition of sodium carbonate
following development of a yellow colour in the positive control. An absence of the yellow
colour indicates that it could be a possible inhibitor. The cells were then measured in the plate
reader. Hence a simple, sensitive, reproducible and rapid assay system was developed which
can facilitate the screening of more than 1000 compounds in a day. The assay was validated
using a reporter-geneGFP::CRZ1 fusion to demonstrate the localization of the reporter protein.
The construct demonstrated the sub–cellular localization of the Crz1p protein and visualized
the GFP::Crz1p fusion protein in yeast cells by uorescence microscopy (Polizotto & Cyert,
2001). A pilot screen of 81 bacterial extracts revealed the presence of a butenolide compound
in an extract from Streptomyces strain SM8 that demonstrated calcineurin inhibition. Future
studies such as the interleukin-2 assay (IL-2) and cytotoxicity analysis would be required to
conrm the ecacy of the compound. As calcineurin activates the T cells of the immune sys-
tem, drugs which act as calcineurin inhibitors (CNI) are administered to immunosuppressive
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patients. Studies have revealed that calcineurin-dependent IL-2 is required for regulatory T-
cells (Treg) in vivo. Hence modication of the Treg function by immunosuppressant drugs
(such as CNI) can be of clinical importance (Zeiser et al., 2006). The mechanism involving
the Ca2+/calcineurin pathway is conserved between yeast and mammalian cells (Rusnak &
Mertz, 2000). Hence the inhibitors identied in our study should be further tested in mam-
malian system and could thus be the subject of further characterisation.
Following screening of a Haliclona simulans metagenomic library, eight clones were puta-
tively identied which appeared to display calcineurin inhibition in the aforementioned newly
developed assay system. Following sequencing of one of the clones–HS02P13, it appears
likely that it may encode a gene encoding an exchanger protein. The clone when analysed in
BLASTx displayed 29% identity to a sodium-calcium exchanger protein. The BLAST search
did not show similarities to any of the known calcineurin inhibitor genes such as MCIP 1 and
MCIP 2 that have shown calcineurin inhibition in striated muscles (Yang et al., 2000). The
precise reason behind the observed inhibition in our study is unclear but due to the fact that
in a BLASTx search it displayed similarities to a sodium-calcium exchanger protein then it
could be removing calcium from the cells which is required for the calcineurin activity. So
the inhibition being displayed in the assay may in fact be an artefact of the system. Enzolife
Sciences in 2009 have developed a calcium assay kit for microplates called Fluoforte, which
detects the mobility of intracellular calcium using a urogenic binding dye that undergoes an
electronic change when calcium is bound which results in a higher magnitude of uorescence
(Martin et al., 2004).
Hence, the HS02P13 clone needs to be further evaluated in a calcium binding assay such as
this to conrm that the observed calcineurin inhibition is in fact real. The fact that the H.
simulans metagenomic is maintained in E. coli, may in part be responsible for the lower than
expected success rate in isolating clones from the library which are exhibiting calcineurin in-
hibition. This may result from the potential poor expression of genes derived from the sponge
metagenomic DNA in E. coli. Hence the use of other expression hosts such as S. lividans may
result in better expression levels being observed and thus a potential larger number of clones
exhibiting calcineurin inhibition. Studies have previously shown S. lividans to be a better host
when compared to E. coli in soil metagenomic libraries so the same may be true for sponge
libraries. Scientists from the US constructed a soil metagenomic library in both E. coli and S.
lividans and a functional screening revealed many clones which exhibited hemolytic activ-
ity only in S. lividans and not in E. coli (McMahon et al., 2012). Another expression system
that could be potentially useful for cloning larger DNA fragments is the pCCERI that has the
property to be conjugated into alternative hosts and also increase the expression levels of the
insert in the host (Dunlap et al., 2011).
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The identication of novel antimicrobials produced by bacteria associated with the marine
sponge, Haliclona simulans was the focus of Chapter 5. One of these isolates Streptomyces
sp. SM8 displayed antimicrobial activity against all the strains tested, (namely C. albicans, C.
glabrata, S.cerevisiae, K. marxianus, A. fumigatus, B. subtilis and P. aeruginosa). A number of
dierent culture conditions were then employed in an attempt to dene growth conditions
which would allow maximal production of the antimicrobial compounds. A 3 fold increase in
the production of bioactive compounds was observed when a medium comprising of oatmeal
and articial sea water was employed when comparison to the SM8 culture grown in SYP
medium and articial sea water. Culture conditions are known to aect antibiotic production
in Streptomyces species with numerous examples in the literature including dierent carbon
and nitrogen sources aecting for example production of the nonpolyenic macrolide antibi-
otic AK-111-81 by Streptomyces hygroscopicus 111-81 (Gesheva et al., 2005). Another study has
shown mannitol and asparagine as optimal carbon and nitrogen sources for the eective cul-
tivation and the production of the antibiotic production in Streptomyces sp. 201 (Thakur et al.,
2009). While a recent study has optimized the carbon and nitrogen sources for the production
of a protease in the marine-derived Streptomyces carpaticus (Haritha et al., 2012).
Other recent studies have reported that optimising culture conditions can lead to an improved
production of targeted bioactives, for example; in Pseudonocardia sp. VUK-10, an enhanced
production of the bioactive compounds was observed when the strain was grown in modied
yeast extract-malt extract-dextrose compared to the other media such as the starch-caesin
broth and the tyrosine broth (Usha Kiranmayi et al., 2011).
Marine Streptomyces are a potential source of novel bioactives exhibiting a broad spectrum of
activities. There are many examples in the literature one of which is from an Indian group
who identied four isolates of Streptomyces sp. that showed antagonistic activity against sh
pathogens such as Vibrio sp. and Aeromonas hydrophila. Thin layer chromatography and
spectral analysis showed that the compounds were polyene in nature and could be a promis-
ing antibiotic lead (Dharmaraj & Sumantha, 2009). Another study investigated a crude extract
of a marine sediment-derived Streptomyces avidinii strain SU4 which showed characteristics
of a cytotoxic compound. The crude extract of the isolate exhibited a cytotoxic activity of
64.5 µg/ml against a Hep–2 cell line proving that this marine Streptomyces isolate is a poten-
tial source of a novel anticancer compound (Sudha & Masilamani, 2012). Our study which
employed biochemical based approaches resulted in the identication of an array of antimi-
crobial compounds which included a hydroxylated fatty acid, antimycins, butenolides and an
as yet unknown compound of m/z 227. It has been recently shown that fatty acids exhibit
anti-bacterial activity (Mohamad et al., 2009); (M. Pereira et al., 2011). In the case of these stud-
ies the fatty acids that were observed belong to the unsaturated class of fatty acids. However,
in our study, with the fragmentation pattern in NMR, the bioactive compound was identi-
ed as a saturated fatty acid. Hence, this is the rst report of a saturated fatty acid exhibiting
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anti–bacterial activity. The exact mechanism of the antimicrobial action of fatty acids remains
unclear; however, the main target appears to be the cell membrane. There has been a sug-
gestion that fatty acids may act by disrupting the electron transport chain or interfere with
oxidative phosphorylation, or alternatively may lead to increased uidity of the membrane ul-
timately leading to instability and cell lysis (Desbois & Smith, 2010). In fact a recent study has
shown that specic fatty acids can inhibit the growth of Staphylococcus aureus by disrupting
the cytoplasmic membrane which allows metabolites and low molecular weight proteins to
leak from the cell (Parsons et al., 2012). A newer class of antimycin compounds have recently
been identied from dierent marine Streptomyces. Scientists from China have identied two
new antimycin analogues (A19-A20) from the marine actinomycete, Streptomyces antibioti-
cus H74–18 (Xu et al., 2011). Another group from China also identied two new antimycin
A analogues (B1 and B2) from the fermentation broth of a marine-derived Streptomyces lusi-
tanus which showed anti-bacterial activities against S. aureus and L. hongkongensis (Han et al.,
2012). In this current study we identied antimycins that showed anti-fungal activity against
C. albicans, however, we could not determine the class of antimycins in our marine Strepto-
myces strain SM8 due to an inability to isolate sucient quantities of the antimycin material
for analyses. Hence, an important future goal for this work would be to determine physio-
logical parameters which induce synthesis of these antimycins, such that sucient qualities
of these bioactive molecules could be obtained to allow future structural elucidation studies
to be undertaken.
It is widely accepted that currently available extraction techniques for the isolation of bioac-
tives from marine environments need to be improved, as traditional techniques tend to pro-
duce low yields, present low selectivity, consume high volumes of solvents and involve long
extraction times. Many of the traditional techniques such as soxhlet, solid–liquid extraction
(SLE), or liquid-liquid extraction (LLE) are also not automated and hence reproducibility can
also sometimes be compromised. Therefore there is an ongoing need to develop and combine
cost–eective, selective and environment-friendly techniques as a solution to the aforemen-
tioned problems. Recently a number of new techniques have been implemented to overcome
some of the above mentioned problems. A group in Spain have recently reported the use of
Supercritical uid extraction (SFE) to obtain and stabilize natural vitamins from red pepper
by-products. They used supercritical carbon–dioxide and demonstrated that this method in-
creased the yield of Vitamin-E by 97% (Romo-Hualde et al., 2012). Another group from the US
have developed a technique called accelerated solvent extraction (ASE®) or Pressurized liquid
extraction (PLE) wherein they identied a series of novel sesquiterpenes from the extracts of
ve marine sponges. This was achieved by comparing the extraction procedures of the con-
ventional Kupchan approach to the ASE and comparing the metabolic proling using parallel
HPLC (Johnson et al., 2010). Scientists from Singapore have used pressurized hot water for
solvent extraction in numerous samples involving food analysis, soil sediments and other en-
vironmental samples. They reported that the extraction of certain compounds is dependent
on pressurized water (PHWE) with dierent applied temperatures (Teo et al., 2010). Another
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study used Ultrasound-assisted extraction (UAE) to extract carnosic acid and rosmarinic acid
from plant samples using an ionic liquid based, ultrasound-assisted extraction technique (Zu
et al., 2012). While a Microwave–assisted extraction (MAE) followed by HPLC has recently
been developed by Italian researchers where they have quantitatively analysed the levels of
the mycotoxin, ochratoxin A (OTA) in commercial roasted coee beans (Graziani et al., 2012).
Hence, it appears likely that some of these approaches could be successfully developed and
subsequently employed to improve the extraction eciency of bioactive compounds from
marine microorganisms.
It is clear that extraction procedures to be employed for the isolation of bioactive molecules
should be selected based on the nature of the compounds to be isolated. Various parameters
that can inuence the extraction process include temperature, pH and salt. All extracts should
be tested using functional assays before they enter the purication stage. Another strategy
that has been successfully employed for the identication of novel bioactives which facili-
tates an increase in the yield of the product/metabolite under investigation is the use of co–
culturing (Penttinen et al., 2006); (Hu et al., 2011). One of the best examples of this approach is
the improvement in enzyme production when both A. niger and A. oryzae were co–cultivated
with each other and with M. grisea or P. chrysosporium respectively. An increased enzyme
activity was observed in A. oryzae for β–glucosidase, α–cellobiohydrolase, β–galactosidase,
and laccase in combination with other fungi, in particular with P. chrysosporium. Scientists
from Korea identied an active anti-fouling compound named diterpene from a marine Strep-
tomyces strain PK209 and they reported that the yield of diterpene increased 10.4 fold when
the marine strain was co–cultivated with Alteromonas sp. KNS-16 (Cho & Kim, 2012). An-
other study from China achieved an increased degradation of cypermethrin by co–culturing
Bacillus cereus ZH-3 and Streptomyces aureus HP-S-01, reporting that the half-lives in pure
cultures were longer than the mixed cultures (Chen et al., 2012). These reports provide exam-
ples whereby the overall levels of bioactive material being produced by the microorganism,
which continues to be a bottleneck in the identication of the bioactive compounds; may be
increased through approaches such as co-culturing techniques, which together with the opti-
misation of both extraction process and purication strategies may help overcome this impor-
tant bottleneck. A combination of these renements could facilitate a more robust pipeline
by ultimately helping in the more rapid identication of novel bioactives thereby facilitating
with dereplication strategies in the overall biodiscovery process.
7.4 Genome mining studies
Genome sequencing can provide a platform by which it is possible to both detect and poten-
tially predict the nature of the metabolites being produced by any bacterial species. Hence
Chapter 6 focussed on the identication of biosynthetic pathways potentially involved in
metabolites production in the SM8 strain. Genome sequencing and subsequent genome min-
ing of SM8 revealed nine secondary metabolic clusters potentially involved in antibiotic pro-
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duction in the strain. Some of these clusters are likely to be involved in the production of
known metabolites such as antimycin and gramicidin whilst some have as yet unknown func-
tions with high similarity (97-99% nucleotide match) to clusters found in other Streptomyces,
particularly Streptomyces sp. S4 (Seipke et al., 2011b); (Seipke et al., 2011a). Transcriptional
analysis revealed the expression of gramicidin, antimycin, one unknown NRPS and two hy-
brid clusters. As mentioned earlier, the strain was grown for 12 days in both SYP and OM
containing articial sea water and the bioactive compound(s) were extracted in an attempt
to correlate the observed activities with that of the gene-expression studies. It was found
that the anti–fungal activity was highest on day 6 and while reduced thereafter remained
constant after day 8 in SM8 cultures grown on OM medium. But in SYP, however the ob-
served activity was similar on days 2 and 4 but decreased gradually thereafter. With respect
to anti-bacterial activity, the observed activity was similar to the anti-fungal activity on the
OM growth medium but in SYP, activity was only observed only on days 2 and 4; suggesting
that OM may be a better growth medium for anti-bacterial metabolite production than SYP.
The biochemical analyses performed in Chapter 5 had shown that antimycins are one of
the metabolites involved in anti–fungal activity which was consistent with gene–expression
studies. It can be hypothesised that the metabolites produced by some of the other clusters
(NRPS3 and Hybrid 2,3) may be contributing to the anti-fungal activity. The other hypothesis
is that the anti–bacterial activity could be contributed by the unknown NRPS3, unknown Hy-
brid3 and antimycin gene clusters expressed by SM8. The genome of SM8 was interrogated
to identify biosynthetic pathway that may be involved in the biosynthesis of butenolides.
Butenolides are a class that include a family of α, β and γ unsaturated lactones. Recent stud-
ies have reported that the most characterised γ-butyrolactone autoregulators are A–factor,
methylomycin furan (MMF) and avenolide in the avermectin biosynthetic pathway in Strep-
tomyces avermitilis (Kitani et al., 2011). We searched for the homologue of the existing class,
the γ-butyrolactone autoregulator receptor protein, consisting of avaR1, avaR2, avaR3 and
two genes aco and cyp17 in the SM8 genome using BLASTx but no signicant matches were
obtained. It should be noted that the butenolides found in SM8 appear to belong to a family
of α, β–unsaturated lactones for which no biosynthetic pathway have so far been identied.
Hence without further experimental data it is not possible to identify genes that may be in-
volved in the biosynthetic pathway of this family of butenolide compounds.
One of the unknown clusters, namely hybrid cluster3 in SM8 that showed high levels of tran-
scription was further analysed in an attempt to predict the metabolite(s) being produced from
this cluster. Genomic analysis of Streptomyces sp S4 also resulted in the identication of many
putative antibiotic biosynthetic pathways (Seipke et al., 2011a). The unknown hybrid cluster3
from SM8 was found to be 98% identical to the Streptomyces sp S4, a single ant symbiont that
produced multiple anti–fungals. Based on this level of similarity, it can be predicted that the
unknown cluster could be involved in the production of a novel antibiotic. After closing gaps
in the available SM8 DNA sequence by PCR, it was possible to predict potential secondary
metabolites genes using several bioinformatics tools. An unusual AT domain signature was
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identied that could be an integrated (cis) AT acting as a discrete (trans) AT. If this is the
case then this would be the rst report to date of this type of AT signature as it does not be-
long to the four types of discrete AT architecture that have been identied to date in bacteria
(Musiol & Weber, 2012). As antimycins were identied both in the biochemical and genomic
analysis, it was decided to perform a gene knockout of the antimycin cluster in SM8, to de-
termine whether the observed anti–fungal activity was in fact due to the product(s) of this
cluster. A subsequent metabolic prole of both the SM8 wild type and antimycin mutant
conrmed that the mutant had lost the ability to produce antimycin. Due to the fact that an-
timycin production had been lost in the mutant and that the observed anti–fungal activity was
not completely abolished in the strain, this suggested that some other metabolite(s) may be
contributing to the activity. To identify the additional clusters involved in the bioactivities,
various approaches such as gene knockout, heterologous gene–expression and overexpres-
sion of regulatory genes could be implemented. Examples of where such approaches have
been successfully employed include the study demonstrating the repression of antibiotic pro-
duction and sporulation in S. coelicolor when the TetR family transcriptional regulator was
overexpressed by a collaborative approach from scientists from the US and South Korea (Lee
et al., 2010). Another example includes the enhanced production of daptomycin, an antibiotic,
by overexpressing the accessory genes anking the NRPS genes responsible for daptomycin
production in S. roseosporus (Yu, 2012). Some of the other strategies which could be employed
to identify the metabolites responsible for the observed anti–fungal activity in SM8 include
regulating the transcriptional control by various parameters such as carbon and nitrogen
source, pH, temperature and also the addition of transcriptional regulators such as (LysR and
DeoR family), photoreceptors (REC) and transcriptional regulators with other DNA binding
domains (AraC, Spo0A, Fis) (Bromann et al., 2012). Recently a group from Korea has used
genome–based functional discovery of cryptic genes using MS–guided bioinformatic analy-
sis of genomic sequences (Park et al., 2012), which could also prove a useful approach with
respect to SM8. Thus genome mining has not only helped in the identication of secondary
metabolic pathways but has also given us an insight into the overall genetic make-up of the
strain which can be helpful for the discovery of cryptic pathways and also the identication
of novel compounds/bioactives.
7.5 Conclusions and future prospects
This study has resulted in the development of a high throughput assay which may prove
useful in the identication of calcineurin inhibitors and which may nd utility in the marine
biotechnology research community as a whole. In addition preliminary genome scanning ap-
proaches of the marine isolate Streptomyces SM8 have identied several potential secondary
metabolism gene clusters that could be involved in the synthesis of novel antibiotics. Genome
mining has also identied several silent clusters whose expression needs to be up-regulated
so that the nature of the metabolites can be identied. Both chemical analysis and genome
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analysis which has been employed on Streptomyces strain SM8 have proven to be success-
ful in allowing the discovery of a wide array of bioactives which may be potential future
biopharmaceutical applications.
In my opinion, the best pipeline for drug discovery when culture–dependent approaches are
being employed is that following initial screening of the isolate to determine bioactivity, the
genome of the strain should then be sequenced and subsequently analysed. Whole genome
analysis based approaches thus allow for a signicant improvement in the overall understand-
ing of the biosynthetic pathways in the producing bacterium, thereby facilitating approaches
whereby these pathways can be genetically manipulated to allow the subsequent identica-
tion of the relevant novel biocompound(s); while also allowing for approaches to be employed
to allow for increased levels of production of these compounds in either the host strain or in
heterologous host systems.
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